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Summary 
 
The endoplasmic reticulum (ER) has a distinct morphology, which is formed of sheets and 
tubules. These different domains are devoted to diverse functions such as co-translational 
protein translocation, lipid synthesis, protein folding, quality control and transport of proteins and 
lipids to different organelles. Close contacts of the ER with other organelles promote survival 
and growth of cells. The contacts with the plasma membrane (PM) are essential for lipid 
transport and Ca2+ signalling.  
 
A component of the cortical ER in yeast is the polytopic membrane protein Ist2. Sorting of Ist2 
into the cortical ER depends on its cortical sorting signal (CSS), which directly binds PM-lipids. 
Since it was unknown whether Ist2 remains in the cortical ER or travels to the PM by an 
unconventional pathway, I investigated the localization of Ist2 in mammalian cells. I found that 
Ist2 resides in the ER, where it forms peripheral domains that are in close proximity of the PM. 
In order to further investigate the features of the peripheral ER structures, I tagged mammalian 
type 1 membrane proteins with the CSSIst2 and analyzed their localization. As a consequence of 
the interaction of CSSIst2 with the PM-lipids, all tested chimeras were recruited to peripheral ER 
structures. Moreover, I demonstrated that these peripheral ER domains are static and in 
continuity with the rest of the ER.  
 
Besides yeast Ist2, mammalian STIM1 and STIM2 proteins, are capable of forming ER-PM 
contact sites. STIM proteins function in signal amplification during store-operated Ca2+ entry. 
They sense the ER Ca2+ levels by their N-terminal EF-hand domains and upon depletion of ER 
Ca2+, they multimerize and form ER-PM contact sites. At these sites they interact with and 
activate the PM Ca2+ channel, Orai1. I investigated the molecular mechanism behind this ER-
PM contact site formation. By in vitro liposome binding experiments, I showed that both STIM1 
and STIM2 cytosolic C-termini bind to PM-lipids via their lysine (K)-rich domains. Taken 
together, I found that the formation of ER-PM contact sites is dependent on expression of a 
transmembrane protein with a PM-lipid binding signal. 
 
Finally, since STIM1 was previously shown to localize to the cell surface, I focused on its ER-
retention mechanisms. I identified two types of mechanisms. In the first mechanism, the ER-
retention is achieved by multiple di-arginine signals. The second mechanism is dependent on 
cytosolic Ca2+ levels. I found that depletion of cytosolic Ca2+ promoted trafficking of STIM1 to 
the cell surface, where it may activate Orai1. I propose that STIM1 indirectly senses the 
cytosolic Ca2+ via its K-rich domain, which binds to Ca2+/calmodulin. Thus, STIM1 integrates the 
Ca2+ signals in the ER and the cytosol.   
 
Zusammenfassung 
 
Das endoplasmatische Retikulum (ER) ist in seiner Morphologie verschiedenartig. Es setzt sich 
aus plattenförmigen und tubulären Strukturen zusammen. Die verschiedenen Domänen des 
ERs erfüllen vielfache Funktionen u.a. in der kotranslationalen Proteintranslokation, der 
Lipidsynthese, der Qualtitätskontrolle und dem Protein- und Lipidtransport zu unterschiedlichen 
Organellen. Das ER steht in engem Kontakt mit anderen Organellen, um Überleben und 
Wachstum einer Zelle zu gewährleisten. Zusätzlich bildet das ER Kontakte mit der 
Plasmamembran (PM) aus. An diesen Kontakten finden Lipidtransfer und Kopplung von Ca2+-
Signalen statt. 
 
Eine Komponente des kortikalen ERs in der Bäcker-Hefe ist das integrale Membranprotein Ist2. 
Die Sortierung von Ist2 in das kortikale ER erfolgt mit Hilfe seines kortikalen Sortierungssignals 
(CSS), das an Lipide der PM bindet. Da bisher nicht bekannt war, ob Ist2 im kortikalen ER 
verbleibt oder durch einen unkonventionellen Weg zur Plasmamembran gelangt, habe ich die 
Lokalisation von Ist2 in mammalischen Zellen untersucht. Meine Ergebnisse demonstrieren, 
dass Ist2 das ER nicht verläßt und dort periphere Domänen ausbildet, die in enger 
Nachbarschaft zur PM liegen. Um die Merkmale dieser peripheren ER-Strukturen weiter zu 
analysieren, habe ich mammalische Typ1-Membranproteine mit dem CSSIst2 markiert und deren 
Lokalisation untersucht. Durch die Interaktion des CSSIst2 mit Lipiden der PM wurden alle 
getesteten Chimären zu den peripheren ER-Strukturen rekrutiert. Weiterhin konnte ich zeigen, 
daß diese peripheren ER-Strukturen statisch und mit dem restlichen ER verbunden sind. 
 
Neben dem Hefeprotein Ist2 sind die mammalischen Proteine STIM1 und STIM2 ebenfalls in 
der Lage, ER-PM-Kontaktstellen zu bilden. STIM-Proteine haben ihre Funktion in der 
Signalverstärkung während des Speicher-abhängigen Ca2+-Eintritts. Sie erkennen Ca2+-
Konzentrationen durch ihre N-terminalen EF-Hand-Domänen. Nach Ca2+-Depletion des ERs 
multimerisieren sie und formen ER-PM-Kontaktstellen, an denen sie mit dem Ca2+-Kanal der 
PM, Orai1, interagieren und diesen aktivieren. Darüber hinaus habe ich den molekularen 
Mechanismus der Ausbildung von ER-PM-Kontaktstellen aufgedeckt. Durch in vitro Liposomen-
Bindungsstudien habe ich gezeigt, dass die C-Termini von STIM1 und STIM2 mittels ihrer Lysin 
(K)-reichen Domänen an Lipide der PM binden. Diese Ergebnisse verdeutlichen, daß die 
Ausbildung der ER-PM-Kontaktstellen von der Expression einen integralen membranenprotein 
mit einem PM-Lipid-Bindungssignal abhängig ist.  
 
Da für das STIM1-Protein bereits eine Lokalisation an der Zelloberfläche demonstriert worden 
war, habe ich seine Retention im ER untersucht. Dabei konnte ich zwei Mechanismen 
identifizieren. Der erste Mechanismus beruht auf dem Zurückhalten des STIM1-Proteins im ER 
über mehrere Di-Arginin ER-Retentionssignale. Der zweite Mechanismus ist abhängig von der 
cytosolischen Ca2+-Konzentrationen. Meine Ergebnisse zeigen, dass die Depletion von 
cytosolischem Ca2+ den Transport von STIM1 an die Zelloberfläche fördert, wo STIM1 Orai1 
aktiviert. Ausgehend von meinen Daten erkennt STIM1 indirekt das cytosolische Ca2+ durch 
seine K-reiche Domäne, die Ca2+ im Komplex mit Calmodulin bindet. Somit integriert STIM1 
Ca2+-Signale im ER und im Cytosol. 
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1 Introduction 
 
The eukaryotic endoplasmic reticulum (ER) is an organelle that is devoted to diverse functions. 
These functions include the co-translational translocations of proteins across or into the ER 
membrane, proper folding and modification of proteins, and synthesis of phospholipids and 
sterols. In addition to its functions in synthesis of proteins and lipids, the ER is the major store of 
calcium ions (Ca2+). The ER regulates the release of the Ca2+ into the cytosol and the uptake of 
cytosolic Ca2+.  
1.1  The morphology of the ER 
 
Among all eukaryotic organelles, the ER has a striking architecture, which is made up of distinct 
domains that are devoted to different functions and structures (1). This complex structure can 
be divided into morphologically different regions, which can easily be visualized by fluorescence 
microscopy. The nuclear envelope that separates the nuclear material from cytosol is formed of 
sheet-like structures (2). In continuity with the nuclear envelope, the ER extends throughout the 
cytosol by forming tubular and sheet-like structures (3) (Figure 1.1).  
 
 
 
Figure 1.1 Morphology of the ER. 
(A) COS cells expressing GFP-Sec61β at morphologically distinct ER regions, nuclear envelope (NE), 
peripheral sheets (S) and tubules (T). (B) Magnification of tubular ER structures. Taken from and modified 
after (1). 
 
Initially, the ER was classified as rough ER (RER) and smooth ER (SER) (4). The RER is the 
domain where the ribosomes are attached and the translation of most membrane or luminal 
proteins takes place (5, 6). On the other hand the SER does not contain ribosomes and it 
functions as a transitional domain where the budding of the vesicles and transport of proteins to 
the other organelles occur. Moreover, the SER makes contacts with the other organelles (1, 7, 
8).  
 
A B 
Introduction 
 2 
Since the co-translational translocation of proteins into the ER is essential, RER is the universal 
domain of ER in all eukaryotic cells. SER also has some common roles in all cell types, such as 
the trafficking of proteins. However, the amount of the SER membrane changes according to 
cell type and the activities of SER can vary for different cell types. For instance in muscle cells 
the SER has a role in Ca2+ release and uptake for contraction (Sarcoplasmic Reticulum) and in 
liver cells it is important for detoxification of hydrophobic substances (9). 
1.1.1 Factors that determine the structure of ER 
 
Membranes, which are formed of phospholipid bilayers, are spherical or laminar structures in 
aqueous environment. However, some organelles such as Golgi and ER have distinct and 
complex structures compared to spherical lysosomes and peroxisomes (10). In order to create 
these distinct membrane structures, such as ER tubules and sheets, functions of specific 
proteins are required. These proteins maintain the morphology of the ER by either giving a 
shape by stabilizing the membrane curvature or tethering two membranes to each other or to 
the cytoskeleton (10).  
1.1.1.1 Formation of ER-tubules 
 
Two leaflets of a lipid bilayer have the tendency to remain together. Insertion of a protein only 
into one leaflet can facilitate membrane bending. Membrane-shaping proteins often have a 
common mechanism to induce membrane curvature. This mechanism is the insertion of an 
amphipathic α-helix into the cytosolic leaflet of the membrane (e.g. epsin and dynamin) (11, 12). 
The reticulons and DP1/Yop1 proteins are highly abundant integral membrane proteins that are 
required for the generation of the tubular ER (10, 13). These two classes of proteins are highly 
conserved and are able to homo-oligomerize. They are not only capable of forming networks of 
ER tubules in vivo but also in vitro (13, 14, 15).  
 
Apart from other membrane-shaping proteins, reticulons and DP1/Yop1 have distinct structures. 
They do not have amphipathic helices; instead they contain two approximately 33-amino acid-
long hairpin transmembrane domains (TMDs). These TMDs are too long to span the membrane 
bilayer once, and too short to span the membrane bilayer twice. They indeed are only inserted 
into the cytosolic leaflet of the ER membrane. This insertion of reticulons and DP1/Yop1 results 
in bending of the membrane and consequently generates tubules, which are around 50 nm in 
diameter (13, 16). Moreover, their depletion in yeast and as well in mammalian cells converts 
the ER tubules into sheets and their overexpression results in increased ER tubulation (13, 17).  
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1.1.1.2 Formation of ER-sheets 
 
Peripheral ER sheets are enriched in polyribosomes and complexes for translocation of 
proteins. This enrichment of polyribosomes and large protein complexes, promote the 
generation of a flat ER structure. The studies proved that stripping of the ribosomes from the ER 
membrane by puromycin creates more tubular structures compared to untreated cells (18). In 
contrast, overexpression of p180, a ribosome binding integral ER membrane protein, increases 
the amount of stacked ER sheets (19). Moreover, compared to the ER tubules, the planes of the 
ER sheets contain only little or no reticulon or DP1/Yop1 proteins (1). 
 
A recent study showed that a coiled-coil protein Climp63 serves as a luminal ER spacer and 
thereby helps forming sheets. However, the Climp63 and/or polyribosomes are not sufficient to 
form the ER sheets on their own. Interestingly, reticulons and DP1/Yop1, which are localized to 
the edges of the sheets, play a crucial role in generation of the sheets. It is suggested that 
Climp63 has a role in spacing the luminal space of the ER sheets to accommodate necessary 
chaperone proteins, whereas reticulons and the DP1/Yop1 localize to the edges of the sheets 
and stabilize the high curvature of the edges. Indeed the abundance of reticulon and DP1/Yop1 
is important for determining the whole ER morphology (20). Moreover, the function of reticulons 
and DP1/Yop1 in forming both tubules and sheets is evolutionarily conserved. These proteins 
are present in lower eukaryotes, whereas the Climp63 is not. Again this defines reticulons and 
DP1/Yop1 as the main factors for determining the morphology of the ER (20). 
 
1.1.2 Interaction of ER with the cytoskeleton  
 
The interaction of organelles with the cytoskeleton can facilitate the movement and positioning 
of the organelles in cells and might affect their morphologies. The interaction of microtubules 
with ER can easily be visualized in mammalian cells (21, 22, 23). The ER tubules, which are 
more dynamic than the ER sheets, can co-align with the growing microtubules. In vitro studies 
showed that the distribution and movement of ER but not the tubule formation are achieved by 
the help of microtubules (24). 
 
The ER tubules travel along the microtubules by two different mechanisms (1). The first 
mechanism is the movement of ER by attachment to microtubule tips. In mammalian cells the 
interaction of two proteins, STIM1, which is an integral ER-membrane protein and EB1, a 
microtubule (+)-end binding protein, supports the movement of the ER together with the growing 
tip of microtubule towards the PM (25). The second mechanism is the sliding of the ER along 
the microtubule (1). During sliding, the ER tubules jump onto the shaft of the microtubule 
instead of binding to the growing tip. Kinectin, which is an integral ER membrane protein, is one 
of the proteins that function in the movement of the ER (26, 27). Kinectin interacts with the 
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motor protein kinesin and this allows the movement of the ER along the microtubules (27, 28). 
Moreover, the rate of sliding is found to be faster then tip movement (1, 23).  
 
1.2  Interaction of ER with other organelles 
 
The eukaryotic organelles are separate but interdependent units of the cells. In order to 
communicate and exchange metabolites, they form physical contacts. For instance, the ER 
forms different kind of contacts with the membranes of mitochondria, Golgi, and the PM. These 
interactions have crucial roles in mechanisms such as non-vesicular transport of lipids and Ca2+ 
signalling. Here some of these interactions are briefly described.  
1.2.1 Interaction of ER with mitochondria 
 
The interaction between the ER and the mitochondria is required for cell function and survival. 
These close contacts between these two organelles modulate Ca2+ signalling and provide lipid 
and protein transport (29, 30). The Ca2+ ions that are stored in the ER can be taken up by the 
mitochondria after their release during cell signalling. And the efficiency of this process requires 
a proper spacing between these two organelles. Moreover, during phospholipid synthesis, this 
linkage should be created precisely to provide the lipid transfer between two membranes. The 
proteins, which function in lipid transfer mechanism, remain unknown (31).  
 
Studies on the ER-mitochondria contact sites showed that mitofusin protein, MFN2, which is a 
dynamin-like GTPase functions in formation of ER-mitochondria junctions. Either homo- or 
hetero-complexes of MFN2 at the ER membrane and MFN2 or MFN1 at the mitochondria are 
capable of forming these bridges (32). These contacts have crucial functions in Ca2+ signalling. 
The Ca2+ concentration of the ER is increased around 2-fold in mouse embryonic fibroblasts 
lacking MFN2 (29). Moreover, after release of Ca2+ from the ER resident inositol 3-phosphate 
(IP3) receptors, the uptake of Ca2+ into MFN2-deficient mitochondria was found to be markedly 
reduced. These findings demonstrate the correlation between the ER-mitochondria contact sites 
and Ca2+ uptake into mitochondria. Therefore this juxtaposition of both organelles is crucial 
during Ca2+ signalling (29, 33).  
 
A more recent study revealed that the ER-mitochondria contact sites are formed by a protein 
complex, called ERMES (ER-Mitochondria encounter structure). This complex is formed by at 
least four proteins: Mmm1 (integral ER membrane protein), Mdm12 (cytosolic protein), Mdm10 
and Mdm34 (integral mitochondria outer membrane proteins) (30). The interactions of these 
proteins create ER-mitochondria junctions. Researches until now proposed that ERMES 
function is required for Ca2+ exchange from the ER to mitochondria and mitochondrial protein 
import (30, 34). In addition, this complex also has a role in regulation of lipid transfer from ER to 
the mitochondria (35). 
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In order to regulate mitochondrial morphology and motility, a tailed-anchored mitochondrial 
protein, Gem1 (Miro in metazoans), binds to kinesin motor protein. Gem1 needs to be bound to 
Ca2+ in order to bind kinesin, and release it from the microtubules, (36). This binding to Ca2+ 
occurs at the ERMES-mediated ER-mitochondria contact sites, where the local Ca2+ 
concentration reaches high levels (30) (Figure 1.2).  
 
 
Figure 1.2 Proposed role of ERMES in Ca2+ exchange. 
ER-mitochondria contact sites may create higher Ca2+ concentration compared to other sites of cytosol. In 
turn, Gem1 (Miro in metazoans) binds the Ca2+ ions and regulate mitochondrial morphology and motility. 
Taken from (30). 
 
 
ERMES complex has also been shown to have a role in mitochondrial protein import. Mdm10 in 
addition to its function in ERMES regulates the assembly of β-barrel proteins (such as Tom40) 
by interaction with the SAM (sorting and assembly machinery) complex. Thus suggests a 
crosstalk between the ER-mitochondria junctions and mitochondrial protein import (34) (Figure 
1.3).  
 
 
Figure 1.3 Proposed role of ERMES in mitochondrial protein import. 
Mdm10, which has role in both ERMES complex and SAM complex may regulate the assembly of outer 
mitochondrial membrane β-barrel proteins such as Tom40. Taken from (30). 
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Furthermore, ERMES complex mediates a shorter distance between ER and mitochondria, and 
thereby allows non-vesicular transfer of lipids between ER and mitochondria. This distance 
facilitates the targeting of soluble lipid carrier proteins such as oxysterol-binding protein (OSBP) 
and ceramide-transfer protein (CERT) (30, 37) (Figure 1.4).  
 
 
Figure 1.4 Proposed role of ERMES in phospholipids exchange. 
ER-mitochondria contact sites may facilitate the targeting and shuttling of soluble lipid-carrier proteins 
between two organelles. Taken from (30). 
 
1.2.2 Interaction of ER with Golgi  
 
The ER makes physical and functional contacts with the Golgi. One of these contacts is created 
by apposing of ER and Golgi membrane in order to transport lipids. Another contact is formed 
during vesicular protein transport from ER to Golgi. These two mechanisms will be briefly 
described in the following sections. 
1.2.2.1 Non-vesicular lipid transport 
 
The studies, which investigate the interaction between the ER and the Golgi revealed that 
integral ER membrane proteins VAP-A and VAP-B interact with oxysterol-binding protein 
(OSBP) and ceramide-transfer protein (CERT), which are crucial for phosphoinositide and 
sphingolipid biosynthesis (38, 39). The interaction between VAPs and OSBP and CERT 
promotes non-vesicular lipid transport between two membranes. CERT is a soluble protein, 
comprised of three functionally important domains, which bind to VAP, ceramide and 
phosphoinositide of Golgi (phosphoinositide 4 phosphate, PI4P). The binding to the ER located 
VAPs and Golgi resident PI4P brings two organelles in a close proximity, where the ceramide 
can easily be transported. The transport of ceramide is crucial for the synthesis of sphingolipids, 
which occur in the Golgi (1). The high levels of sphingolipids and glycosphingolipids promote 
the phosphorylation of CERT, which inactivates it and results in the reduction in ceramide 
transport (40) (Figure 1.5). 
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Figure 1.5 Lipid transport at ER-Golgi contact sites. 
CERT functions in ceramide transport from ER to Golgi. CERT binds to ER-localized VAPby its FFAT 
domain and interacts with the Golgi membrane by its PH domain. The START domain binds and transfers 
the ceramide. CERT is inhibited by phosphorylation, which is regulated by the levels of sphingolipids such 
as sphingomyelin (SM) and glycosphingolipids (GSL). Taken from (40). 
                   
1.2.2.2     Vesicular protein transport  
 
Proteins transported across the eukaryotic ER, include soluble proteins that are secreted from 
the cell and membrane proteins that either stay in the ER or reach other organelle membranes 
of the secretory pathway (41, 42). Most membrane proteins are co-translationally translocated 
into the ER through the translocon complex. The translocon, which is a protein conducting 
channel, is formed of the Sec61 complex, which is comprised of the channel forming α and γ 
subunits and the interacting β subunit (41). Translocated proteins start to fold co-translationally 
in the ER lumen. The ER lumen is similar to the extracellular space as it has a high Ca2+ 
concentration of around 500 µM and provides a more oxidizing environment than the cytosol 
(43). Specific set of enzymes and chaperone proteins, which are ubiquitously expressed, assist 
folding of proteins in the ER. In most cases, individual subunits of proteins are folded before the 
assembly into higher oligomeric structures takes place (44).  
 
Protein folding and quality control in the ER 
 
The ER not only provides a suitable environment for folding of proteins but also governs a 
crucial role in quality control. The quality control mechanism primarily depends on ER 
chaperones, which recognize the misfolded intermediates through exposed hydrophobic 
surfaces, immature gylcans or unpaired cysteines (43). As a consequence these misfolded 
proteins are retained in the ER or retrieved back from the Golgi complex. Moreover, immature 
proteins, which form aggregates, are also excluded from vesicles exiting from the ER (43, 45). 
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During the formation of multimolecular protein complexes, ER retention mechanisms indirectly 
control the correct folding and assembly (46, 47). For instance, ion channel subunits contain ER 
retention signals, which are masked by correct assembly of these subunits into a channel and 
this masking promotes exit from the ER. One of these retention signals is the cytosolic di-lysine 
(KKXX) ER retention signal, which is present in several immune receptor subunits (47, 48). The 
proteins with type I topology (the C terminus is in the cytosol), the di-lysine signal is found at -3 
and -4/-5 positions from the C terminus (K(X)KXX) (49). The other retention signal is di-arginine 
ER-retention signal (RXR), which can be positioned nonspecifically at any place of cytosolic 
domains of both type I and type II membrane proteins (50). For example, the quality control 
during assembly of the inward rectifying potassium channel (Kir6.2/Sur1 complex) is achieved 
by these di-arginine ER retention signals (RXR). Both proteins contain RXR motifs and are 
localized to the ER if the channel is not correctly assembled. During the assembly of the 
channel, the RXR signals are shielded and after that the channel can travel through the Golgi to 
the cell surface (51) (Figure 1.6).  
 
Protein transport between ER and Golgi  
 
In order to move further along the secretory pathway, proteins exit the ER either by unspecific 
bulk flow or by selective recruitment into vesicles (52, 53). The proteins that are destined to be 
transported from ER to the other compartments through the Golgi are initially localized to 
specific sites of ER, which are called ER exit sites (54). At the ER exit sites, the cargo proteins 
are loaded into vesicles, which are formed by coatomer coat complex II (COPII). COPII vesicle 
formation at the ER is conserved in eukaryotic cells and requires the small GTPase Sar1, 
Sec23 and the cargo recruiter Sec24 (55). Moreover the Sec13/31 complex is required for the 
stabilization and the polymerization of coat subcomplexes, which provides a membrane bending 
force to allow the formation of COPII vesicle (54). In order to recruit proteins into the COPII 
vesicles, specific amino acid motifs, the so called ER export signals, are required. These signals 
are identified to be acidic in nature and usually have a DXE or EXD motif. This motif is 
recognized by the COPII component, Sec24 (53).  
 
The ER-resident proteins that escape from ER or misassembled proteins are retrieved back to 
the ER from the Golgi via COPI vesicles. COPI vesicles recognize specific signals of soluble or 
membrane proteins. ER-resident soluble proteins that are retrieved back to the ER carry a 
retention signal, which is the KDEL sequence (56). This KDEL signal is recognized by a KDEL 
receptor in the Golgi membrane and retrieved back to the ER (57). 
 
The signals that play a role in retention or retrieval of membrane proteins can be classified in 
two groups: di-lysine and di-arginine signals. The proteins that carry the di-lysine motif are 
recognized by α and β subunits of the COPI coat and thus retrieved back to the ER (58). On the 
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other hand, di-arginine ER retention signal has a more complex feature than the di-lysine signal. 
A combinatorial screening approach by using Kir6.2 C-terminal domain showed that Arg-based 
signals conform to the consensus Φ/Ψ/R-R-X-R, in which Φ/Ψ denotes an aromatic or bulky 
hydrophobic residue and X is any amino acid. The identity of X can modulate the signal, where 
negatively charged residues or small, non-polar side chains inactivate the signal (59) (Figure 
1.6).  
 
 
 
Figure 1.6 Regulated trafficking of inward rectifying potassium channel. 
Both Kir6.2 and Sur1 (small and large rectangular shapes, respectively) have di-arginine retention signal 
(red dot). These proteins are retrieved back from the Golgi via COPI vesicles if they do not form a correct 
assembly. The correct assembly of the channel shields the di-arginine ER retention signals and results in 
exit from the ER by COPII vesicles. Furthermore, with the contribution of 14-3-3 proteins, which may mask 
the retention signals, channel can travel to cell surface. Taken from and modified after (50). 
 
 
1.3  Interaction of ER with the plasma membrane 
 
The ER forms contact sites with the plasma membrane (PM) in order to fulfil various cellular 
functions, such as lipid transfer and Ca2+ signalling. These contact sites are found both in yeast 
and in mammalian cells (60, 61, 62). In the next sections, some of the proteins that are involved 
in formation of ER-PM contact sites will be described. 
 
 
 
COPII 
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1.3.1 OSBP proteins 
 
The sterol concentration in cellular membranes is tightly controlled; for instance, the ER has 
around 5 mol% cholesterol (63) whereas the PM has 30-50 mol% (64). In both yeast and 
mammalian cells, sterols are synthesized de novo in the ER and transported to the PM via non-
vesicular transport pathway. This trafficking is Brefeldin A (BFA) insensitive and requires ATP-
dependent carrier proteins (65). BFA is a drug that blocks the trafficking through the Golgi (66). 
This non-vesicular transport of sterols between membranes is mediated by OSBPs and OSBP-
related proteins (ORPs). These proteins are a conserved family of soluble proteins and are also 
called sterol-binding lipid transfer proteins (LTPs). The OSBP and ORPs are not only capable of 
binding oxysterols, which are the regulators of cholesterol metabolism, but also 
phosphoinositides and many other sterol derivatives, including cholesterol (67, 68, 69).  
 
All ORPs, including the Saccharomyces cerevisiae Osh (OSBP homologue) proteins, harbors 
an OSBP-related domain (ORD). The budding yeast has seven OSBP homologues (Osh). Four 
Osh proteins (from Osh4 to Osh7) consist of only an ORD, whereas the other three contain 
additional domains such as phosphoinositide-binding pleckstrin homology (PH) domain (70). 
Osh family proteins function in trafficking of cholesterol from the ER to the PM, since in vitro 
studies demonstrated that Osh proteins could transfer sterols between the membranes (71, 72).  
 
In addition to their function in sterol transport, the Osh proteins are recently shown to have the 
function of regulating phosphoinositide metabolism at ER-PM contact sites (73). The PH-
domain containing family member, Osh3, is found to localize at the ER-PM contact sites and 
this localization is dependent on the levels of PI4P at the PM, suggesting a role for Osh3 as 
sensor of PI4P of PM and activator of Sac1 (73). Sac1 is a lipid phosphatase, which hydrolyzes 
PI4P. In addition to Osh3, the ER VAP proteins, Scs2/Scs22 control the PI4P levels and the 
activity of Sac1. Osh3, in addition to its lipid-binding PH domain, contains a protein-protein 
interaction domain (FFAT) that binds Scs2/Scs22 (74). Therefore, a proposed model for the 
formation of ER-PM contact sites would be as following: In the presence of high concentrations 
of PI4P at the plasma membrane, the PH domain of Osh protein binds PI4P of the PM whereas 
the FFAT domain binds Scs2/Scs22 in the ER. As a consequence, ER is brought to a close 
proximity of the PM. Following recruitment of the ER to the PM, the ER resident Sac1 binds to 
PI4P and thus regulates the phosphoinositide metabolism (73) (Figure 1.7).  
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Figure 1.7 PI4P turnover at ER-PM contact sites.  
High PM PI4P levels recruit and activate Osh3 at ER-PM contact sites. Osh3 interacts with VAP proteins 
Scs2/Sc22 at the ER membrane by FFAT domain and binds to PM via its PH domain. Sac1 is recruited at 
these contact sites and there it regulates the phophoinositide metabolism. Taken from (73). 
 
1.3.2 Junctophilin proteins 
 
In excitable cell types, such as muscle cells, the junctions between the endo/sarcoplasmic 
reticulum (ER/SR) and PM are frequently formed and they are named as junctional membrane 
complexes (75). This ER/SR-PM contact sites formation is a prerequisite for a cross talk 
between the Ca2+ channels, which localize in either ER/SR (Ryanodine Receptors- RyR) or PM 
(voltage-gated Ca2+ channels- VGCC) (76). The formation of SR-PM contact site is mediated by 
junctophilins (JPHs), which are consistently expressed in excitable cells (75, 77). The JPHs 
function to transmit the Ca2+ influx signal to the Ca2+ release signal. Upon influx of Ca2+ from 
VGCC, which is in the PM, the RyR releases Ca2+ that is stored in ER/SR. This cross talk of 
these two channels is achieved by JPHs (Figure 1.8). This process is crucial for contraction of 
muscles, release of insulin from pancreatic β-cells and synaptic plasticity in neurons (78, 79).        
 
There are four JPH isoforms in mammals and they all are single-pass type 2 membrane 
proteins. Primary sequence analysis suggests that all JPH isoforms contain “membrane 
occupation and recognition nexus” (MORN) motifs clustered near the N-terminus, which faces 
the cytosol (80). The MORN motifs are suggested to mediate association with the PM, either 
directly by interacting with lipids or indirectly through membrane-bound adapter proteins (81). 
The α-helical domain, which follows the MORN domain, is believed to determine the distance 
between the PM and the ER/SR. Electron microscopy studies showed that the distance 
between the ER/SR and PM is around 12 nm (75, 82). Moreover, genetic deletion of JPH2 in 
mice resulted in the formation of fewer and improperly aligned junctional membrane complexes 
in cardiac muscle (75). Intriguingly, overexpression of JPH1 in amphibian embryonic cells 
promoted the generation of 12 nm junctions between the ER/SR and PM (83). 
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Figure 1.8  Proposed function of Junctophilin-2 in cardiac myocytes. 
PM depolarization results in the opening of voltage-gated Ca2+ channels (VGCC), which promote influx of 
Ca2+. Following the Ca2+ influx, ryanodine receptors (RyR2) release a greater amount of Ca2+ from the 
sarcoplasmic reticulum (SR). This results in Ca2+-induced contraction of the sarcomere. For relaxation of 
the myocyte Ca2+ is pumped back into the SR by sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) or 
removed from the myocyte by the Na+/Ca2+ exchanger (NCX). For the proper excitation-contraction 
coupling in cardiac myocytes, proper function of junctophilin-2 (JPH2) is required (Taken from (84)). 
 
1.3.3 Ist2 protein 
Physical contacts between the cortical ER and the PM also play a role in the sorting of the 
polytopic membrane protein Ist2 in budding yeast. Ist2, which is synthesized from a bud-
localized mRNA, travels to the PM-associated cortical ER (85). From there the protein may 
travel further to domains of the PM independently of the function of the classical secretory (sec) 
pathway (86, 87). The cortical ER of the yeast lies in close proximity to the PM and forms 
contacts with a distance of 30 nm or even less (60, 88, 89). Therefore, in yeast it is very difficult 
to distinguish whether the localization of a protein is at the cortical ER or the PM.  In the case of 
Ist2, cell fractionation and protease protection experiments suggested that it reaches the PM 
(86).  
1.3.3.1 Transport of Ist2 to ER-PM contact sites in yeast 
In case IST2 mRNA is not transported, Ist2 is translated at the perinuclear ER, from where the 
protein diffuses quickly to the cortical ER. This transport of Ist2, which is the accumulation at 
PM-associated ER, is mediated by the C-terminal region of 69 amino acids (878–946) (90). This 
region is defined as the cortical sorting signal of Ist2 (CSSIst2). This signal has two functionally 
important regions. The N-terminal region consists of single amino acid repeats of threonine, 
histidine and serine residues (T/H/S-cluster). This T/H/S-cluster functions most likely as a 
multimerization domain, since its function can be replaced by another multimerization domain. 
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In addition, the length of T/H/S-cluster (50 amino acids) is important for the function of of the 
CSSIst2 (90). This T/H/S cluster provides the necessary distance between the ER and the PM for 
the function of the CSSIst2. 
The C-terminal region of CSSIst2 (last 18 amino acids) is rich in lysine residues and capable of 
forming a short amphipathic α-helix (85). This amphipathic α-helix formation is predicted to 
cover the last 11 amino acids. The N terminal region of the helix is rich in basic residues and 
they are important for the localization of Ist2. The mutation of four lysine and one histidine 
(K931A/K933A/H934A/K935A/K936A) was shown to cause a weak perinuclear accumulation of 
Ist2. This suggests that multiple basic residues are required for the function of CSSIst2.In 
addition, the mutational analysis of the Ist2 sorting signal revealed that positions of hydrophobic 
residues (L938, L939 and L942) at one side of the amphipathic α-helix are also required for 
sorting of Ist2 (85) (Figure 1.8) 
 
 
 
Figure 1.9 Domain structure of yeast Ist2. 
(A) Ist2 has eight transmembrane (TM) domains. Its N- and C-terminus faces the cytosol. Last 69 amino 
acids of Ist2 forms the cortical sorting signal (CSSIst2). CSSIst2 has two functionally important domains, 
T/H/S-cluster for multimerization, and K/L sequence (K-rich domain) for binding PM-lipids. Taken from (91) 
(B) Last 11 amino acids of K-rich domain forms amphipathic α-helix, which has a hydrophobic patch on 
one basic patch on the other side. Taken from (85). 
 
 
 
A 
B 
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Since the IST2 mRNA localizes to the bud, the role of mRNA localization in trafficking of Ist2 
was investigated. The mRNA-binding protein She2 recognizes the stem loop of IST2 mRNA, 
which functions as mRNA localization signal (92, 93). This signal is part of the sequence 
encoding the CSSIst2. However, it was found that the function of the CSSIst2 is independent of 
IST2 mRNA localization. The disruption of the secondary structure of the stem-loop mRNA 
sequence and the experiments performed in she2Δ mutants did not change the localization of 
the protein (90).  
As it was shown for the recruitment of soluble proteins from the cytosol to the PM, the sorting of 
the polytopic protein Ist2 depends on interaction with PM lipids (85). Basic residues and the 
amphipathic α-helix are required for binding of the CSSIst2 to PI(4,5)P2-containing PM-like 
liposomes, suggesting that this interaction is necessary and sufficient for efficient transport of 
Ist2 from the perinuclear to the cortical ER (85, 91). In vivo, it was shown that the CSSIst2 can be 
functionally replaced by a bona fide PI(4,5)P2-specific lipid-binding domain from 
phospholipaseC-δ1 (PLC-δ1) but not by other lipid-binding domains, which recognize PI3P 
(phosphoinositide 3 phosphate) or PI4P. Attached to other integral ER membrane proteins, the 
CSSIst2 targeted these proteins to the cortical ER. Thus, interaction of CSSIst2 with lipids serves 
as a dominant and a novel mechanism for sorting of integral membrane proteins to the ER-PM 
contact sites (91). 
1.3.3.2 CSSIst2-tagged membrane proteins form ER-PM contact sites in mammalian 
cells  
Since yeast is not suitable for the investigation of exact localization of Ist2, due to its cell wall 
and constitutive cortical ER, additional localization studies were performed in mammalian cells. 
In this work, I attached the CSSIst2 to the integral ER-membrane proteins, such as CD4, MHC 
Class I, TAP1, Kir6.2. Interestingly the resulting chimeras were recruited to peripheral ER 
structures, which are in close proximity to the PM (94, 95). The formation of these patches was 
achieved by direct interaction of CSSIst2 with the phosphoinositides of the PM. In my thesis, I 
show that the peripheral ER patches are stable and immobile structures that are in continuity 
with the rest of the ER. In parallel to my study, another group showed by siRNA experiments 
that the CSSIst2-induced peripheral ER formation was dependent on both COPI and the 
microtubule (+)-end binding protein EB1 (95). 
1.3.3.3 Possible function of Ist2 at the ER-PM contact sites 
Ist2 is the yeast member of the mammalian ANO/TMEM16 family, which shares approximately 
20% sequence similarity and a similar membrane topology (96). TMEM16A and TMEM16B 
were recently identified as calcium-activated chloride channels of the PM (97, 98, 99). These 
channels are expressed in multiple tissues and play important roles in cellular physiology, 
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including epithelial secretion of electrolytes and water, sensory transduction, regulation of 
neuronal and cardiac excitability, and regulation of vascular tone (98, 99).  
A more recent study on other member of TMEM16 family, TMEM16F, revealed that this protein, 
which is located at the PM, functions as phospholipids scramblase. It mediates the translocation 
of phosphatidylserine from the inner leaflet to the outer leaflet. Moreover, this function of 
TMEM16F is dependent on cytosolic Ca2+ levels and the increase of cytosolic Ca2+ activates the 
protein (100).  
Although Ist2 cannot react to the cell surface in mammalian cells, it may function as chloride 
channel or as phospholipids scramblase at the cortical ER. Nevertheless, the function of Ist2 
still remains to be elusive. 
1.3.4 STIM proteins 
 
Interestingly, the phenomenon of Ist2 transport to the cortical ER in yeast shares some 
similarities with the intracellular distribution of stromal interaction molecule 1 (STIM1) and 2 
(STIM2) in mammalian cells. STIM1 was originally described as a PM protein of bone marrow 
stromal cells, hence the original name stromal interaction molecule (101), and of the chronic 
myeloid leukemia cell line K562 (102). Further studies showed that STIM1 localizes 
predominantly in the ER (61, 103, 104, 105), with its N-terminus localized in the ER lumen. The 
N-terminus of STIM1 has a size of approximately 22 kDa after cleavage of its signal sequence.  
 
STIM1 has a crucial role in Ca2+ signalling during T cell activation. It basically carries out two 
functions in order to activate CRAC (Ca2+ release-activated Ca2+) channels. STIM1 first senses 
the ER Ca2+ store depletion and second, activates the Ca2+ channels in the PM. This process is 
called store-operated Ca2+ entry (SOCE), where the store is the ER (106-108).  
          
Activation of T cells 
 
The stimulation of immune cells and many other non-excitable cell types involves the opening of 
CRAC channels in the PM. As a consequence, the cytosolic Ca2+ concentration increases from 
approximately 100 nM at resting state to more than 1000 nM (109). Ca2+ entry into the cytosol is 
critical for responses of all immune cells. In T cells, a sustained Ca2+ uptake regulates 
proliferation and cytokine production. SOCE is the primary mechanism of Ca2+ influx in T cells. 
The SOCE is initiated by ligand binding to the T cell receptors (TCR). This ligand binding results 
in generation of a cascade of signaling events. This cascade starts with the activation of 
tyrosine kinases (such as ltk), which phosphorylate and activate phospholipase C. The 
phospholipase C hydrolyzes PI(4,5)P2 (phosphoinositide 4,5 bisphosphate) in the PM to IP3 
(inositol 1,4,5 triphosphate) and diacylglycerol. IP3 then binds to IP3 receptors (IP3R) in the ER 
membrane and the binding results in release of Ca2+ to the cytosol. The depletion of ER Ca2+ 
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stores leads to the oligomerization of STIM proteins, which in turn form ER-PM contact sites. At 
these sites, STIM proteins interact with and open the PM Ca2+ channels (CRAC or Orai1). As a 
result of Ca2+ uptake into the cytosol, the calmodulin (CaM)-dependent phosphatase calcineurin 
is activated. Calcineurin then dephosphorylates the transcription factor NFAT (nuclear factor of 
activated T cells), which translocates into the nucleus and initiates the transcription of cytokines 
(reviewed in (110) and (108)) (Figure 1.9).  
 
 
Figure 1.10 Signaling pathway that connects SOCE with NFAT-dependent gene transcription in 
T cells.  
(A) Resting T cells have intracellular free Ca2+ concentrations of 50–100 nM that are maintained by the PM 
Ca2+ ATPase (PMCA), the SERCA that pumps Ca2+ into the lumen of the endoplasmic reticulum (ER), and 
Na+-Ca2+ exchangers (NCX, not shown). Immunoreceptors include antigen receptors on T cells (TCR). 
The concentration of free Ca2+ in the ER is several hundred µM; hence the EF-hand of STIM1 is saturated 
with Ca2+, and STIM1 does not form higher-order oligomers. The transcription factor NFAT is heavily 
phosphorylated and localized to the cytoplasm. (B) Activated T cells. T cell receptors assemble into 
signaling complexes that contain scaffold proteins such as LAT, tyrosine kinases such as Itk, and 
phospholipase C (PLC)γ (not all of which are shown). IP3 produced by PLCγ binds to IP3 receptors in the 
ER membrane, causing the release of Ca2+ from the ER. As a result of the depletion of ER Ca2+ stores, 
Ca2+ dissociates from EF-hand of STIM1 and causes a conformational change that leads to 
oligomerization. The STIM oligomers move to ER–PM contact sites, recruit Orai1 proteins to these sites, 
and cause CRAC channels to open. The resulting increase in cytosolic Ca2+ promotes binding of CaM to 
phosphatase calcineurin, which dephosphorylates NFAT and causes its nuclear translocation, thus 
activating NFAT-dependent transcription of cytokines. Taken from (108) 
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1.3.4.1 STIMs sense the ER Ca2+ concentration 
 
The lumenal N-terminus of STIM1 is responsible for Ca2+ sensing. NMR studies demonstrated 
that human STIM1 (58–201) fragment is composed of two EF-hands and a sterile α motif (SAM) 
domain (111). Only the first EF-hand is capable of binding Ca2+, whereas the other makes 
interactions with the SAM domain. This EF-SAM protein fragment is monomeric, when it is 
bound Ca2+. As shown by biophysical studies, in the absence of Ca2+, the protein shows a 
substantial unfolding and starts to form dimers and aggregates (111, 112). 
 
Since the concentration of Ca2+ in the ER lumen is hundreds of micromolar (µM), STIM1 should 
have a low affinity for Ca2+ in order to function as a sensor. The experiments that are performed 
by a recombinant STIM1 luminal domain revealed that a Kd of STIM1 for Ca2+ is around 500–
600 µM (112). On the other hand, STIM2 was shown to be more sensitive upon changes of 
Ca2+ in the ER, suggesting a function as a basal regulator. This suggests that STIM2 function is 
not only related to signal amplification but also to refilling the ER Ca2+ stores (113).  
1.3.4.2 Oligomerization and distribution of STIMs 
 
The activation of STIM1 by decrease of ER Ca2+ levels drives its oligomerization, which starts 
with an aggregation of the Ca2+-binding EF-hand- and SAM domains in the N-terminus (107). 
The conformational changes upon the oligomerization of the N-terminal domains of STIMs 
spread into their cytosolic domain. The cytosolic domains of STIMs are comprised of two coiled-
coil domains, a serine/proline rich domain and a lysine (K)-rich domain. Recent studies showed 
that a region covering the second coiled-coil domain is important for the interaction with the 
CRAC channel at the PM (Orai1). This domain is named as CAD (CRAC activation domain, 
residues 342-448) or SOAR (STIM1 Orai-activating domain, residues 344-442) (114, 115) 
(Figure 1.10).  
 
 
 
Figure 1.11 Domain structure of STIM proteins. 
STIM proteins are type 1 membrane proteins. SS, signal sequence, EF-SAM, consists of two EF-hands 
and a SAM domain, TMD, transmembrane domain, CC, coiled-coil domain, P, proline-rich domain, K, K-
rich domain. 
 
Additionally, STIM1 has been shown to associate with microtubules by binding to the 
microtubule plus end tracking protein EB1 through a TxIP motif in STIM1 (25, 116). Time-lapse 
studies showed that EB1 binds and recruits STIM1 to ER-PM contact sites through growing 
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microtubule (117). In HeLa cells it was shown that the knockdown of EB1, which suppresses 
microtubule growth, or treatment with taxol to shorten microtubules, destroyed the STIM-
microtubule colocalization, but did not affect store-operated Ca2+ entry (25).  
1.3.4.3 Localization of STIM1 to the ER-PM contact sites and CRAC activation 
 
Depletion of ER Ca2+ drives the oligomerization of STIM proteins, which move to ER structures 
located proximal to the PM, called puncta. At puncta, STIM proteins recruit Orai1, which is the 
CRAC channel of the PM (61, 103, 118, 119). Recruitment of Orai1 depends on its C-terminal 
cytoplasmic tail, since Orai1 lacking its C-terminal tail fail to colocalize with STIM1 (120, 121). 
The positive residues in the CAD of STIM1, binds the acidic amino acids at the C-terminal 
domain of Orai1 (residues 272-291) and therefore activates the CRAC channel (114, 115, 122, 
123). Studies addressing the stoichiometry of STIM1 and Orai1 showed that a STIM1 dimer, or 
two independent STIM1 molecules, gates a tetrameric Orai1 channel. This multimer formation is 
necessary for CRAC current activation (119). Furthermore, the cytosolic coiled-coil domains of 
STIM1 may correlate with the ability to activate the CRAC channel (122). 
 
The studies in order to investigate the interactions that retain STIM1 at the ER–PM contacts 
revealed that the short polybasic segment at the STIM1 C-terminus, K-rich domain, has a role 
(114, 124, 125). The K-rich domain was shown to interact with phosphoinositides at the 
cytosolic face of the PM (94, 126). The depletion of both PI(4,5)P2 and PI(3,4,5)P3 
(phosphoinositide 3,4,5 triphosphate) of the PM, abolished STIM1 migration to puncta (126). In 
consistence with this data, experiments performed in this study revealed that STIM1 C terminus 
could bind PI(4,5)P2. In the same study, I showed that the STIM2 C-terminus bind to both 
PI(4,5)P2 and PI(3,4,5)P3 more efficiently than the STIM1 C-terminus (94).  
 
Moreover, in addition to binding PM-lipids, isotermal calorimetry and nuclear magnetic 
resonance studies revealed that peptides of STIM1 and STIM2 K-rich domains bind to 
Ca2+/CaM (127). This finding is really important, since it is well known that the Ca2+ sensor CaM 
interacts with many proteins such as phosphatase calcineurin, cytoskeletal proteins and ion 
transporters and regulates their functions (reviewed in (128)). CaM interacts with target proteins 
through hydrophobic and electrostatic interactions (129). Binding of CaM to the target peptide 
might promote formation of an α-helix (130). Nevertheless, how the binding of CaM and PM-
lipids to the K-rich domain influences the function of STIMs remains unknown.                                      
1.3.4.4 Control of STIM1 activation 
 
The activity of the CRAC channel is strictly regulated, as Ca2+ overload leads to undesirable 
outcomes such as apoptosis. The activation of STIM1 is controlled by an intra-molecular 
interaction between an acidic residue-rich auto-inhibitory domain (302-322) and a polybasic 
region (382-386) in CAD (131, 132). The auto-inhibitory domain of STIM1 is highly homologous 
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to a domain in the C terminus of Orai1, which also binds to CAD at the polybasic region (123, 
131, 132). This intra-molecular interaction therefore masks the interaction surface of CAD and 
Orai1, thereby functioning as a regulatory switch (114, 115, 132). Additional regulation involves 
a Ca2+-dependent feedback inhibition of the CRAC channel, where an inactivation domain (475-
483) of STIM1 together with Ca2+/CaM inactivates the channel (133, 134). The EF-hand 
containing protein CRACR2A stimulates STIM1 and Orai1 complex formation at low cytosolic 
Ca2+, whereas high cytosolic Ca2+ dissociates the CRACR2A, STIM1 and Orai1 complex and 
thereby terminates SOCE (135).  
1.3.4.5 Interaction of STIM1 with other Ca2+ channels 
In addition to Orai1, STIM1 was shown to interact directly with TRPC (transient receptor 
potential channel) proteins in biochemical and functional assays, suggesting that via a specific 
mechanism STIM1 can gate TRPC channels (136, 137, 138). There are seven TRPC proteins 
in mammals. In a study investigating the interplay between STIM1 TRP channels, it was found 
that STIM1 binds TRPC1, TRPC4 and TRPC5 and determines their function as SOCs. 
Moreover, STIM1 also regulates TRPC3 and TRPC6. This regulation is not by direct interaction 
but STIM1 indirectly mediate the heteromultimerization of TRPC3 with TRPC1 and TRPC6 with 
TRPC4 (137). 
STIM1 is also required for activation of the ARC (arachidonate-regulated Ca2+-selective) 
channel (139). The ARC channel is a hetero-pentameric channel, which is formed by two Orai3 
and three Orai1 proteins. The function of the ARC channel in immune cells remains elusive, but 
in other cell types its activation occurs independent of ER Ca2+ stores (140). 
1.3.4.6 Localization of STIM1 to the cell surface 
 
Initial studies on immune cells have shown that STIM1 localizes to the cell surface (101, 102). 
The N-terminal region of the mouse homologue of STIM1 was shown to bind to pre-B cells and 
this increases their proliferation. In addition to binding pre-B cells it was shown that the N-
terminal domain of STIM1, which is expressed in bone marrow stromal cells, binds to mature B 
lymphocytes and other lympho-haematopoietic cell lineages probably by interactions with the 
ligands or receptors on these cells (101). These studies provide indirect evidence that STIM1 
functions at the cell surface to mediate cell–cell interactions and growth regulation (102). 
 
Moreover, the studies with the activation of ARC channels suggested that the activation of the 
channel is achieved by STIM1, which localizes to the cell surface (140). It was previously shown 
that STIM1 couldn’t reach to the cell surface if it is tagged at its N-terminus by a tag that 
exceeds a certain size, such as YFP. Consequently, STIM1 tagged with hexahistidine tag was 
detected on the cell surface of HEK293 cells (141).  
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1.4  Aim of the thesis 
 
In yeast, the polytopic membrane protein Ist2 localizes to the cortical ER and this localization 
depends on its cortical sorting signal (CSS), which directly binds to PM-lipids. Protease 
protection experiments suggested that Ist2 may reach the cell surface. However, in yeast with 
localization of the cortical ER beneath the PM, it was difficult to determine the exact localization 
of Ist2. One of the aims of this work was therefore to investigate the localization of Ist2 in 
mammalian cells. These cells provide better microscopic resolution of ER and PM, since static 
peripheral ER structures are rare.  
 
The second aim of this study was to investigate whether the sorting mechanism of yeast Ist2 to 
the ER-PM contact sites is conserved in mammalian cells. In order to investigate this 
phenomenon, I tagged mammalian integral membrane proteins with CSSIst2 and observed their 
localization by fluorescence and confocal microscopy. I explored the structural features of these 
domains in order to define their mobility and continuity with the rest of the ER.  
 
Thirdly, I analyzed the mammalian integral membrane proteins, STIM1 and STIM2, which show 
similar localization phenotypes as the integral membrane proteins that are tagged with the 
CSSIst2. In order to fulfil their function in store-operated Ca2+ entry, STIMs form ER-PM contact 
sites. Therefore, I analyzed the ER-PM contact site formation mechanism of these proteins. In 
addition to microscopy approaches, I performed in vitro liposome binding experiments with the 
purified cytosolic C-terminal domains of STIM1 and STIM2 and investigated the requirements of 
this protein-lipid interaction. 
 
Finally, I focused my studies on the regulation of STIM1 localization. STIM1, in addition to its 
localization in the ER, was shown to localize to the cell surface. However, in order to function in 
store-operated Ca2+ entry, it must be retained in the ER. Therefore, I investigated the 
mechanisms, which retain STIM1 in the ER. Moreover, I underlined an alternative function of 
the cell surface-located STIM1.   
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2 Materials and methods 
 
2.1  Molecular Biology Methods 
 
Frequently used buffers can be found in the Appendix section. 
2.1.1 Polymerase Chain Reaction (PCR) 
Materials and Equipment 
Pfu polymerase (Agilent Technologies) 
Taq polymerase (New England Biolabs - NEB) 
10X Pfu Polymerase Buffer (Agilent Technologies) 
dNTP (NEB) 
Primers (ordered from MWG) 
PCR tubes (G. Kisker GbR) 
T3 Thermocycler (Biometra) 
2.1.1.1 Standard PCR 
 
The DNA fragments were amplified by PCR, from a plasmid, which is used as a DNA template. 
The primers contained restriction sites and 4 extra flanking bases at their 3´-ends. The PCR 
reaction mixture was prepared as below: 
 
Table 2.1 Standard PCR reaction mixture 
Template DNA  100 ng 
10 × Pfu Buffer 1 × 
dNTP mix 250 µM 
Forward primer  0.5 µM 
Reverse primer 0.5 µM 
Pfu polymerase 1 µl 
Taq polymerase 0.5 µl 
dH2O  
Total 50 µl 
 
The amplification was performed according to the conditions described below. The elongation 
time was calculated as 1.5 minutes per 1 kb of fragment to be amplified.  The reaction was 
repeated for 25 cycles (steps 2-4). 
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Table 2.2 Standard PCR conditions 
Step Temperature Time 
1 95°C 30 sec 
2 95°C 30 sec 
3 58-60°C 1 min 
4 68°C  1.5 min/kb 
5 68°C 5 min 
6 4°C ∞ 
 
2.1.1.2 Site-directed mutagenesis 
 
In order to create point mutations, site-directed mutagenesis was performed. The primers were 
designed as having the desired mutation site in the middle and 15 bases long annealing sites 
on both 3´ and 5´-ends. The PCR reaction mixture for all mutagenesis experiments was as 
following:  
 
Table 2.3 PCR reaction mixture for site-directed mutagenesis 
Template DNA  50 ng 
10 × Pfu Buffer 1 × 
dNTP mix 250 µM 
Forward primer  0.1 µM 
Reverse primer 0.1 µM 
Pfu polymerase 1 µl 
dH2O  
Total 20 µl 
 
The amplification was performed according to the conditions described below. The elongation 
time was calculated as 2 minutes per 1 kb of fragment to be amplified. The samples reaction 
was repeated for 18 cycles (Steps 2-4). 
 
Table 2.4 PCR conditions for site-directed mutagenesis 
Step Temperature Time 
1 98°C 30 sec 
2 98°C 30 sec 
3 55°C 1.5 min 
4 68°C  2 min/kb 
5 4°C ∞ 
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2.1.2 Cloning 
 
The PCR amplified fragment (insert) and the vector were cut with same restriction enzymes, 
followed by purification and ligation. The correct ligation reaction was analyzed by restriction 
digestion following transformation and plasmid DNA isolation from the transformants.  
 
Materials  
 
Restriction enzymes (NEB) 
10X Restriction Enzyme Buffer (NEB) 
100X BSA (NEB, B9001S) 
T4 DNA Ligase (NEB, M0202S) 
T4 DNA Ligase Buffer (NEB, B0202S) 
QIAquick Gel Extraction Kit (Qiagen) 
Ethidium Bromide Solution (5mg/ml) 
Agarose (Biozym Sientific GmbH) 
Mini-DNA isolation kit (Qiagen) 
Nucleobond Midi-prep kit (Macherey-Nagel) 
6X Gel loading dye (NEB, B7021S) 
E. coli DH5α strain 
LB plates  
UV transilluminator (Bio-Rad)
2.1.2.1 Restriction digestion 
 
Digestion reactions were performed in the appropriate buffer and the temperature 
recommended by the enzyme manufacturer (NEB). For cloning experiments 5-7 µg of vector 
DNA was digested in a final volume of 50 µl. In order to digest the PCR amplified inserts, the 
PCR amplified DNA was initially purified by a PCR purification kit (Qiagen) and the DNA 
fragments were eluted in 40 µl of dH2O.  For digestion reactions, 40 µl of the PCR amplified 
DNA was used in a final volume of 50 µl reaction.  
 
For control digestions of plasmid Mini-prep DNA, 500 ng of DNA was used in a final volume of 
10 µl reaction. The digestions were performed for 2 hours and the samples were run on 
Agarose gel after addition of 6X gel loading dye.   
 
For the isolation of the insert and the digested vector backbone from the Agarose gel, the 
QIAquick Gel Extraction Kit was used. The insert DNA was eluted in 30 µl of dH2O, whereas 40 
ml of dH2O was used for the elution of the vector DNA.  
2.1.2.2 Agarose Gel Electrophoresis 
 
1/6 volume gel loading dye was added to the DNA from PCR or restriction digestion. The 
samples were loaded onto a 1% agarose gel containing 1 ng/ml ethidium bromide. The NEB 
Quick-Load 1 kb ladder was used as a marker to compare fragment sizes. Gels were run at 50-
80 Volts for around 1 hour in TAE buffer. DNA bands were visualised by UV light on a 
transilluminator.  
Materials and methods 
 24 
2.1.2.3 Ligation 
 
In order to produce new plasmids, opened vector and inserts were ligated by using T4 DNA 
ligase. The ligation was performed either for 1 hour at 37°C or overnight at 16°C. The ligated 
fragments were then transformed into E. coli DH5α strain. The ligation reaction and the control 
was prepared as shown below: 
 
Table 2.5 Ligation Reaction mixture 
  Ligation Control 
10 × Ligation Buffer 1X   
Vector (Plasmid DNA) 50-200 ng   
Insert (PCR product) 1:3 – 1:6 molar ratio  0 
T4 Ligase  1 µl   
dH20     
Final Volume 10 µl 10 µl 10 µl 
 
2.1.3 Transformation 
 
The plasmid DNAs or the DNA from the ligation reactions were transformed into E. coli DH5α 
strain. Simply, 250 ng of a plasmid or 10 µl of the ligation reaction was added into 100 µl of 
competent cells. Cells then were incubated on ice for 30 minutes and heat shocked for 45 
seconds at 42°C. After addition of 750 µl of LB medium, the cells were incubated at 37°C heat 
block for 1 hour shaking. The cells were then plated on LB plates, containing the appropriate 
antibiotic.  
2.1.4 Plasmid DNA Isolation 
 
Plasmid DNA was isolated from E. coli cells, which were grown overnight in 5 ml LB with 
appropriate antibiotic. For the isolation of plasmid DNA the Qiagen plasmid MINI-DNA isolation 
kit was used according to the manufacturer’s protocol. In order to isolate bigger amounts of 
plasmid DNA, 200 ml E. coli culture was grown and the Nucleobond Midi-prep kit was used for 
isolation.  
 
Table 2.6 Plasmids used in this study 
Plasmid Description Resistance 
in E. coli 
Source 
pEE01 GFP-Ist2-HA7-8  Kan T. Bitew 
  pEE03 CD4-AAXX   Amp B.Schwappach 
pEE05 GFP-Ist2  Kan K. Maass 
pEE07 CD4-GFP  Amp This study 
pEE08 CD4-GFP-CSSIst2  Amp This study 
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pEE09 CD4-mCherry-CSSIst2  Amp This study 
pEE10 EGFP  Kan Clontech 
pEE15 Kir6.2-HA-GFP  Amp This study 
pEE16 Kir6.2-GFP-CSSIst2  Amp This study 
pEE17 Kir6.2-GFP-PH  Amp This study 
pEE18 MHCI-GFP  Kan F. Momburg 
pEE19 MHCI-GFP- CSSIst2  Kan This study 
pEE20 TAP1-GFP  Kan F. Momburg 
pEE21 TAP1-GFP- CSSIst2  Kan This study 
pEE23 TAP2-tdimer(12) Kan F. Momburg 
pEE30 YFP-STIM1EF (D74A)  Kan T. Meyer 
pEE31 YFP-STIM2EF (D80A),  Kan T. Meyer 
pEE32 
CD4-GFP-CSSIst2 (K931A, K933A, H934A, 
K935A, K936A) 
Amp This study 
pEE33 CD4-GFP- CSSIst2 (L939P)  Amp This study 
pEE34 CD4-GFP- CSSIst2 (941K-2A-942L)  Amp This study 
pEE35 CD4-GFP- CSSIst2 (L942Q)  Amp This study 
pEE41 Sur1  Amp B. Schwappach 
pEE44 SH4-mCherry  Amp This study 
pEE45 Kir6.2-GFP-STIM1C Amp This study 
pEE46 Kir6.2-GFP-STIM2C  Amp This study 
pEE47 expression, GFP-STIM1C  Amp This study 
pEE48 expression, GFP-STIM1C ΔCC  Amp This study 
pEE49 
expression, GFP-STIM1C ΔK (deletion of last 25 
aa, used in lipid binding) 
Amp This study 
pEE50 expression, GFP-STIM1 K-rich  Amp This study 
pEE53 expression, GFP-STIM2C  Amp This study 
pEE54 expression, GFP-STIM2C ΔCC  Amp This study 
pEE55 expression, GFP-STIM2 ΔK  Amp This study 
pEE56 expression, GFP-STIM2 K-rich  Amp This study 
pEE57 expression, GFP-STIM2 K-rich (K729P) Amp This study 
pEE58 expression, GFP-STIM2 K-rich (L726-A-F727)  Amp This study 
pEE60 expression, GFP-STIM2 K-rich (K718,719A)  Amp This study 
pEE62 YFP-STIM1EF ΔK  Kan This study 
pEE63 YFP-STIM2EF ΔK  Kan This study 
pEE64 YFP-STIM2EF (K729P)  Kan This study 
pEE65 YFP-STIM2EF (L726-A-F727)  Kan This study 
pEE66 YFP-STIM2EF (K718,719A)  Kan This study 
pEE68 pIRES-GFP dual promoter, Orai1 Amp B. Niemeyer 
pEE69 pIRES-GFP dual promoter, Orai2 Amp B. Niemeyer 
pEE70 pIRES-GFP dual promoter, Orai3  Amp B. Niemeyer 
pEE71 HA-STIM1  Kan This study 
pEE72 HA-STIM2  Kan This study 
pEE82 GFP-Sec61γ Kan H. Lorenz 
pEE84 ss-RFP-KDEL  Kan H. Lorenz 
pEE92 HA-STIM1ΔK  Kan This study 
Materials and methods 
 26 
pEE94 HA-ΔNext-STIM1  Kan This study 
pEE96 HA-STIM1ΔK STIM2 K-rich  Kan This study 
pEE103 TRPC1 Amp D. Clapham 
pEE104 TRPC4 Amp D. Clapham 
pEE127 HA-STIM1 R500A (500RQR to AQA)  Kan This study 
pEE128 
HA-STIM1 R500,530A (500RQR and 530RQR 
to AQA)  
Kan This study 
pEE130 HA-STIM1 R311,500,530A  Kan This study 
pEE137 HA-STIM1 R530A   Kan This study 
pEE138 HA-STIM1ΔK, R500A Kan This study 
pEE139 GFP-Orai1  Kan This study 
pEE142 
expression, GFP-STIM1C  ΔK (deletion of last 
15 aa, used in CaM binding)  
Amp This study 
pEE157 expression, GFP-STIM1C ΔK K3A Amp This study 
pEE158 expression, GFP-STIM1C ΔK H2AA  Amp This study 
pEE159 expression, GFP-STIM1C ΔK H2AA  Amp This study 
pEE160 expression, GFP-STIM1C ΔK ΔCaMI  Amp This study 
pEE161 expression, GFP-STIM1C ΔK ΔCaMI-II  Amp This study 
pEE162 GFP-NFAT  Kan R. Kehlenbach 
pEE163 GalTase-RFP  Kan H. lorenz 
 
 
2.2  Mammalian Cell Culture Methods 
 
 
Material, Media and chemicals 
 
10 cm dishes (TPP) 
Cryo-tubes (NeoLab) 
DMEM Glutamax (Gibco, 61965) 
DMEM/F12 (Gibco, 21331) 
Opti-MEM (Gibco, 31985) 
Fetal Bovine Serum (FBS) (Gibco, 10270-
106) 
Glutamine (Gibco, 25030)  
Sodium pyruvate (Gibco, 11360) 
0.05% Trypsin-EDTA (Gibco, 25300) 
DMSO (Sigma) 
Fugene HD (Roche) 
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2.2.1 Cell lines 
 
Table 2.7 Cell lines used in this study 
Cell Line Description 
HEK293 HEK293 cells are human embryonic kidney cells and can either be adherent 
or suspension cells.  
HEK293T HEK293T cells are human embryonic kidney cells and can either be 
adherent or suspension cells. The HEK293T cells are transformed with large 
T antigen of the SV40 virus. 
HeLa  HeLa cells are adherent cells derived from human cervix carcinoma.  
U2OS U2OS cells are human osteosarcoma cells and are adherent cells  
RPE-1 RPE-1 cells are human retinal-pigmented epithelial cells and are adherent 
cells. They are telomerase reverse transcriptase immortalized. 
 
2.2.2 Maintaining cells in culture 
 
All cells were grown and maintained at 37°C, 5 % CO2 in a cell incubator. Culture conditions 
vary widely for each cell type. Below is shown the cell type specific culturing conditions. 
 
Table 2.8 Culturing conditions of cell lines used in this study 
Cell Line Description 
HEK293 DMEM/F12, 10% FBS, 2mM Glutamine 
HEK293T DMEM/F12, 10% FBS, 2mM Glutamine 
HeLa  DMEM Glutamax, 10% FBS, 2mM 
Glutamine, 1mM Sodium Pyruvate 
U2OS DMEM Glutamax, 10% FBS, 2mM 
Glutamine, 1mM Sodium Pyruvate 
RPE-1 DMEM/F12, 10% FBS, 2mM Glutamine 
 
 
In order to to replenish nutrients and avoid the potentially harmful metabolic byproducts and 
dead cells, the cells were passaged every 2 or 3 days according to the confluency of the cells.  
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2.2.2.1 Passaging of the cells 
 
In order to passage the cells, the medium was aspirated and the adharent cells were gently 
washed once by 10 ml of 1X PBS. PBS was then aspirated and 2 ml of Trypsin-EDTA was 
added onto cells and distributed all over the plate for the detachment of the cells from the plate. 
The Trypsin-EDTA was aspirated and the cells were incubated in 37°C incubator for maximum 
10 minutes. 10 ml of appropriate medium was added onto cells to resuspend and collect the 
cells. The number of the cells was calculated by counting with a haemocytometer and they were 
seeded at a confluency according to the type of experiment that would be performed. For 
continuation of the cells in culture, 1/10 dilution was done. 
2.2.2.2 Freezing and thawing of the cells 
 
For freezing, the cells were harvested at 1000 rpm for 2 minutes and washed once with 1X 
PBS. After removal of the PBS, the cells were resuspended in freezing medium, which contains 
10% DMSO and 90% FBS. 1 ml of the suspension was added into each cryo-tube. In general, 
from one 10 cm dish with 80% confluency, 2 ml of cell suspension was generated. The tubes 
containing the cells were then placed in -80°C freezer. For longer storage, the cells were 
transferred to the liquid nitrogen tanks.  
 
For thawing, the cells taken from liquid nitrogen were placed into 37°C water bath. In order to 
avoid the toxic effect of DMSO, this process should be performed quickly. As soon as the cells 
were thawn, they were transferred into 15 ml falcon tubes containing the appropriate medium. In 
order to get rid of residual DMSO, the cells were washed with the medium for two times. After 
the last wash, they were resuspended in medium and transferred into 10 cm dishes and placed 
in 37°C incubator.  
2.2.3 Transfection of cells 
 
In order to introduce plasmids into the cells, the Fugene HD transfection reagent was used. For 
different cell lines, different reaction mixtures were prepared.  
 
Table 2.9 Transfection conditions for different cell lines used in this study 
Cell Line DNA : Fugene HD  
HEK 293T 
HEK293 
1 µg : 2.5 µl 
HeLa  1 µg : 3 µl 
U2OS 1 µg : 3 µl 
RPE-1 1 µg : 3 µl 
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The reaction mixture was prepared as described in manufacturer´s manual. Briefly, the DNA 
was diluted 1:100 in Opti-MEM (per 1 µg DNA, 100 µl Opti-MEM) and the Fugene HD was 
added by continuous pipetting 20-30 times.  
 
Table 2.10 Transfection reaction mixture 
DNA 1 µg 
Opti-MEM 100 µl 
Fugene HD 2.5-3 µl 
  
The mixture was kept in RT for 20 minutes and then added onto the pre-seeded cells. 
 
For a better transfection efficiency, the cells were seeded one day before into appropriate 
dishes according to the type of the experiment.  
 
2.3  Microscopy Techniques 
 
Materials and Chemicals 
 
12-well dishes (TPP) 
Round coverslips (12 mm diameter, Peske) 
35 mm glass bottom dishes (0.16–0.19 mm) (MatTek) 
Formaldehyde (methanol free, Polysciences, 04018) 
ER-Tracker Blue-White DPX dye (Invitrogen, E12353) 
FURA-2AM (Invitrogen, F1221) 
Leibovitz's medium (Gibco, 21083) 
Thapsigargin (Tg, Calbiochem, 586005) 
DAPI (4′,6-diamidino-2-phenylindole) 
 
 
Equipment 
Olympus CellR inverted microscope 
Zeiss Axiovert 200M inverted microscope 
Nikon Ti inverted microscope 
PerkinElmer UltraView spinning disc confocal on Nikon Ti inverted microscope 
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2.3.1 Immunofluorescence  
 
Table 2.11 Antibodies used in immunofluorescence experiments 
Antibody Species Dilution Source 
anti-HA.11 Clone: 16B12 mouse 1:1000 BAbCO 
anti-calreticulin rabbit 1:300 Affinity 
Bioreagents 
anti-calnexin rabbit 1:50 A. Helenius 
anti-Sec61β rabbit 1:300 B. Dobberstein 
anti-Sec61γ rabbit 1:100 S. High 
anti-TRAM rabbit 1:50 T. Rapoport 
anti-PDI mouse 1:300 Abcam 
anti-GRP78/BiP rabbit 1:100 Abcam 
anti-rabbit Alexa Fluor® 546 goat 1:600 Invitrogen 
anti-mouse Alexa Fluor® 568 goat 1:600 Invitrogen 
 
Solutions 
 
Fixation Solution-1 
 
Total dH2O 10X PBS 10% FA 1 M sucrose 
15 ml 8.625 ml 1.5 ml 3 ml 1.875 ml 
 
Fixation Solution-2 
 
Total dH2O 10X PBS 10% FA 
15 ml 12 ml 1.5 ml 1.5 ml 
 
 
In order to prepare cells for observation with fluorescence microscopy, the cells were first 
seeded onto ethanol-washed coverslips, which were placed in 12-well dishes. 300000 
HEK293T cells or 100000 U2OS or RPE-1 cells were seeded. The next day, cells were 
transfected with 0.5-1 µg of desired plasmid. For co-transfection experiments, in total of 1 µg 
DNA was used. The transfection was done for 14-20 hours. The next day, the 
immunofluorescence was performed as following: 
 
The medium was aspirated and the adherent cells were washed gently two times by 1X PBS (1 
ml per well). In the case of HEK293T cells, after aspiration of the medium, the fixation solution 
was added directly. After the PBS wash, 1 ml of fixation solution-1 was added onto cells and 
incubated for 20 minutes at room temperature (RT). The fixation solution-1 was aspirated and 
the cells were washed two times with 1X PBS. The fixation solution-2 was added and incubated 
for 10 minutes at RT. After fixation, the cells were washed and for permeabilization of the cells 1 
ml of permeabilization solution (0.3% Triton, 0.05% SDS in 1X PBS) was added into each well. 
The incubation with the permeabilization solution was done for 15 minutes at RT. After 
permeabilization the cells were washed two times with 1X PBS. In order to get rid of nonspecific 
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binding of antibodies, the 1 ml of blocking solution (10% FBS in 1X PBS) was added onto cells 
and incubation was performed for 1 hour at RT.  
 
For incubation with the primary antibody, the desired concentration of the antibody was 
prepared in 1X PBS, which was containing 5% FBS. 25 µl of the antibody solution was dropped 
onto a parafilm and the coverslip, cells facing the antibody drop, was placed onto the drop.  The 
primary antibody incubation was done for 1 hour at RT. The coverslips then placed back into the 
12-well dish and were washed three times with 1X PBS. The secondary antibody was prepared 
in the same way and this time the samples were kept in dark for 1 hour. After the incubation 
with the secondary antibody, the coverslips were placed back in the 12-well dish and washed 
three times with 1X PBS. In order to mount the coverslips onto the slides, 20 µl of mowiol was 
used. The fixed cells on the coverslip were dipped into dH2O prior to mounting on slides. The 
samples were dried either for 1 hour at 37°C or overnight at 4°C. 
The treatments with Tg or EGTA were performed prior to fixation.  
2.3.2 Epi-fluorescence microscopy of fixed cells 
 
In order to visualize the localizations of the proteins of interest, either Olympus CellR inverted 
microscope with Plan-Apo 60X / 1.4 numerical aperture (NA) oil objective or Zeiss Axiovert 
200M inverted microscope with Plan Apo 63X / 1.4 NA oil objective with 360, 488 and 561 nm 
filters were used. The images were then prepared by using either ImageJ and Adobe 
Photoshop or Metamorph softwares.  
2.3.3 Epi-fluorescence microscopy of live cells 
 
For staining the entire ER of the U2OS cells expressing GFP-Ist2-HA7-8, the cells were seeded 
in 35-mm glass bottom dishes. The cells were transfected with 1 µg of the DNA for 18 hours. 
Prior to the microscopy, the cells were incubated 30 minutes at 37°C in 2 ml of Leibovitz's 
medium, containing 10% FBS and 1 µM ER-Tracker Blue-White DPX dye, which can be imaged 
by DAPI (4′,6-diamidino-2-phenylindole) filter. Imaging was performed by using a Zeiss Axiovert 
200M Plan Apo 63X / 1.4 NA oil objective with 360 and 488 nm filters. 
2.3.4 Total Internal Reflection Fluorescence Microscopy (TIRFM) 
 
The U2OS cells were seeded in 35-mm glass bottom dishes. Next day they were co-transfected 
with the CD4-GFP (0.5 µg) and SH4-mCherry (0.5 µg) or CD4-GFP-CSSIst2 (0.5 µg) and SH4-
mCherry (0.5 µg). 18 hours after the transfection, the cells were fixed as explained in part 2.3.1. 
After fixation, they were kept and imaged in 1X PBS. The images were acquired with a TIRF 
system on a Nikon Ti inverted microscope with a TIRF 60x/1.49 NA oil objective and 488 and 
561 nm laser lines. A Hamamatsu ORCA-AG high-resolution sensitive black and white camera 
was used to acquire the images. The images were prepared by using ImageJ and Adobe 
Photoshop. 
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2.3.5 Confocal Microscopy 
 
The U2OS cells, which were grown in 35-mm glass bottom microwell dishes were transfected 
with 1 µg of the mentioned constructs for 18 to 20 hours. 30 minutes prior to imaging, the cells 
were incubated with 1 µM ER-Tracker Blue-White DPX dye in 2 ml of Leibovitz’s medium 
containing 10% FBS. They were washed once with 1X PBS and the images were acquired in 2 
ml of Leibovitz's medium containing 10% FBS at 37°C. The live cell confocal images were 
acquired on a PerkinElmer UltraView spinning disc confocal on Nikon Ti inverted microscope 
with 405 and 488 nm laser lines and a Hamamatsu EM-CCD camera. The Plan Apo 100x/1.4 
NA oil objective was used to acquire z-stack with 150 nm interval spacing. To increase 
localization precision, z-stacks were deconvolved with Huygens software 3.1 (Scientific Volume 
Imaging). 
2.3.5.1 Fluorescence Recovery After Photobleaching (FRAP) and Fluorescence Loss in 
Photobleaching (FLIP) 
 
The U2OS or HeLa cells, which were grown in 35-mm glass bottom dishes were transfected 
with 1 µg of mentioned constructs. For co-transfection, in total of 1 µg DNA was used, e.g. 0.5 
µg of Kir-GFP-CSSIst2 and 0.5 µg of ss-RFP-KDEL. They were imaged in Leibovitz's medium 
containing 10% FBS at 37°C. The PerkinElmer UltraView spinning disc confocal system on a 
Nikon Ti inverted microscope with 60x Plan Apo/1.2 NA water objective was used for imaging. 
The 488, 514 and 561 nm laser lines were used for photobleaching the specified area with 
100% power. For FRAP experiments of full and half patch, after photobleaching, images were 
acquired at half-second intervals for 300 seconds (n = 6). For FRAP of GFP-Sec61γ that is 
localized to a patch or to reticular ER was bleached by a 488-nm laser line and the images were 
acquired in one second intervals for 120 seconds (n = 4). For FRAP of ss-RFP-KDEL, the laser 
lines 514 and 561 nm were used and the image acquirement was performed in 60 millisecond 
intervals for 20 seconds (n = 6).  
 
For the FLIP experiment, ss-RFP-KDEL in a full patch was bleached with the laser lines 514 
and 561 nm with 100% power. The images were acquired every 60 milliseconds for 600 
seconds (n = 4).  
 
For all FRAP and FLIP experiments the fluorescence decrease was normalized according to 
overall bleach of a neighbouring cell. The background was subtracted. For the analysis of 
bleaching, the corrected fluorescence intensity (cFI) was calculated according to the formula 
below and the mean averages of the normalized data for each set of FRAP experiments were 
plotted and FRAP curves were fitted to a single exponential curve by using Microsoft Excel. 
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cFI =  [(FIFRAP – FIbg) / (FIFRAPt0 – FIBGt0) x 100] x [(100 – FIbleach / FIbleacht0) / 100] + 1 
 
FIFRAP = fluorescence intensity of bleached region at any time 
FIBG = fluoresce intensity of a background region at any time 
FIFRAPt0 = fluorescence intensity of bleached region at time zero 
FIBGt0 = fluoresce intensity of a background region at time zero 
FIbleach = fluorescence intensity of a region in neighbouring cell at any time 
FIbleacht0 = fluorescence intensity of a region in neighbouring cell at time zero 
2.3.6 Intracellular Ca2+ Imaging 
 
Chemicals 
2-Aminoethoxydiphenyl borate (2-APB, Sigma, D9754) 
 
Ringer Solution 
155 mM NaCl  
4.5 mM KCl  
1 mM MgCl2  
10mM D-Glucose  
5 mM Hepes  
2mM CaCl2  
 
Tg Solution 
155 mM NaCl  
4.5 mM KCl  
1 mM MgCl2  
10mM D-Glucose  
5 mM Hepes 
1 µM Tg 
 
2-APB Solution 
155 mM NaCl  
4.5 mM KCl  
1 mM MgCl2  
10mM D-Glucose  
5 mM Hepes  
2mM CaCl2  
50 µM 2-APB 
pH adjusted with HCl to 7.4 
 
For the imaging of cytosolic Ca2+ levels, the HEK293T cells were seeded in 35 mm glass 
bottom dishes and transfected with the mentioned STIM1 constructs (0.5 µg) and pIRES-GFP 
dual promoter Orai1 (0.5 µg) for 18-20 hours. Prior to imaging, the cells were loaded with 4 µM 
FURA-2AM dye for 30 min in Ringer solution at 37ºC. The cells were then incubated in Ringer 
solution for an additional 30 min at 37ºC. 5 min prior to imaging, cells were kept in the nominally 
Ca2+ free (NCF) Ringer solution (without CaCl2). During the experiment, the buffers were 
changed as shown in the graphs at indicated times. Imaging was performed by Nikon Ti 
inverted microscope with 20X SFluor objective. Images were taken every 5 seconds with 340nm 
and 387nm excitation wavelengths. The transfected cells according to GFP signal were 
selected for analysis. The analysis of the images and the calculation of the intensity ratios 
(F340/F387) were done by the Nikon imaging software (NIS-elements). The averages of at least 
150 cells from three independent experiments were calculated and the graphs were plotted in 
Microsoft Excel.  
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2.4  Biochemistry Techniques 
 
2.4.1 Expression and purification of 6xHis-GFP-fusion proteins 
 
Materials and Chemicals 
Microfluidizer (EmulsiFlex-C5) 
Isopropyl-β-D-thiogalactopyranosid (IPTG, Applichem) 
E. coli BL21 (DE3) Codon Plus 
Spectrophotometer (Pharmacia Biotech) 
Ni-NTA (nitrilotriacetic acid) Agarose Beads (Qiagen) 
LB Ampicillin (LB+Amp) 
Imidazole (Merck) 
EDTA-free protease Inhibitor complex (Roche) 
Dialysis Membrane (Spectrum, MWCO=12000-14000 kDA) 
 
Buffers 
 
Lysis Buffer 
 
50 mM Tris/HCl pH 7.5 
250 mM NaCl 
20 mM Imidazole 
2 mM EDTA 
Dialysis Buffer 1 
50 mM Tris/HCl pH 7.5 
250 mM NaCl 
 
 
Dialysis Buffer 2 
25 mM Hepes pH 7.5  
150 mM KCl 
(pH adjusted by KOH) 
 
Elution Buffer 
50 mM Tris/HCl pH 7.5 
250 mM NaCl 
300mM Imidazol
 
2.4.1.1 Expression of 6xHis-GFP-fusion proteins 
 
For the expression of GFP-fusion constructs, they were transformed into E. coli BL21 (DE3) 
Codon Plus strain. A pre-culture was prepared over day in 50 ml of LB+Amp. The culture was 
then diluted to 0.1 OD in 500 ml LB +Amp and incubated for additional 1-1.5 hours at 37ºC until 
the OD reached 0.4-0.6. The cultures were cooled down to RT by incubating for 30 min at RT. 
After addition of 0.25 mM IPTG to final concentration, they were incubated at 25ºC overnight.  
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2.4.1.2 Purification of 6xHis-GFP-fusion proteins 
 
Next day cells were spun down at 4000 rpm for 10 minutes and resuspended in 30 ml of ice-
cold lysis buffer containing 1mM PMSF, 10 mM β-mercaptoethanol and protease inhibitor 
complex. The lysis of the resuspended cells was performed by a microfluidizer at a pressure of 
15000-20000 bars. The lysate was then centrifuged by using a pre-cooled Ti45 rotor at 32000 
rpm for 45 minutes. In the mean time the Ni-NTA beads were washed three times with cold lysis 
buffer in 50 ml falcon tubes. The centrifugation of the beads was done at 1000 rpm for 1 minute. 
The supernatant of the lysate was then added onto the pre-washed beads and incubated for 1 
hour at 4ºC rotating.  
 
After the incubation for protein binding, the non-specific binding of other proteins were 
eliminated by several washing (3 to 5 times) steps with 25 ml of lysis buffer. The beads were 
transffered to 15 ml falcon tube and 2 ml of elution buffer was added. After incubation with the 
elution buffer for 1 hour at 4ºC rotating, the beads were spun down. The supernatant was 
loaded into dialysis membrane. Dialysis was performed in dialysis buffer-1 for CaM Binding 
experiments and in dialysis buffer-2 for liposome binding experiments. A step-wise dialysis was 
performed by incubation for instance in 500 ml of dialsis buffer-1 contaning 150 mM Imidazole 
and dialysis buffer-1 contaning 75 mM Imidazole for 1 hour and overnight in 1 L dialysis buffer-
1.  
 
Next day, the proteins were transferred into 1.5 ml tubes and stored at -20ºC.  Samples were 
run on 10% SDS-PAGE and analyzed by Coomassie Blue Staining. 
 
2.4.2 Calmodulin binding assay 
 
Materials and Buffers 
Calmodulin (CaM) affinity resin (Agilent technologies, 214303-52) 
NP-40 (Calbiochem) 
 
CaM binding buffer 
25 mM Tris/HCl pH 7.5 
150 mM NaCl 
1 mM CaCl2 or 0.5 mM EGTA 
0.1 % NP-40 
 
2X Sample Buffer 
100 mM Tris/HCl pH 6.8  
4% SDS  
20% glycerol  
100 mM DTT 
0.1% bromophenol blue 
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30 µl of the CaM beads were washed with CaM binding buffer. The amount of NP-40 or 
concentration of NaCl was adjusted according to the type of the experiment. The GFP or GFP-
fusion proteins (1 µM) were incubated with CaM beads in 600 µl of CaM binding buffer for 1 h at 
4ºC, rotating. The beads were then spun down at 2000 rpm for 1 minute and a sample from the 
supernatant was taken as unbound fraction. The beads were washed four times with the CaM 
binding buffer for elimination of non-specific binding of proteins. 2X sample buffer was added to 
the beads and they were boiled at 95ºC for 5 min. The samples were then run on 10% SDS-
PAGE. Blots were developed with a GFP antibody (1:5.000, SantaCruz). 
2.4.3 Liposome binding assay 
 
Materials and Equipment 
Round-bottom flask (±10ml volume) 
Pipettes (Hamilton)  
Methanol (Sigma-Aldrich Fluka) 
Chloroform (Sigma-Aldrich Fluka) 
HEPES (Roth) 
KCl (Calbiochem) 
Lipids (Avanti Polar Lipids) 
Spectrofluormeter (Jasco FP-6500) 
Mini Extruder (Avanti Polar Lipids) 
1000 nm filters (Avanti Polar Lipids) 
Dynamic Light Scattering (Zetasizer 
1000HSA; Malvern Instruments) 
NanoDrop (ND1000 Spectrophotometer)
 
Table 2.12 Lipids used for preparation of liposomes 
Lipid 
Ordering 
Number Source 
Phosphatidylcholine 
 (PC) 840055 
Bovine 
liver 
Phosphatidylethanolamine  
(PE) 840026 
Bovine 
liver 
Phosphatidylserine  
(PS) 840032 
Porcine 
brain 
Phosphatidylinositol  
(PI) 840042 
Bovine 
liver 
Sphingomyelin  
(SM) 860061 
Poultry 
eggs 
Cholesterol 
(CL) 700000 
Ovine 
wool 
Rhodamine- 
phosphatidylethanolamine 
(Rhod-PE) 810158 synthetic 
Phosphatidylinositol-4,5-
bisphospahe 
(PIP(4,5)P2) 
840046 
 
Porcine 
brain 
Phosphatidylinositol-3,4,5-
triphospahe 
(PIP(3,4,5)P3) 
850166P 
 synthetic 
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HK-buffer  
25mM HEPES 
150mM KCl 
pH 7.4 (with KOH)
 
2.4.3.1 Preparation of liposomes 
 
The lipids were added one by one in a methanol and chloroform washed round-bottom flask by 
using Hamilton pipettes. The mixture of the lipids was dried with a rotary evaporator (350mPa 
and down, 150rpm, 37˚C water bath) and after evaporation of the chloroform, the drying was 
continued at 20mPa for at least 20 minutes. The dried pellet was resuspended by continues 
shaking in HK-buffer containing 10% sucrose resulting in liposomes with 4mM concentration. In 
order to have 4mM concentration of liposomes, initially prepared 1 ml lipid mixture (3mM) was 
dissolved in 750 µl of HK-buffer containing 10% sucrose. The sucrose is necessary to pellet 
liposomes during centrifugation in further steps. The resuspended liposomes were 
homogenized by 10 freeze thaw cycles. The freezing was performed in a box containing some 
dry ice and isopropanol. The frozen liposomes were thaw in 37˚C water bath. During freezing 
and thawing, flasks were rotated so that the liposomes freeze in a more homogeneously 
distributed way on the surface of the flask- thin layer like. After this homogenization step, 
liposomes were sized by using a mini-extruder and a filter membrane, which has a pore size of 
40-1000 nm. This extrusion was performed 21 times and the liposomes were transferred into 
1.5 ml tubes. They were stored in 4˚C fridge for 3-5 days. Table 2.13 shows an example for 1 ml 
of PI(4,5)P2 containing PM like liposome preparation. 
 
The sizes of the liposomes were checked by dynamic light scattering to be around 200 nm 
(roughly 180 nm to 230 nm) in diameter.  
Table 2.13 PM-PI(4,5)P2 -like liposome preparation (1 ml of lipid mixture) 
Lipid MW (Da) mol% conc. (mg/ml) Volume (µ l) 
PC 786.12 12.5 25 24 
PE 768.06 9 10 41 
PS 810.03 5 10 24 
PI 909.12 5 10 27 
PIP(4,5)P2 1098.19 5 1 329 
SM 703.44 12.5 10 53 
CL 386.66 50 10 116 
Rhod-PE 1233.04 1 1 74 
  100   
Average MW 589.52  Sum (µ l) 689 
   Chloroform (ml) 1.31 
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2.4.3.2 Liposome binding 
 
In the case of having two different types of liposomes, such as PC or PM-like, the ratios were 
arranged according to their rhodamine signals. The readings were done by spectrofluormeter. 
The 488 nm excitation and 585/20 nm emission was used for rhod-PE.  
 
In order to calculate the concentrations of the GFP-fusion recombinant proteins, the amount of 
GFP alone was calculated by Nanodrop. The GFP signals of the other fusion proteins, which 
were detected by spectrofluometer were normalized to GFP alone. The 488 nm excitation and 
530/20 nm emission was used for GFP. The ratio between the fluorescence of GFP-fusion 
protein and GFP alone was then multiplied with the concentration of GFP alone.  
 
Prior to incubation of the protein with the liposomes, the 25 µl of liposomes were blocked in 100 
µl of HK-buffer containing 4% of BSA in Thermomixer for 1 hour at 25˚C shaking at 400 rpm. 
The liposomes were washed with 1 ml of HK-buffer and centrifuged down at 15000 xg for 10 
min at 25˚C. The supernatant was aspirated and 1 or 3 µM of protein diluted in 100 µl of HK-
buffer was added to the liposomes. The incubation was done in Thermomixer for 3-4 hours at 
25˚C and 400 rpm.   
 
After incubation, the liposomes were washed with 1 ml of HK-buffer and spun down at 15000 xg 
for 10 min at 25˚C. The pellet was resuspended in 300 µl of HK-buffer and the binding was 
analyzed by flow cytometry as described in section 2.5.2. 
 
2.4.4 Preparation of yeast membranes and proteinase K treatment 
 
Materials and Buffers 
Glass beads 0.425-0.6 mm (Sigma) 
Proteinase K (Merck) 
 
Lysis Buffer 
20 mM Hepes 
50 mM Potassium Acetate 
5 mM Magnesium Acetate 
pH was adjusted to 7.6 by KOH 
 
 
HU Buffer 
8 M Urea 
5% SDS 
200 mM Tris/Hcl pH 6.8 
1 mM EDTA 
0.025% Bromophenol blue 
4% β-mercaptoethanol 
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Ist2Δ cells (MATa ist2Δ::HIS3MX by C. Jüschke-CJY3) expressing either GFP- HAN-Ist2 or 
GFP-Ist2-HA7-8 were grown in selective medium containing 2% (w/v) raffinose. Expression was 
induced by the addition of 2% (w/v) galactose for 2 hours. Cells from 5 OD600 units were spun 
down and resuspended in 1 ml of a Lysis Buffer. Lysis was performed on ice with glass beads 
and vortexing. The beads were centrifuged at 1200 xg, for 2 minutes, at 4°C. The supernatant 
was then transferred into new tube and centrifuged for 20 minutes at 25000 xg and the resulting 
pellets was resuspended in Lysis Buffer and incubated at 37°C for 30 minutes with 5 µg/µl 
proteinase K.  
 
After addition of HU buffer to the samples, they were heated in 50°C heat-block for 20 minutes 
prior to loading on 15% SDS-gel.  
 
2.4.5 SDS-PAGE and Immunoblotting 
 
Materials and Equipment  
Mini Protean Gel System (BioRad) 
Nitrocellulose membrane (0.45 µM pore size, Protran, Whatman) 
Luminescent Image Analyzer LAS-4000 (FUJIFILM) 
ColorPlus Prestained protein Ladder (NEB, P7711S) 
Acrylamide 37.5 :1 (rotiphorese gel 30, Roth) 
TEMED (Sigma) 
APS (Sigma) 
SDS (Roth) 
Tween-20 (Sigma) 
Chemiluminescence Blotting Substrate (Roche) 
2.4.5.1 SDS-PAGE 
 
Protein samples were separated under denaturing conditions by SDS-PAGE. Mini gels 
(0.75 mm or 1 mm) were prepared according to the following scheme: 
Table 2.14 Solution mixture for polyacrylamide gel preparation 
Separating Gels 
(10 ml) 
Stacking Gel  
(5 ml)  
10 % 15 % 4 % 
30 % Acrylamide 37.5 : 1 3.3 ml 5 ml 670 µl 
dH2O 4.5 ml 2.8 ml 3 ml 
2 M Tris-HCl pH 8.8 2 ml 2 ml - 
0.5 M Tris-HCl pH 6.8 - - 1.25 ml 
10 % SDS 100 µl 100 µl 50 µl 
10 % APS 50 µl 50 µl 50 µl 
TEMED  5 µl 5 µl 5 µl 
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Samples were loaded on polyacrylamide gels and run at 25 mA for approximately 1 hour in 
SDS-PAGE running buffer. ColorPlus prestained broad range protein marker was used to 
compare protein sizes. 
 
2.4.5.2 Immunoblotting 
 
Table 2.15 Antibodies used in immunoblotting experiments 
Antibody Species Dilution Source 
anti-HA.11 mouse 1:5000 BabCo  
anti-GFP rabbit 1:5000 SantaCruz 
anti-Kar2 rabbit 1:20000 M. Seedorf 
anti-Ist2 rabbit 1:10000 M. Seedorf 
 
 
Proteins were transferred onto nitrocellulose membranes by semi-dry blotting. The standard 
blotting conditions were 110 mA per blot for 2 hours. Proteins on nitrocellulose membranes 
were stained with Ponceau S solution (1 % (v/v) acetic acid, 0.5 % (w/v) Ponceau S) for 5 min 
washed with H2O. 
 
In general, blots were blocked in 5 % dry skimmed milk dissolved in 1X PBS containing 
0.05 % (w/v) Tween (PBS-T) for 30 minutes at RT. The blots were incubated at 4 °C overnight 
with the primary antibody in 5% milk in PBS-T. Next day the blots were washed three times with 
1XPBS-T. After washing, they were incubated with the secondary antibody coupled to 
horseradish peroxidase in 5% milk in PBS-T for up to 1 hour at RT. The blots were washed 
three times with PBS-T. After incubation with the Chemiluminescence Blotting Substrate, light 
emission was acquired by LAS-4000. 
 
2.5  Flow cytometry 
 
Materials, Buffers and Equipment 
6-welldishes (TPP) 
FACS tubes (NeoLab) 
Enzyme-free PBS-based cell dissociation buffer (Gibco, Cat. 13151-014) 
FACSFlow buffer (BD, 342003) 
Propidium iodide (Invitrogen, P3566) 
Brefeldin A (BFA) (Sigma, B7651) 
FACScan (Becton Dickinson) 
FACS Calibur (Becton Dickinson) 
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2.5.1 Flow cytometry of cells 
 
Table 2.16 Antibodies used in flow cytometry experiments 
Antibody Species Dilution Source 
anti-CD4-R-phycoerythrin (PE) mouse 1:100 Dianova, (OMA1-03301) 
anti-HA.11 mouse 1:200 BabCo 
anti-mouse PE-conjugated 
AffiniPure F(ab’)2 fragment 
goat 1:200 
1:150 
Dianova (115-116-146) 
Invitrogen (P852) 
 
 
Cells were grown in 6-well dishes. HEK293, HeLa and U2OS cells were transiently transfected 
with 1 µg of GFP-Ist2-HA7-8, CD4-GFP or CD4-GFP-CSSIst2 constructs for 18 hours. For the 
analysis of the surface expression of HA-tagged STIMs, the HEK293T cells were transfected 
with 0.5 µg of HA-STIM construct with 0.5 µg GFP or pIRES-GFP dual promoter Orai1. HeLa 
and U2OS cells were collected by using enzyme-free PBS-based cell dissociation buffer, 
HEK293 and HEK293T cells were simply collected by resuspension in their medium and 
transferred in pre-chilled 1.5 ml tubes. Cells were then spun down in a 4ºC centrifuge at 2,000 
rpm for 2 minutes. After washing once with 1 ml FACSFlow buffer they were incubated with 
CD4-PE or HA.11 antibodies in 100 µl of FACSFlow buffer on ice for 30 minutes for surface 
staining. Cells were then washed once with FACSFlow buffer. The secondary antibody 
incubation for HA-tagged constructs was performed with PE-conjugated AffiniPure F(ab’)2 
fragment goat anti-mouse IgG antibody (1:200 Dianova or 1:150 Invitrogen) in 100 µl of 
FACSFlow buffer on ice for 30 min. Cells were then washed with ice-cold FACSFlow buffer and 
resuspended in 300 µl of FACSFlow buffer containing 1 µg propidium iodide (PI). Fifteen 
thousand HEK293 and HeLa, 10000 U2OS and 30000 HEK293T cells were gated for PI-
negative population and the CD4 or HA surface signal was measured by using FACScan. The 
cut offs for GFP-positive cells were set according to cells either nontransfected and stained with 
antibodies or transfected with CD4-AAXX and not stained with antibodies. The cut offs for HA 
and CD4 surface signals were set according to cells transfected with GFP.  
 
The percentage of the cells expressing HA-tagged or CD4 protein on the cell surface was 
calculated according to the ratio of PE-positive cells to PE- and GFP-positive cells. For the 
EGTA or Tg treatment, 2 mM EGTA or 1 µM Tg was added to the cells in medium for 1 hour 
prior to experiment. To block the secretory pathway, after transfection for 12 hours, the cells 
were treated with 1 µg/ml BFA for 6 hours. Three independent sets of experiments were done 
and the averages of the experiments were plotted in Microsoft Excel. The standard error of the 
mean (s.e.m.) was calculated for the error bars. 
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2.5.2 Flow cytometry of liposomes 
 
The setup of the flow cytometry of liposomes was previously done as described in (142). FACS 
Calibur was used to count the rhodamine-positive liposomes. The GFP signal cutoff was done 
by liposomes contaning no protein. 30000 liposomes were counted and the data were 
processed with CellQuest Pro software. The background binding of GFP alone was substracted. 
In addition, shape index factor of the rhodamine signal was calculated by dividing the 
rhodamine signal of GFP-fusion protein to rhodamine signal of GFP alone. Briefly the formula 
below was used to determine the corrected fluorescence units (cFU), thus binding. 
 
  (FUGFP-fusion – FUGFP-alone) 
 
         (FU RhodamineGFP-fusion / FU RhodamineGFP-alone) 
 
The data of three independent experiments were prepared and the graphs were plotted in 
Microsoft Excel. 
 
cFU = 
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3 Results 
 
In yeast, Ist2 protein predominantly localizes to the cortical ER and makes contact with the PM 
through an interaction between its cortical sorting signal (CSSIst2) and the lipids of the PM. 
Protease protection experiments showed that Ist2 could also reach to the cell surface 
independently of Golgi function. However, the cortical ER beneath the PM makes it difficult to 
determine the exact Ist2 in yeast. This led me to investigate this drawback in mammalian cells. 
The ER of mammalian cells is also capable of forming contacts with the PM, however it does 
not accumulate beneath the PM as yeast cortical ER does. Mammalian cells, which are larger in 
size, give higher microscopic resolution and were therefore suitable to study the localization of 
Ist2. Moreover, it was of interest to gain information on the conservation of the novel trafficking 
pathway of Ist2 in mammalian cells. Since the CSSIst2 is not conserved in mammalian 
homologues of Ist2 (TMEM16 family), I attached CSSIst2 to the cytosolic C-termini of mammalian 
integral proteins and investigated the localizations of these chimeras in detail.  
 
Moreover, by in silico analysis, we identified that the K-rich region of CSSIst2 shows similarity 
with the K-rich domain of mammalian STIM2 protein. This led me to investigate the molecular 
mechanism that lies behind the localization of STIM proteins.  I showed that both STIM1 and 
STIM2 are capable of forming ER-PM contact sites via their K-rich domain by binding to PM 
lipids as K-rich region of CSSIst2 does.  
 
Furthermore, STIM1, which dominantly stays in the ER, was initially shown to travel to the cell 
surface. I was therefore interested in the regulation of STIM1 localization, which is either to ER-
PM contact sites or to the cell surface. I identified two types of signals that retain STIM1 in the 
ER. One of these signals is the di-arginine based ER retention signal and the other is the K-rich 
domain, which I showed that is regulated by cytosolic Ca2+ levels. I furthered my studies on the 
cell surface function of STIM1 and found Orai1 as likely interacting Ca2+ channel.   
 
3.1  Yeast Ist2 forms ER-PM contact sites in mammalian cells 
 
Initial experiments in yeast showed that a pool of Ist2 may reach to the cell. This trafficking of 
Ist2 to the cell surface was independent of the Golgi function, suggesting that Ist2 follows an 
unconventional trafficking pathway. In order to investigate whether Ist2 reaches to the cell 
surface and whether this unconventional transport is conserved in mammalian cells, I 
investigated the localization of Ist2 in different cell lines, such as human embryonic kidney cells 
(HEK293), human cervix cancer cells (HeLa) and human bone osteosarcoma cells (U2OS). For 
detection at the cell surface, a hemagglutinin (HA) tag between the predicted transmembrane 
domains (TMD) 7 and 8 of Ist2 were inserted, resulting in GFP-Ist2-HA7–8 (cartoon, Figure 
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3.1A). In order to predict the TMDs, TMHMM server (http://www.cbs.dtu.dk/services/TMHMM-
2.0/) was used. Moreover, treatment of isolated membranes from yeast expressing green 
fluorescence protein GFP-Ist2-HA7–8 with proteinase K (PK) generated a major HA fragment of 
approximately 15 kDa (Figure 3.1B, lane 4). On the other hand treatment of membranes 
expressing GFP-Ist2 with an HA tag at the N-terminus of Ist2, however, resulted in digestion of 
the N-terminally located HA tag (Figure 3.1B, lane 2). This indicates that the N-terminus of Ist2 
and the loop between TMDs 7 and 8 are located on opposite sides of the membrane. In the 
same experiment, a fraction of Kar2, which is present in the ER lumen, was protease protected, 
whereas the C-terminal domain of Ist2 was completely digested (Figure 3.1B, lanes 2 and 4). As 
the Ist2 N- and C-terminus are oriented toward the cytosol (87), these results confirmed that the 
loop between TMDs 7 and 8 faces either the ER lumen or the exterior of the cell.  
 
If Ist2 reaches the cell surface of cells, the HA epitope will be exposed toward the exterior and 
one can measure the amount of GFP-Ist2-HA7−8 on the cell surface with HA-specific antibody 
staining. The experimental setup was controlled by co-expression of a GFP-tagged version of 
the ATP-sensitive potassium channel subunit Kir6.2 and its subunit SUR1 (51). Kir6.2 contains 
two TMDs, cytosolically orientated N- and C-termini, and exposes a di-arginine ER-retention 
signal. Between the two TMDs, Kir6.2 contains an HA epitope (see cartoon, Figure 3.1C). 
Interaction with SUR1 inactivates the di-arginine signal of Kir6.2 and the correctly assembled 
channel travels to the cell surface (51). After cotransfection, many of the GFP-positive HEK293 
cells exposed HA on their surface as shown by flow cytometry (Figure 3.1C). 
 
Figure 3.1 The HA tag in GFP-Ist2-HA7-8 faces the ER lumen and/or extracellular space. 
 
(A) Cartoon of different topologies of Ist2 in membrane vesicles with an engineered HA epitope between 
TM domains 7 and 8 or at the N-terminus. (B) Western blot of membranes from ist2Δ yeast cells 
expressing GFP-HAN-Ist2 or GFP-Ist2-HA7-8. After treatment of membranes from GFP-HAN-Ist2 and GFP-
Ist2-HA7-8 expressing yeast cells with PK, Kar2, Ist2 and Ist2 with the HA tag were detected with specific 
antibodies. For detection of the C-terminal domain of Ist2, we used an antibody raised against GST-Ist2 
residues 589-946. (C) Cartoon of the topology of Kir6.2-GFP with a HA tag positioned between the two TM 
domains (Kir6.2-HA-GFP). FACS diagram of HA surface staining of GFP-positive HEK293 cells 
cotransfected with Kir6.2-HA-GFP and SUR1. 
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3.1.1 Yeast Ist2 localizes at intracellular patch-like structures 
After showing that the HA tag faces the ER lumen and/or extracellular space, I tested the 
localization of GFP-Ist2-HA7-8 by immunofluorescence and flow cytometry. In both 
nonpermeabilized and permeabilized HEK293 cells, which were transfected with GFP-Ist2-HA7-8 
a peripheral GFP fluorescence was observed (Figure 3.2A). In permeabilized cells a perfect 
overlap between the GFP and the HA signals was observed. However, in nonpermeabilized 
cells, these structures were not recognized by the HA antibody. This indicates that the 
engineered HA tag is not recognized at the cell surface, suggesting that Ist2 resides at 
peripheral intracellular structures.  
 
Figure 3.2 Ist2 localizes to intracellular structures in different cell types. 
(A) Epifluorescence microscopy of HEK293 cells after transfection with GFP-Ist2-HA7-8. GFP fluorescence 
(green) and antibody staining of HA (red) at the surface of nonpermeabilized cells and in permeabilized 
cells are shown. The scale bar in this figure and all following figures corresponds to 10 µm, if not 
mentioned otherwise. (B) GFP fluorescence of HEK293, HeLa and U2OS cells expressing GFP-Ist2-HA7-8 
and FACS diagrams of HA surface staining of GFP-positive cells. (C) Localization of GFP-Ist2 in different 
cell types. GFP fluorescence of HEK293, HeLa and U2OS cells expressing GFP-Ist2 visualized by 
epifluorescence microscopy. 
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In order to obtain better spatial resolution of these peripheral structures and to analyze whether 
their formation is a general phenomenon, localization studies of GFP-Ist2-HA7-8 was carried on 
in different cell lines, such as epithelial HeLa and U2OS cells. Epifluorescene microscopy 
revealed that HeLa and U2OS cells express GFP-Ist2-HA7-8 in morphologically different patch-
like structures, changing from dot-like appearance to large rectangular-shaped ones (Figure 
3.2B). In addition to the patches, HeLa cells often showed a diffuse intracellular GFP signal, 
suggesting that some of the GFP-Ist2-HA7-8 remained at reticular ER structures. This was 
different from the situation in U2OS cells, which developed patches without any apparent 
reticular localization of GFP-Ist2-HA7-8. Different transfection methods (lipid- or Ca2PO4-
mediated transfection) had no impact on the formation of patches (data not shown). 
Quantification of the HA surface signal by flow cytometry in GFP-Ist2-HA7-8-transfected 
HEK293, HeLa and U2OS cells showed that the HA tag was not accessible for antibodies 
added from the outside (Figure 3.2B). This suggests that Ist2 does not localize to the surface of 
all tested cells. Moreover, the HA tag had no influence on the intracellular distribution of Ist2, 
since the GFP-Ist2-HA7-8 and GFP-Ist2 without the HA tag localized similarly (Figure 3.2C and 
B). 
Together, these results revealed that Ist2 in mammalian cells resides at peripheral but 
intracellular membranes. 
3.1.2 Yeast Ist2 localizes at peripheral ER structures 
The next question was to identify these peripheral intracellular structures. Localization studies in 
living U2OS cells by epifluorescence microscopy revealed that some of the ER co-localized with 
GFP-Ist2-HA7-8 patches (Figure 3.3). In this experiment, the entire ER was stained with the ER-
specific lipid dye ER-Tracker™.  
 
Figure 3.3 Yeast Ist2 localizes to patch-like ER structures in U2OS cells. 
Co-localization of GFP-Ist2-HA7-8 (green) and ER-tracker (red) in U2OS cells. The inserts show patch 
formation of GFP-Ist2-HA7-8 and recruitment of some of the ER to these patches. 
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3.1.3 The CSSIst2 targets integral membrane proteins to PM-associated domains of the 
ER 
As it does in yeast cells (85, 91), the CSS in GFP-Ist2 may bind to PI(4,5)P2 and/or other PIPs 
in the mammalian PM. This interaction may result in the recruitment of ER to the PM and 
explain why GFP-Ist2-HA7-8 was not detected at the cell surface. To test whether this 
recruitment of ER to the PM is achieved by the function of the CSSIst2, the CSSIst2 was attached 
to the cytosolically oriented C-terminus of the T-cell surface glycoprotein CD4 (Figure 3.4A). 
Staining with an antibody that recognizes the N-terminus of CD4 in nonpermeabilized HEK293 
cells showed that 76% of the GFP-positive cells express CD4-GFP at the cell surface. On the 
other hand, quantification of CD4-GFP-CSSIst2 in GFP-positive HEK293 cells showed that only 
26% of these cells had CD4 at the cell surface (Figure 3.4B).  
Furthermore, I investigated whether this small amount of surface expression of CD4-GFP-
CCSIst2 is dependent on the function of the Golgi. For this purpose, I treated the cells with 
brefeldin A (BFA) 6 hours prior to measurement of the surface-located CD4 by flow cytometry. 
Trafficking of CD4-GFP-CSSIst2 to the surface was BFA sensitive, indicating that a certain 
fraction of CD4-GFP-CSSIst2 reached the surface of HEK293 cells via transport along the 
classical secretory pathway (Figure 3.4B).  
 
 
Figure 3.4 The CSSIst2 traps CD4 at intracellular structures.  
(A) Cartoon of the topology of GFP-Ist2 and CD4-GFP tagged with CSSIst2. The position of two N-linked 
glycosylation sites in CD4 is indicated. (B) Quantification of HEK293 and U2OS cells expressing CD4 on 
their cell surface by flow cytometry after transfection with CD4-GFP and CD4-GFP-CSSIst2. HEK293 cells 
were treated for 6 h with BFA (+BFA). The data represents the average of three independent experiments 
and the error bar of this and all following flow cytometry quantifications show the standard error of the 
mean (s.e.m.) 
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Moreover, I tested the localization of CD4-GFP-CSSIst2 in U2OS cells and found that the vast 
majority of these cells had no CD4-GFP-CSSIst2 on their surface. This suggests that the CSSIst2 
retains the majority of CD4 in U2OS cells at intracellular structures. In U2OS cells, CD4-GFP-
CSSIst2 fluorescence appeared as distinct patches at the cell periphery (Figure 3.5A, middle 
panel and insert), while CD4-GFP alone was distributed over the entire cell. CD4-GFP was 
enriched in the region of the Golgi with GFP signal visible at cell edges corresponding to CD4-
GFP at the PM (Figure 3.5A, left panel). Detection of the ER marker calreticulin by antibody 
staining in CD4-GFP-CSSIst2 expressing U2OS cells revealed that the formation of CD4-GFP-
CSSIst2 containing patches had a dramatic impact on the distribution of calreticulin. Instead of an 
ER-like reticular staining, as in CD4-GFP expressing cells, calreticulin showed a clear co-
localization with peripheral CD4-GFP-CSSIst2 (Figure 3.5B). 
 
 
 
 
Figure 3.5 CSSIst2 drags CD4 into patch-like ER structures. 
(A) Sequence of the last 18 residues of yeast Ist2. According to the prediction program ‘AmphipaSeek’, the 
last 11 residues are shown as α-helical wheel projection (143). The arrows indicate mutations into alanine. 
GFP fluorescence detected by epifluorescence microscopy of U2OS cells expressing CD4-GFP, CD4-
GFP-CSSIst2 and CD4-GFP-CSSIst2 with K931, K933, H934, K935 and K936 to A mutations (K to A). (B) 
GFP fluorescence of U2OS cells after transfection with CD4-GFP (green) and CD4-GFP-CSSIst2 (green) 
and antibody staining of calreticulin (red) visualized by epifluorescence microscopy. 
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This suggests that the majority of CD4-GFP-CSSIst2 localized at specific ER domains and that 
the expression of CD4-GFP-CSSIst2 resulted in a dramatic reorganization of the ER. 
 
As the CSSIst2 signal can drive CD4-GFP into distinct patch-like structures, which seem close 
but on the cytosolic side of the PM, I further investigated the responsible residues of this signal 
that result in this patch-like localization of the ER. Previous in vitro experiments showed that the 
positively charged residues of the CSSIst2 and an amphipathic α-helix of 11 residues with 
hydrophobic side chains on one side of the helix are essential for the binding to PI(4,5)P2-
containing PM-like liposomes (85, 91). This indicates that an interaction between positive 
residues of the CSSIst2 and lipids at the PM recruits yeast Ist2 to PM-associated domains of the 
cortical ER. In yeast, the efficient transport of Ist2 from the perinuclear to the cortical ER was 
diminished by mutation of K931, K933, H934, K935 and K936 to alanine (85). In the context of 
CD4-GFP-CSSIst2 in U2OS cells, this mutation (denoted as K to A) abolished the formation of 
patches. Mutated CD4-GFP-CSSIst2 localized at structures resembling the general ER (Figure 
3.5A, right panel), suggesting that mutation of K931, K933, H934, K935 and K936 abrogates the 
function of the CSSIst2 as a strong signal for sorting to the cell periphery. Moreover, these 
results suggest that this mutation most likely interferes with the α-helical structure of the CSSIst2 
C-terminus and as a result leads to the exposure of a linear KKKL sequence, which then 
functions as ER-retention signal. 
3.1.4 Mutations in CSSIst2 changes the morphology of the ER 
 
In order to study the structural requirements of this lipid-protein interaction, additional mutations 
were created in the K-rich region of CSSIst2. One of the mutations was L939P, which is expected 
to destroy the amphipathic α-helix structure due to introduction of the proline. As expected, the 
patch formation was demolished and instead, a more tubular ER forms were created (Figure 
3.6). Another mutation was created to destroy the amphipathic behavior of the helix. In this 
mutation two alanine residues were inserted in between K941 and L942. This mutation gave a 
similar phenotype as the L939P mutation. The exaggerated formation of ER-tubules in both 
mutants might be due to either interaction of the mutant CSSIst2 with ER-lipids or an increased 
association with microtubules. Indirect immunofluorescence experiments showed that these 
structures co-localize with tubulin, supporting the latter possibility (data not shown). Another 
mutation was created in order to reduce the hydrophobicity of the α-helix. In this case leucine 
residue was mutated into a glutamine residue (L942Q). This mutation resulted in more reticular 
localization. As seen in figure 3.6, all mutations destroyed the formation of ER-PM contact sites, 
suggesting the importance of the basic, hydrophobic and the α-helical structure in binding to PM 
lipids.  
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Figure 3.6 Mutations in CSSIst2 abolish the binding to PM lipids. 
First row shows the localization of CD4-GFP-CSSIst2 (green) and the other rows show the mutants of 
CSSIst2 (green). The calreticulin was stained in order to visualize the ER (red).  
 
3.1.5 The peripheral ER structures are in close proximity to PM 
 
The localization of both GFP-Ist2-HA7-8 and CD4-GFP-CSSIst2 revealed that, the CSSIst2 
promotes formation of specialized ER domains. In order to study the localization of these 
domains in detail, I performed more advanced microscopy experiments.  
 
In order to visualize the peripheral and perinuclear ER in cells expressing CD4-GFP-CSSIst2 in 
more detail, confocal microscopy was applied. An xy-view of a CD4-GFP-CSSIst2 expressing cell 
showed the formation of patches at a position, where this cell is in contact with the coverslip 
(Figure 3.7A, bottom view). The corresponding z-plane from the middle of this cell revealed a 
weaker staining of CD4-GFP-CSSIst2 at perinuclear and reticular ER structures, which were 
stained with ER-Tracker (Figure 3.7A, middle views). The arrows indicate staining of CD4-GFP-
CSSIst2 at perinuclear ER. A reconstruction of the z-view of a CD4-GFP-CSSIst2 expressing 
U2OS cell showed that the majority of CD4-GFP-CSSIst2 accumulated in patches, which were 
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distributed over the entire cell surface (Figure 3.7B). These patches seemed to be continuous 
with perinuclear and intracellular structures, without a disruption of the perinuclear ER. 
 
The limited axial resolution of the confocal microscope (approximately 500 nm) does not allow 
exact statements about the position of the patches with respect to the PM. Therefore; total 
internal reflection fluorescence microscopy (TIRFM) was applied. By this approach fluorophores 
within 100 nm of the PM are selectively excited, allowing to resolve the structures, which are in 
close proximity to the PM (144). At many positions at the bottom of a U2OS cell, the staining of 
CD4-GFP overlapped with the PM marker SH4-mCherry, indicating that these proteins localize 
to the PM within the resolution of TIRFM (Figure 3.7C, second row). The dark spots in SH4-
mCherry expressing cells correspond to parts of the cells that are not attached to the coverslip. 
In TIRFM, fluorophores at these positions are not excited, which results in their dark 
appearance. Co-localization of CD4-GFP-CSSIst2 and SH4-mCherry at the PM with TIRFM 
showed that CD4-GFP-CSSIst2 patches are in close proximity to the PM (Figure 3.7D, bottom 
row). Epifluorescence images of the corresponding cells are shown in figure 3.7C and D (upper 
rows).  
 
Taken together, the expression of CD4-GFP-CSSIst2 induces peripheral calreticulin-positive ER 
domains, which are aligned close to the PM. 
 
 
Figure 3.7 CD4-GFP-CSSIst2 localizes at PM-associated ER patches.  
(A) U2OS cells after transfection with CD4-GFP-CSSIst2 visualized by confocal microscopy. CD4-GFP-
CSSIst2 localization is shown in green and ER-Tracker staining in red. The bottom view shows the z-plane 
where the cell is in contact with the coverslip and the middle view shows co-staining of CD4-GFP-CSSIst2 
and ER-Tracker at the perinuclear ER (indicated by arrows). (B) Reconstruction of a z-view from a cell 
expressing CD4-GFP-CSSIst2. N denotes the nucleus. (C) Co-localization of CD4-GFP (green) and SH4-
mCherry (red) by epifluorescence and TIRF microscopy. (D) Co-localization of CD4-GFP-CSSIst2 (green) 
and SH4-mCherry (red) by epifluorescence and TIRF microscopy. 
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3.1.6 The CSSIst2 functions as dominant sorting signal in mammalian cells 
Next, I investigated whether the formation of peripheral ER patches is a general process, and 
occurring independently of features of the membrane protein that contains the CSSIst2. For this 
purpose CSSIst2 was attached to the cytosolically oriented C-termini of three different integral 
membrane proteins: the major histocompatibility complex class I heavy chain H-2Kb (MHCI), 
Kir6.2 and the ATP-dependent transporter associated with an antigen presentation subunit 
TAP1. MHCI has a similar topology and localization as CD4, but it requires the MHCI light chain 
β2-microglobulin as well as the TAP peptide transporter and associated molecules for efficient 
peptide loading and trafficking to the PM (145). TAP1 is an ER-resident multi-spanning 
membrane protein, which forms a heterodimeric peptide transporter with TAP2 and is strictly 
retained in the ER (146). In U2OS cells, which lack β2-microglobulin and SUR1, transfection of 
either MHCI-GFP or Kir6.2-GFP or TAP1-GFP resulted in an expression at the reticular ER 
(Figure 3.8A). The attachment of the CSSIst2 to these three proteins led to a patch-like 
localization of the corresponding chimeras at positions where these cells are in contact with the 
coverslip (Figure 3.8A, bottom views). Moreover, the ER-Tracker co-localized with these 
peripheral patches, confirming these structures are the domains of the ER. The corresponding 
z-planes from the middle of these cells revealed a weaker staining of the chimeras (Figure 3.8A, 
middle views). These data suggest that the CSSIst2 overrides the endogenous sorting signals of 
CD4 (Figure 3.5), MHCI, Kir6.2 and TAP1 (Figure 3.8A). 
Since TAP1 and TAP2 form a stable complex, I examined whether TAP1-GFP-CSSIst2 targets 
the assembled TAP heterodimer into patches. This was analyzed by co-expression of TAP1-
GFP-CSSIst2 and TAP2-tdimer2(12) in U2OS cells. The heterodimer showed the identical 
localization in patches as the TAP1-GFP-CSSIst2 monomer (Figure 3.9A). This indicates that 
TAP1-GFP-CSSIst2 forms a complex with TAP2 and that the CSSIst2 functions as dominant 
signal for the TAP1-TAP2 heterodimer. 
To further characterize the PM-associated ER patches, I investigated their protein composition. 
I performed antibody staining of different ER proteins in CD4-GFP-CSSIst2 expressing U2OS 
cells. Peripheral patches contained calnexin in addition to calreticulin but not Sec61γ (Figure 
3.9B, C). This suggests a specific protein composition of the peripheral patches: CD4-GFP-
CSSIst2 recruited calreticulin and calnexin, whereas the translocon component Sec61γ remained 
separated from the patches. Since the two lectin-like chaperones calnexin and calreticulin 
interact with and assist the folding of proteins that carry monoglucosylated N-linked glycans 
(43), I studied whether the recruitment of these two chaperones depends on the presence of N-
linked glycans in CD4. 
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Figure 3.8 The CSSIst2 sorts different membrane proteins into peripheral ER patches.  
(A) Topology of MHCI, Kir6.2 and TAP1. Epifluorescence microscopy of U2OS cells after transfection with 
the indicated proteins tagged with GFP (top row). (B) Confocal microscopy of U2OS cells after transfection 
with the indicated proteins tagged with GFP-CSSIst2 (green) and co-staining with ER-Tracker (red). Shown 
are bottom and middle z-planes. 
 
Expression of MHCI-GFP-CSSIst2, which also receives an N-linked glycan, resulted in the 
recruitment of calnexin and calreticulin into peripheral patches. However, the expression of 
TAP1-GFP-CSSIst2, which does not contain an N-linked glycosylation site, did not recruit 
calnexin and calreticulin (Figure 3.9B; Table 3.1). In addition to calnexin and calreticulin, the 
presence of protein disulfide isomerase (PDI), translocon-associated protein Sec61β, 
translocating chain-associating membrane protein TRAM, ER luminal Hsp70-like chaperone BiP 
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(Binding immunoglobulin Protein) and TAP2 was tested (Table 3.1). Translocon components 
and BiP were not enriched in patches, arguing that the induced peripheral ER domains are 
separated from the rough ER. TAP2 is an example for another ER protein that is not enriched in 
CD4-GFP-CSSIst2 and MHCI-GFP-CSSIst2 containing peripheral ER. The peptide transporter 
subunit TAP2 is unstable in the absence of TAP1 and not expected to be redirected to the ER 
periphery by MHCI-GFP-CSSIst2 (147, 148). 
 
 
Figure 3.9 CSSIst2 functions as a strong signal.  
(A) Epifluorescence microscopy of U2OS cells after transfection with TAP2-tdimer2(12) (red), and co-
transfection with TAP1-GFP (green) or TAP1-GFP-CSSIst2 (green). (B) Epiflouresence microscopy of cells 
after transfection with CSSIst2 tagged proteins (green) and co-staining of ER with either calnexin or (C) 
Sec61γ. 
 
In summary, the presence of a specific set of proteins suggests that the induced peripheral ER 
represents a subdomain of the smooth ER. Moreover, the properties of the different reporter 
proteins with CSSIst2 influence the composition of these peripheral ER domains. 
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Table 3.1 Accumulation of the indicated ER proteins at peripheral patches induced by 
expression of CD4-GFP-CSSIst2, MHCI-GFP-CSSIst2 and TAP1-GFP-CSSIst2 in U2OS cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.7 The CSSIst2-dependent peripheral ER formation does not alter the function of the 
ER 
 
In order to investigate the effect of ER-PM contact site formation on the function of ER, the 
anterograde trafficking from ER to Golgi was investigated. For this reason, I used red 
fluoresence protein (RFP)-tagged GalTase, which localizes to Golgi (Figure 3.10B). I performed 
a fluorescent recovery after photobleaching (FRAP) experiment, where I bleached the Golgi 
localized GalTase-RFP and checked the recovery of the Golgi fluorescence. If the peripheral 
ER formation abolishes the trafficking from ER to Golgi, the recovery of GalTase-RFP in Golgi 
would not be similar as in the control cells. In order to induce the peripheral ER formation, I co-
expressed GalTase-RFP and Kir-GFP-CSSIst2. As a control, I analyzed cells co-expressing 
Kir6.2-GFP and GalTase-RFP. In Hela cells, Kir6.2-GFP-CSSIst2 localized to patch-like ER 
structures (Figure 3.10A). Both in control cells, co-expressing Kir6.2-GFP and GalTase-RFP, 
and cells expressing Kir6.2-GFP-CSSIst2 and GalTase-RFP, the recoveries of Golgi 
fluorescence were identical (Figure 3.10B and C).  
 
This suggests that the trafficking from the ER to the Golgi was not affected by the formation of 
CSSIst2-dependent ER-PM contact sites. 
 
 
ER markers 
 
CD4-GFP- 
CSSIst2 
 
MHCI-GFP- 
CSSIst2 
 
TAP1-GFP- 
CSSIst2 
Calreticulin Yes Yes No 
Calnexin Yes Yes No 
PDI Yes Yes No 
Sec61β Yes No No 
Sec61γ No No No 
TRAM No No No 
GRP78/BiP No No No 
TAP2 No No Yes 
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Figure 3.10 CSSIst2-dependent ER-PM contact site formation does not alter the trafficking from 
ER to Golgi 
(A) Fluorescence of Kir6.2-GFP-CSSIst2 (green) and ER-tracker (red) in living HeLa cells. (B) The left 
image shows the fluorescence before (pre-bleach), the middle images show 1 second after (bleach) and 
300 seconds after photobleaching (post-bleach) of Golgi. The right image shows the localization of Kir6.2-
GFP in the same cell. The bottom part shows the quantitation of FRAP analysis of Golgi during the first 
300 seconds (n = 6). All bleached areas are indicated and the scale bars of all FRAP experiments 
correspond to 2 µm. (C) The left image shows the fluorescence before (pre-bleach), the middle images 
show 1 second after (bleach) and 300 seconds after photobleaching (post-bleach) of Golgi. The right 
image shows the localization of Kir6.2-GFP-CSSIst2 in the same cell. The bottom part shows the 
quantitation of FRAP analysis of Golgi during the first 300 seconds (n = 6).  
 
 
3.1.8 CSSIst2-induced PM-associated ER domains are stable structures 
In order to further investigate the properties of the peripheral ER patches, I analyzed the 
mobility of the CSSIst2-tagged protein in these patches. Confocal laser scanning microscopy of 
living U2OS cells expressing Kir6.2-GFP-CSSIst2 revealed that most of the patches were static. 
Only occasionally, fission and fusion events were observed (data not shown).  
Photobleaching of a complete Kir6.2-GFP-CSSIst2 patch (of approximately 3 µm diameter) 
revealed that the recovery of fluorescence in this area was extremely slow. Five minutes after 
photobleaching, the signal of the bleached area remained low (Figure 3.11A, post-bleach 
image). On the other hand, within a patch, Kir6.2-GFP-CSSIst2 displayed mobility. When a 
region corresponding to approximately 50% of a patch was bleached, fluorescence of the 
bleached area recovered to 40% of the pre-bleach intensity with a t1/2 recovery of 26 seconds 
(Figure 3.11A, lower panel). These experiments indicate that individual patches can be 
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considered as stable units with little exchange of Kir6.2-GFP-CSSIst2 between individual 
patches. However, the protein is mobile within a patch. 
Next, I studied whether the lumen of these patches is continuous with the rest of the ER. For 
this purpose, the Kir6.2-GFP-CSSIst2 was co-expressed with an artificial luminal ER marker 
comprising of a signal sequence, RFP and the ER-retention signal KDEL (ss-RFP-KDEL). 
FRAP of a complete Kir6.2-GFP-CSSIst2 patch revealed a t1/2 recovery of ss-RFP-KDEL of 1.4 
seconds (Figure 3.11B, blue curve). This t1/2 recovery was similar to the t1/2 recovery of ss-RFP-
KDEL (0.8 seconds) at reticular ER (Figure 3.11B, green curve) and t1/2 recovery, which was 
similar to what has been observed for ss-GFP-KDEL in the ER of CHO cells (149). These data 
indicate that the diffusion of this lumenal ER reporter between general ER and peripheral ER 
patches is similar to its diffusion within the reticular ER.  
 
Figure 3.11 PM-associated ER domains are stable structures. 
(A) Fluorescence of Kir6.2-GFP-CSSIst2 in living U2OS cells. The left image shows the fluorescence before 
(pre-bleach), the middle image 1 second after (bleach) and the right image 300 seconds after 
photobleaching (post-bleach) of an entire patch (top panels) or one half of a patch (bottom panels). The 
bottom part shows the quantitation of FRAP analysis of complete patch compared to half patch during the 
first 120 seconds (n = 6). All bleached areas are indicated and the scale bars of all FRAP experiments 
correspond to 2 µm. The time-points of the bleach and the post-bleach images are indicated. (B) 
Fluorescence of ss-RFP-KDEL in cells transfected with Kir6.2-GFP-CSSIst2. The first image of the top row 
shows Kir6.2-GFP-CSSIst2 (green). The bottom row shows ss-RFP-KDEL fluorescence in a cell without 
transfection of Kir6.2-GFP-CSSIst2. The bottom part shows the quantitation of these FRAP experiments (n 
= 6).  
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This is consistent with the results from fluorescence loss in photobleaching (FLIP) analysis with 
repeated bleaching of a Kir6.2-GFP-CSSIst2 patch, which resulted in loss of ss-RFP-KDEL 
fluorescence at the entire ER (Figure 3.12A). In addition to the lumenal ER protein ss-RFP-
KDEL, I investigated whether an integral membrane protein (Sec61γ) can diffuse into a 
peripheral ER patch. Compared to endogenous Sec61γ (Figure 3.9C), the overexpressed GFP-
Sec61γ was localized at peripheral ER patches. Photobleaching of CD4-mCherry-CSSIst2 
patches revealed a t1/2 recovery of 14.5 seconds (Figure 3.12B, blue curve). This was similar to 
the t1/2 recovery of 11 seconds of GFP-Sec61γ to reticular ER (Figure 3.12, green curve).  
Taken together, these FRAP and FLIP data show that CSSIst2-induced peripheral ER patches 
are in continuity with the rest of the ER. 
 
Figure 3.12 CSSIst2-driven peripheral patches are in continuity with the ER.  
(A) Co-expression of Kir6.2-GFP-CSSIst2 and ss-RFP-KDEL and repeated photobleaching (FLIP) of ss-
RFP-KDEL in the indicated area. The bottom part shows the quantitation of the loss of ss-RFP-KDEL 
fluorescence (n = 4). (B) Fluorescence of GFP-Sec61γ in cells transfected with CD4-mCherry-CSSIst2. The 
first image of the top row shows CD4-mCherry-CSSIst2 (red). The bottom row shows GFP-Sec61γ 
fluorescence in a cell without transfection of CD4-mCherry-CSSIst2 after similar photobleaching. The 
bottom part shows the quantitation of these FRAP experiments (n = 4). 
 
3.1.9 The CSSIst2 binds PI(4,5)P2 at the PM 
Next, I asked whether different proteins containing CSSIst2 are targeted to similar regions of the 
PM. To address this question, I expressed Kir6.2-GFP-CSSIst2 with CD4-mCherry-CSSIst2. Both 
proteins localized in overlapping patches (Figure 3.13A), suggesting that they are targeted to 
similar domains of the PM. Since in yeast the CSSIst2 could be functionally replaced by the 
PI(4,5)P2-binding PH domain from phospholipase C-δ1 (PLC-δ1-PH) (91), I investigated 
whether this domain targets Kir6.2-GFP in a similar manner. The PH domain was fused to the 
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C-terminus of Kir6.2-GFP resulting in Kir6.2-GFP-PH. Expression of this chimera resulted in 
localization in patches (Figure 3.13B), indicating that they represent physical contacts between 
the ER and PI(4,5)P2 at the PM. To test whether these domains are similar to those targeted by 
the CSSIst2, Kir6.2-GFP-PH was co-expressed with CD4-mCherry-CSSIst2. These proteins 
shared a large degree of co-localization (Figure 3.13C), suggesting that CSSIst2 binds PI(4,5)P2 
at the PM. 
In summary, I found that interaction of a lipid-binding signal in an ER-membrane protein with 
PM lipids, targets ER to the PM.  
 
 
Figure 3.13 The CSSIst2 interacts with PI(4,5)P2 at the PM.  
(A) Co-localization of Kir6.2-GFP-CSSIst2 (green) and CD4-mCherry-CSSIst2 in U2OS cells analyzed by 
epifluorescence microscopy. (B) Localization of Kir6.2-GFP and Kir6.2-GFP-PH in U2OS cells. PH 
denotes the PI(4,5)P2-binding PH domain from phospholipase C-δ1. (C) GFP and mCherry fluorescence of 
U2OS cells expressing Kir6.2-GFP-PH (green) and CD4-mCherry-CSSIst2 (red).  
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3.2  Mammalian STIM proteins form Ist2-like ER-PM contact 
sites 
The formation of ER-PM contact sites occurs naturally in mammalian cells in order to uptake 
Ca2+ from outside into the cytosol. The ER-PM contact site formation is initiated by depletion of 
Ca2+ in the ER and this process is called Store Operated Ca2+ entry (SOCE). STIM proteins are 
the molecular players of this process, which is crucial for the activation of immune cells (see 
Introduction). 
Both STIM1 and STIM2 are single-pass ER membrane proteins. The C-terminus faces the 
cytosol and the luminal N-terminus is comprised of Ca2+ sensing EF-hand and a SAM domain. 
The cytosolic C-terminus has two coiled-coil (CC) domains and an extreme K-rich domain 
(Figure 3.14A).  
In order to investigate whether the ER-PM contact site formation is conserved in mammalian 
proteins, I analyzed the features of STIM1 and STIM2 C-terminal domains in binding to PM 
lipids.  
3.2.1 Comparison of features of CSSIst2 with STIM1 and STIM2 C-termini 
Sequence comparison between the C-termini of STIM1, STIM2 and Ist2 shows that these 
sequences are rich in basic residues (Figure 3.14B). Within the last 18 residues of STIM1, 
STIM2 and Ist2, there are eight to nine lysine or arginine residues and only one (Ist2 and 
STIM2) or none (STIM1) acidic residue (Figure 3.14B). Another feature of the extreme C-
terminus of Ist2 is the formation of an amphipathic α-helix with four hydrophobic leucine 
residues forming a hydrophobic patch on one side of the helix (Figure 3.14C). Circular 
dichroism spectroscopy with a 14 amino acid peptide corresponding to Ist2 933-946 in 
trifluoroethanol confirmed that this sequence has the propensity to adopt an α-helical structure 
(85). Whether the extreme C-termini of STIM1 and STIM2 can adopt an α-helical fold as well 
remains open. The presence of a proline at the extreme C-terminus of STIM1 K-rich region 
makes it unlikely to form a helix (Figure 3.14C). 
To investigate whether the STIM1 and STIM2 have similar activities as CSSIst2, the entire C-
terminal domains of STIM1 and STIM2 were attached to the C-terminus of Kir6.2-GFP (Figure 
3.15A). Kir6.2-GFP-STIM1C showed a similar reticular ER localization as Kir6.2-GFP, whereas 
the attachment of the STIM2 C-terminal domain led to the recruitment of Kir6.2-GFP-STIM2C 
into dot- and patch-like structures (Figure 3.15A).  
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Figure 3.14 The domain structure of STIMs and comparisons of their K-rich domains with the K-
rich region of CSSIst2.  
 
(A) Cartoon of STIM1 and STIM2. EF indicates the N-terminal EF-hand domains, TM the transmembrane 
domains, CC the two coiled-coil domains, CAD the CRAC channel activation domain of STIM1, P the 
proline-rich domains and K the lysine-rich domains. (B) C-terminal sequences of STIM1 (aa 640 to 663 of 
the mature protein, without counting the signal sequence of 22 residues), STIM2 (aa 706 to 732 of the 
mature protein, without counting the signal sequence of 14 residues) and Ist2 (aa 920 to 946, the protein 
does not have a cleaved signal sequence). Basic residues are shown in bold blue and acidic residues in 
red. (C) The α-helices of Ist2 (last 14 residues), STIM2 (last 12 residues) and STIM1 (last 10 residues) 
according to the HeliQuest program (http://heliquest.ipmc.cnrs.fr/). 
 
 
Comparison of different U2OS cells expressing Kir6.2-GFP-STIM2C showed a variable number 
of dots and patches and staining of reticular ER-like structures (Figure 3.15B). Moreover, similar 
to CSSIst2, the C-terminal domain of STIM2 did not change the morphology of the peripheral ER 
(Figure 3.15C).  
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Figure 3.15 STIM2C targets Kir6.2-GFP to similar peripheral structures as CSSIst2 with dot- or 
patch-like appearance.  
 
(A) Cartoon of topology of Kir6.2-GFP with the C-terminal domains of STIM1 and STIM2 and the CSSIst2 
attached to its C-terminus. Epifluorescence microscopy of U2OS cells transfected with these constructs. 
(B) GFP fluorescence of different U2OS cells expressing Kir6.2-GFP-STIM2C visualized by 
epifluorescence microscopy. (C) Confocal microscopy of a cell expressing Kir6.2-GFP-STIM2C (green) 
and co-staining with ER-Tracker (red). Shown are a bottom and a middle z-plane and reconstruction of an 
xz-section of Kir6.2-GFP-STIM2C localization.  
 
Moreover, co-localization of Kir6.2-GFP-STIM2C and CD4-mCherry-CSSIst2 in U2OS cells 
showed that both proteins accumulated at overlapping peripheral domains, whereas co-
expression of Kir6.2-GFP-STIM1C and CD4-mCherry-CSSIst2 did not lead to such co-
localization (Figure 3.16). Taken together, these results suggest that the CSSIst2 and the C-
terminal domain of STIM2 have similar properties with respect to the formation of ER-PM 
contacts. 
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Figure 3.16 STIM2C and the CSSIst2 interact with similar domains at the PM.  
GFP and mCherry fluorescence of U2OS cells expressing CD4-mCherry-CSSIst2 (red) with Kir6.2-GFP-
STIM1C (green) or Kir6.2-GFP-STIM2C (green). 
 
3.2.2 The C-termini of STIM1 and STIM2 interact with PM lipids 
As Kir6.2-GFP-STIM2C patches overlapped with CD4-mCherry-CSSIst2, I investigated whether 
STIM proteins bind to membrane lipids as CSSIst2 does. In order to address this question, a 
FACS-based liposome-binding assay was performed (142). With this approach, the ability of 
GFP-tagged recombinant C-termini of STIM1 (GFP-STIM1C) and STIM2 (GFP-STIM2C) to 
interact with PIP-containing liposomes was explored. As previously shown (85, 91), 
recombinant GFP-CSSIst2 interacts with PM-like liposomes (50 mol% cholesterol, 12.5 mol% 
sphingomyelin, 12.5 mol% phosphatidylcholine, 9 mol% phosphatidylethanolamine, 5 mol% 
phosphatidylserine, 5 mol% phosphatidylinositol) containing 5 mol% PI(4,5)P2, whereas GFP 
did not (Figure 3.17A). This binding of GFP-CSSIst2 was set arbitrarily to 100 to normalize all 
data. The binding of GFP-CSSIst2 to PM-like liposomes required PI(4,5)P2, whereas PC 
liposomes containing 5 mol% PI(4,5)P2 showed an eightfold reduction of GFP-CSSIst2 binding. 
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Figure 3.17 Binding of the C-terminal domain of STIM1 and STIM2 to liposomes.  
(A) Relative binding of recombinant GFP, GFP-CSSIst2, GFP-STIM1C and GFP-STIM2C to PM-like 
liposomes with or without 5 mol% PI(4,5)P2 and to PC liposomes with 5 mol% PI(4,5)P2. Binding of GFP-
CSSIst2 to PM-like liposomes with 5 mol% PI(4,5)P2 was set to 100 (shown as arbitrary units). (B) Relative 
binding of the indicated concentrations of GFP-STIM1C and GFP-STIM2C to PM-like liposomes containing 
5 mol% PI(4,5)P2. The dashed line shows the 95% confidence line and c.F.U. indicates the corrected 
fluorescence units. (C) Relative binding of 1 and 3 µm recombinant GFP-STIM1C (black bars) and GFP-
STIM2C (gray bars) to PM-like liposomes containing either 5 mol% PI(4,5)P2 or PI(3,4,5)P3. The error bars 
in all graphs show the standard error of the mean (n = 3). 
 
GFP-STIM1C and GFP-STIM2C did also bind to PI(4,5)P2-containing PM-like liposomes, with 
more efficient binding of GFP-STIM2C and less binding of GFP-STIM1C as compared to the 
binding of GFP-CSSIst2 (Figure 3.17A). With PC liposomes that contain 5 mol% PI(4,5)P2, 
binding of GFP-STIM1C and GFP-STIM2C was reduced 40- and 4-fold, respectively, as 
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compared to their binding to PM-like liposomes containing 5 mol% PI(4,5)P2. This suggests that 
other lipids than PI(4,5)P2 of the PM are absolutely essential for the binding of the STIM1 C-
terminus to the PM, whereas the STIM2 C-terminus is less selective with respect to PM lipids. 
In order to compare the affinities of the C-terminal domains of STIM proteins and CSSIst2 for 
PI(4,5)P2-containing PM-like liposomes, the KD values were measured. GFP-STIM1C had a KD 
of 8 ± 2 µM and GFP-STIM2C of 3.3 ± 0.8 µM (Figure 3.17B). Under similar conditions, a KD 
value for GFP-CSSIst2 was previously determined to be 12 ±3 µM (91). 
Many other proteins with polybasic clusters, e.g. small guanosine triphosphatases from the Ras, 
Rho, Arf and Rab subfamilies interact with PI(4,5)P2 and PI(3,4,5)P3 at the PM, arguing that 
these lipids play a ubiquitous role in regulating cellular signaling events (150). Therefore, the 
binding of GFP-STIM1C and GFP-STIM2C to PM-like liposomes containing 5 mol% PI(4,5)P2 or 
PI(3,4,5)P3 was compared. At 1 and 3 µM protein concentration, GFP-STIM1C had a clear 
preference for PI(4,5)P2-containing liposomes, whereas GFP-STIM2C showed similar binding to 
PI(4,5)P2- and PI(3,4,5)P3-containing PM-like liposomes (Figure 3.17C). Overall, the binding of 
GFP-STIM2C to PIP-containing liposomes was consistently stronger than the binding of GFP-
STIM1C under all conditions tested. 
The binding of STIM1C and STIM2C to PM lipids, and domains of the STIM C-termini, which 
are responsible for binding to liposomes were further investigated. For the CSSIst2, it was 
previously found that multimerization, which is mediated by the N-terminal part (90), is a 
prerequisite for binding to PI(4,5)P2-containing PM-like liposomes (91). Therefore, both coiled-
coil domains of GFP-STIM1C and GFP-STIM2C were deleted (see cartoon, Figure 3.18A). This 
deletion abolished binding of GFP-STIM1C completely, whereas the corresponding deletion in 
GFP-STIM2C had no effect (Figure 3.18B). GFP-STIM2C-ΔCC showed 62% more binding than 
GFP-STIM2C. In order to test whether the K-rich domains alone interacts with PM lipids, the 
coiled-coil and the P-rich domains were deleted. The resulting constructs contained GFP, the K-
rich domains and 10 additional N-terminal residues (GFP-STIM1 K-rich and GFP-STIM2 K-rich). 
Similar to GFP-STIM1C-ΔCC, no binding for GFP-STIM1 K-rich was observed, suggesting that 
multimerization of STIM1C is necessary for binding to PI(4,5)P2 at the PM. Surprisingly, GFP-
STIM2 K-rich showed 48% more binding than GFP-STIM2C (Figure 3.18B). This indicates that 
multimerization of STIM2 via the coiled-coil domains is not required for the interaction with PM 
lipids. On the other hand, the presence of the proline residue at the extreme C-terminus of the 
STIM1 K-rich domain may abolish the helix formation, thus binding to PM-lipids. In order to 
overcome this drawback, STIM1 may need to multimerize through its coiled-coil domains.  
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Figure 3.18 Contribution of different domains STIM1 and STIM2 to the lipid binding.  
(A) Cartoon of the general domain structure of the C-termini of STIM1 and STIM2. The top row shows the 
coiled-coil domains (CC), the CAD domain of STIM1 overlapping with the second CC, the proline-rich 
domain (P) and the lysine-rich domain (K). The bottom rows indicate which domains were deleted from 
GFP-STIM1C and GFP-STIM2C. (B) Relative binding of these constructs to PM-like liposomes containing 
5 mol% PI(4,5)P2. (C) YFP fluorescence of U2OS cells after transfection with YFP-STIM1EF, YFP-STIM1EF 
ΔK, YFP-STIM2EF and YFP-STIM2EF ΔK visualized by epifluorescence microscopy. 
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The K-rich domains of STIM1 and STIM2 are required for binding to PI(4,5)P2-containing PM-
like liposomes. GFP-STIM1C ΔK showed only background binding and the binding of GFP-
STIM2C ΔK was 10-fold reduced (Figure 3.18B). To test the function of the K-rich domains for 
recruitment of the ER to the PM in vivo, the contribution of these domains to the formation of 
ER-PM contacts was analyzed. As an assay, the localization of overexpressed and mutated 
versions of yellow fluorescent protein (YFP)-tagged STIM1 and YFP-STIM2 were analyzed. 
These proteins carry single point mutations in their EF-hand Ca2+-binding domains (YFP-
STIM1EF and YFP-STIM2EF), which result in their constitutive localization at puncta and patch-
like ER–PM contacts (113). Deletion of the K-rich domains of YFP-STIM1EF and YFP-STIM2EF 
abolished the formation of these ER-PM contacts and YFP-STIM1EF ΔK and YFP-STIM2EF ΔK 
remained at reticular ER (Figure 3.18C), confirming the results of the in vitro lipid binding data. 
3.2.3 Basic and hydrophobic residues are required for the function of the STIM2 lipid 
binding signal 
Previous experiments with Ist2 revealed that different lipids contribute to the interaction with the 
PM (91). Moreover, experiments showed that the function of the CSSIst2 depends on 
multimerization, basic residues and an amphiphatic α-helix with a hydrophobic patch of bulky 
side chains on one side of the α-helix (85). To test whether the basic residues and/or the 
hydrophobic patch contribute to the interaction of the STIM2 K-rich domain with lipids, the effect 
of different mutations in GFP-STIM2 K-rich in binding to PI(4,5)P2- or PI(3,4,5)P3-containing 
PM-like liposomes was analyzed. In order to analyze the effect of basic residues on lipid 
binding, two lysine residues were mutated into alanine. The mutations K718A and K719A had 
the strongest effect and reduced binding to PI(4,5)P2 and PI(3,4,5)P3 liposomes by 44 and 74%, 
respectively (Figure 3.19A). This reduction of binding suggests an electrostatic interaction 
between the K-rich domain of STIM2 and the negatively charged PIPs at the PM. 
By the insertion of an alanine residue in between L726 and F727 (L726-A-F727), the 
hydrophobic patch of the putative amphipathic α-helix was destroyed. This mutation conserved 
the helical structure but destroyed the amphipathic feature. In this case, the binding to PI(4,5)P2 
and PI(3,4,5)P3 liposomes reduced by 33 and 56%, respectively. This suggests that the 
positions of hydrophobic residues on one side of an α-helix contribute to the interaction between 
K-rich domain of STIM2 and lipids (Figure 3.19A).  
Moreover, if the K-rich domain of STIM2 forms an amphipathic α-helix, introduction of a proline 
residue is expected to interfere with helix formation. Therefore, the K729P mutation was created 
in GFP-STIM2 K-rich. Moreover, this mutation would mimic the sequence of the extreme C-
terminus of STIM1 K-rich domain (PLKK). With PI(4,5)P2-containing liposomes, this mutation 
reduced binding by 22% and with PI(3,4,5)P3 liposomes by 48% (Figure 3.19A).  
Overall, these data show that the K-rich domain of STIM2 recognizes PI(4,5)P2 and PI(3,4,5)P3 
at the PM and that the two distinct features of the STIM2 K-rich domain are important for 
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recognition of PM lipids. These features are a cluster of basic residues and a patch of 
hydrophobic residues located on one side of an amphipathic α-helix. 
 
Figure 3.19 Effect of mutations in the K-rich domain of STIM2 on lipid binding and localization 
at ER–PM contacts.  
(A) Relative binding of recombinant GFP-STIM2 K-rich and of GFP-STIM2 K-rich carrying the indicated 
mutations to PM-like liposomes with 5 mol% PI(4,5)P2 or PI(3,4,5)P3. (B) YFP fluorescence of U2OS cells 
after transfection with YFP-STIM2EF and YFP-STIM2EF carrying the indicated mutations visualized by 
epifluorescence microscopy. Representative cells for each phenotype are shown. 
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Finally, the effect of these mutations on the localization of YFP-STIM2EF was tested. Compared 
to YFP-STIM2EF, which localized at puncta and larger patches (Figures 3.18C and 3.19B), YFP-
STIM2EF (K729P) accumulated in smaller puncta with less patch formation. Interference with the 
postulated hydrophobic patch of the amphiphatic α-helix by the L726-A-F727 mutation had a 
stronger effect and led to a complete loss of patch formation, while the localization of YFP-
STIM2EF (L726-A-F727) changed into reticular ER (Figure 3.19B). A similar reticular localization 
was seen with YFP-STIM2EF (K718A, K719A).  
Taken together, these data suggest that the STIM1 and STIM2 K-rich domains bind lipids at the 
PM and thereby contribute to the formation of ER-PM contacts. 
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3.3  Trafficking of STIM1 to the cell surface is regulated by 
multiple signals 
 
Initial studies on STIM1 localization revealed that, STIM1 localizes to the cell surface of the 
stromal and mast cells (101, 102). However, the majority of the protein resides in the ER and 
functions during the SOCE by sensing the Ca2+ levels of the ER and forming ER-PM contact 
sites to activate Ca2+ channels at the PM.  
 
Unlike STIM2, STIM1 does not contain a di-lysine ER-retention signal at its extreme C-terminus 
(Figure 3.14B).  It is therefore unclear what kind of mechanisms retains STIM1 in the ER. I was 
interested in the regulation of STIM1 localization and the mechanisms that retain the protein in 
the ER. I found two types of signals that retain STIM1 in the ER. One of these signals is an 
arginine-based ER-retention signal, and the other is the K-rich domain, which is regulated by 
cytosolic Ca2+. Moreover, I further investigated the additional function of STIM1 on the cell 
surface.  
3.3.1  Di-arginine signals retain STIM1 in the ER 
 
In order to gain insight into the ER-retention mechanism of a STIM1, the protein was N-
terminally tagged with one HA epitope (Figure 3.20B). Previous studies showed that STIM1 
cannot reach the cell surface when a tag at the N terminus exceeds a certain size, e.g. that of 
GFP (141). Therefore, this small HA tag was chosen. If HA-STIM1 travels to the cell surface, 
the protein can be detected on the surface of nonpermeabilized cells, whereas detection of the 
ER-located pool requires membrane permeabilization (Figure 3.20B). Cotransfection of 
HEK293T cells with GFP and HA-STIM1 encoding plasmids revealed that under 
nonpermeabilizing conditions 26% of the GFP positive cells showed HA-STIM1 surface 
localization by fluorescence microscopy (Figure 3.20C lower panel). Under permeabilized 
conditions HA-STIM1 was detected in all GFP-cotransfected cells, which is consistent with its 
predominant ER localization (Figure 3.20C upper panel). Analysis by flow cytometry confirmed 
that 1% of the GFP-positive cells expressed HA-STIM1 on their surface (Figure 3.20D, left 
panel). To ensure specific surface localization, a conservative gating was chosen. This may 
explain the apparent differences in surface localization between immunofluorescence and flow 
cytometry data. 
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Figure 3.20 HA-STIM1 can reach the surface of HEK293T cells.  
(A) The domain structure of STIM1 (SS, signal sequence; EF-SAM, EF-hand and SAM domain; TMD, 
trans-membrane domain, CC, coiled-coil domain; CAD, CRAC activation domain; K, K-rich domain). 
Putative di-arginine signals are depicted and alignment of the K-rich region of human STIM1 and STIM2 is 
shown. Basic residues are shown in blue and the di-lysine ER-retention signal of STIM2 is high lighted. (B) 
Cartoon of membrane topology and intracellular distribution of STIM1. The HA-tag at the N terminus is 
shown as a red box. (C) Immunofluorescence of HEK293T cells co-expressing GFP (green) and HA-
STIM1 (red). The number of GFP-positive cells (in %) with HA-STIM1 staining under permeabilized and 
nonpermeabilized conditions are shown. (D) FACS profiles of HA-STIM1 (PE (R-Phycoerythrin)) and GFP 
(left) or HA-STIM2 and GFP (right) co-transfected HEK293T cells. The cut off for HA surface signal was 
set according to cells transfected with GFP and stained with HA antibodies. 
 
 
In comparison to HA-STIM1, HA-STIM2 was remained intracellular in all cells (Figure 3.20D, 
right panel). This is consistent with the presence of a di-lysine ER-retention signal at the 
extreme C terminus of STIM2. The function of the STIM2 K-rich domain as an ER-retention 
signal was further demonstrated by its transplantation to the C terminus of HA-STIM1, lacking 
its own K-rich domain (HA-STIM1∆K). This transplantation led to intracellular retention of HA-
STIM1∆K STIM2K (Figure 3.21).  
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Figure 3.21 STIM2 K-rich region prevents the surface expression of HA-STIM1.  
FACS profile of HEK293T cells co-expressing GFP and HA-STIM1∆K STIM2K.  
 
In a search for additional retention signals, four di-arginine consensus sites located in the 
cytosolic C terminus of STIM1 were found (Figure 3.20A). One di-arginine signal resides in the 
first coiled-coil domain (RSR311-313), one in the CAD (RER424-426), and two C-terminal of the 
CAD (RQR500-502 and RQR530-532). Since previous studies suggested that RER does not 
function as an efficient di-arginine retention signal (59), the analysis was performed on the other 
three signals. For this purpose, the critical two basic R residues were mutated to non-polar A 
residues. Mutation of RQR500-502 showed the strongest effect on retention, where 20% of the 
transfected cells expressed HA-STIM1 R500A on the cell surface (Figure 3.22A). Under 
nonpermeabilized conditions, HA-STIM1 R500A was detected in almost all cells at the surface 
by immunofluorescence (Figure 3.22B). Mutation of RSR311-313 and RQR530-532 had only 
minor effects with a two-fold increase of cells with HA-STIM1 on the surface as determined by 
flow cytometry. The combination of mutations did not enhance surface localization when 
compared to the single R500A mutation (Figure 3.22C).  
 
This suggests that the retention of STIM1 in the ER is achieved by multiple di-arginine signals 
with RQR500-502 being the most active signal.  
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Figure 3.22 Di-arginine signals retain STIM1 in the ER. 
(A) Quantification of the number of cells with HA-STIM1 and mutant HA-STIM1 on the cell surface 
analyzed by flow cytometry. Di-arginine signals were mutated (RXR to AXA) and the position of the first 
mutated R residue is indicated (R311A, R500A, R530A). (B) Immunofluoresence of nonpermeabilized 
HEK293T cells co-expressing GFP (green) and HA-STIM1 R500A (red). (C) Quantification of the number 
of cells with HA-STIM1 R500,530A and HA-STIM1 R311,500,530A on the cell surface analyzed by flow 
cytometry. 
 
 
Next, I investigated the effect of RQR500-502 mutation on formation of ER-PM contact sites. In 
order to investigate this effect, the ER Ca2+ stores were depleted by a drug, Thapsigargin (Tg), 
which blocks the Sarco/endoplasmic Reticulum Ca2+ ATPase (SERCA) that uptake the cytosolic 
Ca2+ into the ER (151). The depletion of Ca2+ stores by addition of Tg resulted in co-localization 
of HA-STIM1 and GFP-Orai1 in puncta (Figure 3.23A). Similarly, addition of Tg created puncta 
in cells co-expressing HA-STIM1 R500A and GFP-Orai1 (Figure 3.23B). This indicates that the 
mutation of RQR500-502 in STIM1 did not interfere with the recruitment of Orai1 into puncta.  
 
Moreover, I investigated the effect of R500A mutation on SOCE (Figure 3.23C). This was 
analyzed by Ca2+ imaging in HEK293T cells co-expressing HA-STIM1 R500A and Orai1. These 
cells were loaded with the Ca2+-sensitive dye FURA-2AM (acetoxymethyl ester) prior to 
imaging. The addition of 2 mM Ca2+ to Tg-treated cells resulted in rapid influx of extracellular 
Ca2+. As typically observed in SOCE, the addition of 50 µM 2-Aminoethyldiphenyl borate (2-
APB) abolished this Ca2+ influx (152). 2-APB is a drug that blocks SOCE by inactivating IP3 
receptors that release Ca2+ from the ER to the cytosol (153). It was also observed that the co-
expression of Orai1 reduced the amount of HA-STIM1 R500A at the cell surface (Figure 3.23D). 
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Taken together, this data suggests that R500A mutation does not affect the ER-PM contact site 
formation and SOCE. 
 
 
Figure 3.23 R500A mutation does not interfere with the function of STIM1.  
(A) Co-localization of GFP-Orai1 (green) and HA-STIM1 (red) or (B) HA-STIM1 R500A (red) in RPE-1 
cells without treatment or 10 min after addition of 0,5 µM Tg. The insert shows three-fold magnification of 
the indicated region. (C) FURA2-AM loaded HEK293T cells expressing Orai1 and HA-STIM1 or Orai1 and 
HA-STIM1 R500A were kept for 5 min in Ringer solution without Ca2+ (NCF, nominally Ca2+ free) before 
imaging. The ER-stores were depleted for 3 min by 1 µM Tg and the influx of Ca2+ was observed by 
adding Ringer solution containing 2 mM Ca2+. SOCE was blocked by adding 50 µM 2-APB in 2 mM Ca2+ 
containing Ringer solution. Images were acquired every 5 s for 15 min. (D) Quantification of the number of 
cells with HA-STIM1 R500A on the cell surface after co-transfection with GFP or Orai1. 
 
3.3.2 The flexible extreme N-terminus of STIM1 interferes with its localization to the cell 
surface 
 
Another difference between STIM1 and STIM2 in sequence structure was shown for their 
extreme N-termini. This region has been previously characterized as a flexible domain (111). In 
order to study the role of extreme N-terminus in trafficking of STIM1 to the cell surface, I 
generated a construct lacking this corresponding region, which is from amino acid L23 to H57 
(HA-ΔNext-STIM1). Strikingly, the cell surface expression of STIM1 was abolished as observed 
in flow cytometry analysis (Figure 3.24A). On the other hand, this deletion did not interfere with 
the formation of ER-PM contact sites. Upon addition of Tg, the protein was capable of forming 
puncta as similar as wild-type STIM1 (Figure 3.24B). 
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Figure 3.24 Deletion of extreme N-terminus of STIM1 abolishes its surface localization. 
(A) Immunofluorescence of RPE-1 cells expressing HA-ΔNext-STIM1 with and without the treatment of Tg. 
(B) FACS profile of HEK293T cells co-expressing GFP and HA-ΔNext-STIM1.  
 
3.3.3 The K-rich domain of STIM1 functions as an additional ER-retention signal, which 
is regulated by Ca2+/calmodulin 
 
As shown in aforementioned experiments, the K-rich domain of STIM1 can bind to PM-lipids. 
Moreover, independently, it was shown that the K-rich region of both STIM1 and STIM2 are 
capable of binding Ca2+/CaM in vitro (127). I was therefore interested in whether the K-rich 
region contribute to the ER-retention albeit having no KKXX signal.   
 
In order to test the effect of K-rich domain, I generated a construct lacking this domain (from 
R671 to K685) (HA-STIM1ΔK). Deletion of the K-rich domain resulted in an increased number of 
cells with STIM1 localization at the cell surface (Figure 3.25A and 3.26A). In nonpermeabilized 
conditions, 49% of HEK293T cells expressed HA-STIM1ΔK on the cell surface. Compared to 
the mutation of the di-arginine signal at position 500-502, the deletion of the K-rich domain had 
a weaker effect, however the combination of both mutations resulted in strong surface 
localization. Both in flow cytometry and immunofluoresence experiments this strong surface 
localization of HA-STIMΔK R500A was observed (Figure 3.25 B and C and 3.26A). 
 
Based on ER retention via the K-rich region and its interaction with Ca2+/CaM (127), I 
hypothesized that changes in cytosolic Ca2+ levels regulate the intracellular distribution of 
STIM1. In order to challenge this hypothesis, I depleted the cytosolic Ca2+ by addition of 2 mM 
EGTA to the media of the cells and incubated for one hour before the detection of HA-STIM1 at 
the surface by flow cytometry. This time would allow trafficking of HA-STIM1 to the cell surface. 
Addition of EGTA led to a two-fold increase of cells with HA-STIM1 on the surface (Figure 
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3.26B). This Ca2+-dependent increase in the number of cells with HA-STIM1 on the surface 
depends on the K-rich domain. Addition of EGTA to cells expressing HA-STIM1∆K did not 
significantly change the number of cells with surface expression (Figure 3.26B).  
 
 
 
Figure 3.25 Deletion of K-rich region targets STIM1 to the cell surface.  
 
(A) Immunofluorescence of HEK293T cells co-expressing GFP (green) and HA-STIM1ΔK (red) under 
permeabilized and nonpermeabilized conditions. The numbers indicate the percentage of cells with GFP 
and HA signals. (B) FACS profile of the cells co-expressing GFP and HA-STIM1∆K R500A. (C) 
Immunofluorescence of HEK293T cells co-expressing GFP (green) and HA-STIM1ΔK R500A (red) under 
nonpermeabilized condition.  
  
 
Next, in order to test whether the K-rich domain functions as Ca2+ sensor, a binding assay with 
a GFP-tagged C-terminal domain of STIM1 and CaM-coated beads was established. Binding of 
GFP-STIM1C to CaM-beads required Ca2+ and addition of EGTA abolished the interaction 
between STIM1 and CaM. On the other hand, the deletion of the K-rich domain reduced the 
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level of binding but fail to abolish it completely. This suggests the presence of additional 
Ca2+/CaM-binding sites (Figure 3.26C). 
 
 
Figure 3.26 K-rich, which is regulated by Ca2+/CaM binding, retains STIM1 in the ER. 
(A) Quantification of the number of HEK293T cells (in %) with HA on the cell surface after detection by 
flow cytometry in cells expressing HA-STIM1, HA-STIM1 R500A, HA-STIM1ΔK and HA-STIM1ΔK R500A. 
(B) In cells with HA-STIM1 or HA-STIM1ΔK after adding 2 mM EGTA for 1 h. (C) Binding of GFP-STIM1C 
and GFP-STIM1C ΔK to CaM beads in the presence of 1 mM CaCl2 or 0.5 mM EGTA. Unless stated 
otherwise this and all following CaM binding experiments were performed in 0.1% NP-40 and 150 mM 
NaCl buffer. The bound fraction corresponds to five times the amount of input and unbound fractions. 
 
Due to the observation of a high cell-to-cell variation between cells with STIM1 on the surface 
and cells with intracellular STIM1, the cytosolic Ca2+ levels of individual cells were monitored. A 
GFP-tagged version of the nuclear factor of activated T cells (NFAT) was used as a cell-based 
Ca2+ indicator. GFP-NFAT shuttles between the cytosol and the nucleus. It accumulates in the 
cytosol at low and in the nucleus at high concentrations of cytosolic Ca2+ (154). Under our 
experimental conditions, 42% of the transfected cells showed nuclear accumulation of GFP-
NFAT in medium (Figure 3.27A). A high cell-to-cell variation of GFP-NFAT distribution between 
the cytosol and the nucleus was observed in these cells. This cell-to-cell variation of the 
cytosolic Ca2+ may cause the observed differences in HA-STIM1 localization between individual 
cells. Control experiments showed that a decrease in cytosolic Ca2+ levels by addition of EGTA 
reduced the number of cells with GFP-NFAT in the nucleus to 20%, whereas an increase in 
cytosolic Ca2+ levels led to nuclear accumulation in 85% of Tg-treated cells (Figure 3.27B and 
C).  
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Taken together, these data suggest a regulated ER-retention mechanism, which is based on 
two types of signals: di-arginine retention signals and the Ca2+/CaM-binding K-rich domain. The 
latter senses the cytosolic Ca2+ levels and triggers the release of STIM1 from the ER. 
 
 
Figure 3.27 Cell-to-cell variation of cytosolic Ca2+ concentration. 
(A) HEK293T cells expressing GFP-NFAT (green) in normal medium conditions (DMEM/F12, 10% FBS, 2 
mM glutamine). The nuclei are stained with DAPI (blue). The bottom panels show a two-fold magnification 
of the indicated area and examples with nuclear (N) or cytosolic (C) GFP-NFAT staining are indicated. 
Hundred cells with GFP-NFAT accumulated in the nucleus or in the cytosol were counted and the 
percentage of cells with predominant nuclear signal is indicated. (B) Distribution of GFP-NFAT (green) in 
HEK293T cells after adding 2 mM EGTA for 30 min to the media. (C) Distribution of GFP-NFAT after 
addition of 0,5 µM Tg for 30 min to the media. The nuclei are stained with DAPI (blue).  
3.3.4  Store-operated Ca2+-entry interferes with STIM1 trafficking to the cell surface 
 
Based on increased STIM1 trafficking to the cell surface at low concentrations of cytosolic Ca2+ 
levels, I hypothesized that SOCE and subsequent increase in cytosolic Ca2+ reduces the 
trafficking of STIM1 to the cell surface (Figure 3.28A). The increase of cytosolic Ca2+ can be 
achieved by addition of Tg, thereby blocking the Ca2+ uptake into the ER. An additional increase 
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in cytosolic Ca2+ can be achieved by co-expression of Orai1 and promoting uptake of 
extracellular Ca2+ into the cell (Figure 3.28A). In order to test this, cells were treated for 1 h with 
Tg prior to the measurement of surface localized HA-STIM1 by flow cytometry. Tg treatment of 
cells expressing HA-STIM1 resulted in a two-fold reduction of the number of cells with HA-
STIM1 on the surface (Figure 3.28B). This Ca2+-dependent regulation of STIM1 distribution 
depends on the K-rich region. Tg had no effect on the cell surface localization of cells 
expressing HA-STIM1ΔK (Figure 3.28B). Next, HA-STIM1 and HA-STIM1∆K were cotransfected 
with Orai1. The addition of Tg induced contact site formation between the STIM1 variants and 
Orai1 resulted in Ca2+ influx, leading to a reduction of the number of cells with HA-STIM1 and 
HA-STIM1∆K on the surface (Figure 3.28C).  
 
Taken together, these data suggest that high cytosolic Ca2+ levels and direct interaction of 
STIM1 with Orai1 results in intracellular retention of STIM1, independent of its K-rich domain.  
 
 
Figure 3.28 Trafficking of STIM1 is regulated by cytosolic Ca2+ levels. 
(A) Cartoon describing the effect of an increase in cytosolic Ca2+ levels. In resting conditions, STIM1 can 
travel to the cell surface. Following addition of Tg and/or co-expression with Orai1, STIM1 is retained in the 
ER. The increasing gradient of yellow colour demonstrates the increase in cytosolic Ca2+ levels. 
Quantification of the number of HEK293T cells (in %) with HA on the cell surface after detection by flow 
cytometry in cells expressing: (B) HA-STIM1 and HA-STIM1ΔK without and with treatment with 1 µM Tg 
for 1 h. (C) HA-STIM1 and HA-STIM1ΔK as control, HA-STIM1 or HA-STIM1ΔK together with Orai1 
without and with treatment with 1 µM Tg for 1 h. (D) In cells co-expressing Kir6.2-HA-GFP and Sur1 or HA-
STIM1ΔK R500A and GFP. The cells were treated with 1 µg/ml BFA for 6 h before analysis by flow 
cytometry.  
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Next, I analyzed whether the trafficking of STIM1 to the cell surface is through Golgi. In order to 
investigate how STIM1 travels from the ER to the PM, the surface localization of HA-STIM1∆K 
500AQA in BFA-treated cells was analyzed. BFA-treatment reduced the number of cells with 
HA-STIM1∆K 500AQA on their surface three to four fold (Figure 3.28D). A control experiment 
with Kir6.2-HA-GFP and Sur1 showed a similar result, suggesting that STIM1 travels via the 
classical secretory pathway to the cell surface.  
 
3.3.5  Multiple Ca2+/CaM binding sites regulate the function of STIM1 
 
Since deletion of the K-rich domain did not completely abolish binding of STIM1 to Ca2+/CaM, 
the STIM1-Ca2+/CaM interaction was investigated in more detail. CaM can bind proteins through 
electrostatic and hydrophobic interactions (129). In order to test in which way CaM binds to 
STIM1, I performed two different binding conditions. In order to test the role of hydrophobic 
interactions, I performed the binding experiments in changing amounts of detergent (NP-40). 
The other condition was prepared to test the effect of electrostatic interactions and therefore I 
performed the binding experiments in different salt (NaCl) concentrations. Binding of GFP-
STIM1C and GFP-STIM1C ∆K to Ca2+/CaM was resistant to increasing amounts of detergent 
but sensitive to increased NaCl concentration (Figure 3.29A and B). This data indicated that 
Ca2+/CaM binds STIM1 via electrostatic interactions.  
 
Moreover, the contribution of electrostatic interaction was more pronounced in full-length GFP-
STIM1C than in GFP-STIM1C ∆K, supporting an important contribution of basic residues in the 
K-rich domain to binding of Ca2+/CaM.  
 
Although the importance of K-rich domain in binding to Ca2+/CaM was shown by decreased 
binding of GFP-STIM1C ΔK, the K-rich domain of STIM1 alone (last 25 amino acid residues) 
was not sufficient for binding (Figure 3.29C). On the other hand, the K-rich domain of STIM2 
alone was sufficient for binding to Ca2+/CaM (Figure 3.29C). In line with the lipid binding of 
STIM1 and STIM2, where STIM1 but not STIM2 requires its coiled-coil domains for binding to 
PI(4,5)P2, it is plausible that mutimerization of STIM1 is required for binding to Ca2+/CaM. 
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Figure 3.29 Binding of GFP-STIM1C and GFP-STIM1CDK to CaM beads in the presence 
different amounts of detergent and high salt. 
(A) Binding of GFP-STIM1C and GFP-STIM1C ΔK to CaM beads in a buffer (25 mM Tris/HCl pH 7.5, 150 
mM NaCl and 1 mM CaCl2) with increasing NP-40 concentration. (B) Binding of GFP-STIM1C and GFP-
STIM1C ΔK to CaM beads in a buffer (25 mM Tris/HCl pH 7.5, 0.1 % NP-40 and 1 mM CaCl2) with 
increasing NaCl concentration. (C) Binding of GFP-STIM1 K-rich domain and GFP-STIM2 K-rich domain to 
CaM beads in CaM buffer.  
 
In silico analysis of the STIM1 sequence by the calmodulin target database (130) revealed two 
putative CaM-binding sites (CaM-I and CaM-II) located in the evolutionary conserved CAD 
(Figure 3.30A). The polybasic region in CaM-I has been identified as a regulatory switch. It 
either binds Orai1 or interacts with an autoinhibitory domain in coiled-coil domain 1 of STIM1 
(131, 132). The latter interaction arrests STIM1 in a closed conformation under resting 
conditions (132). Multimerization of the coiled-coil domains upon a decrease in the levels ER 
Ca2+ extends the STIM1 structure allowing binding of the polybasic region to the acidic domain 
at the C-terminus of Orai1 (131, 132). It has been suggested that this conformational change 
opens the CRAC channel (132). 
 
As CaM recognizes a hydrophobic face of an α-helix with basic residues (129), I investigated 
whether CaM-I and CaM-II are required for binding to CaM beads. For this purpose the 
indicated hydrophobic residues or the lysine residues were mutated to alanine (Figure 3.30A). 
Both the hydrophobic residues (H1AA, H2AA, and combination of H1AAH2AA) and central 
polybasic residues (K3A) in CaM-I contributed to binding of GFP-STIM1C ∆K to CaM beads. 
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Mutation of the polybasic residues (reduction of binding by 84%, Figure 3.30C) had a stronger 
effect as compared to mutation of hydrophobic residues (reduction of binding by 50 to 68%, 
Figure 3.30B). This suggests the possibility that Ca2+/CaM binding to the polybasic sequence 
controls conformational changes in STIM1. Deletion of the entire CaM-I domain reduced binding 
by 85%, similar to mutation of the polybasic residues, but did not abolish binding to Ca2+/CaM 
completely (Figure 3.30D). This is consistent with the presence of a second CaM-binding site in 
STIM1∆K.  
 
 
Figure 3.30 STIM1 has at least two Ca2+/CaM binding sites. 
(A) Cartoon of STIM1 with acidic auto-inhibitory domain located in the first coiled-coil domain, two 
predicted CaM-binding sites (CaM-I, residues 373-395 in human STIM1) and (CaM-II, residues 409-427) in 
the second coiled-coil domain overlapping with CAD, and the K-rich domain. The amino acid sequences of 
CaM-I, CaM-II and K-rich domains of different vertebrates and drosophila are shown and conserved acidic 
residues of the auto-inhibitory domain are indicated in red, conserved hydrophobic residues (H1 and H2) 
of CaM-I in green, and conserved basic residues of CaM-I in blue. Introduced mutations of either 
hydrophobic or K residues to A in CaM-I are marked with stars. (B) Binding of GFP-STIM1C ∆K and GFP-
STIM1C ∆K with mutations of hydrophobic residues (H1AA, H2AA and H1AAH2AA) in CaM-I to CaM beads. 
The bound fraction corresponds to five times the amount of input and unbound fractions. The bound 
fractions were quantified and the amount of bound GFP-STIM1C ∆K was set to 100. (C) Binding of GFP-
STIM1C ∆K and GFP-STIM1C ∆K with mutations of basic residues (K3A) in CaM-I to CaM beads. (D) 
Binding of GFP-STIM1C ΔK with deletion of CaM-I (372-394) and deletion of the region covering both 
CaM-I and CaM-II domains (372-427) to CaM beads. 
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However, the deletion of a larger region covering CaM-I, CaM-II, and connecting residues 
stimulated binding to CaM beads to a level above binding of GFP-STIM1C ∆K (Figure 3.30D). 
This suggests that deletion of the regulatory switch domain may change the conformation of 
STIM1, which results in the exposure of additional CaM-binding sites.  
 
Taken together, this data indicates that multiple Ca2+/CaM molecules bind to STIM1 and may 
regulate its function. 
3.3.6 The cell surface pool of STIM1 activates Orai1  
 
Since STIM1 travels in a cytosolic Ca2+-regulated manner to the cell surface, it was of interest to 
investigate whether STIM1 fulfils an additional function at the PM. At resting conditions, in the 
absence of Tg, HA-STIM1∆K R500A localized in both reticular ER-like structures and in the PM 
(Figure 3.31A). This indicates that SOCE did not occur under these experimental conditions. 
Moreover, HA-STIM1∆K R500A was not retained in the ER by co-expression of Orai1 (Figure 
3.31B) as HA-STIM1 R500A was, suggesting that disruption of retention signals in STIM1 
weaken the interaction with Orai1 at puncta.  
 
In order to test the function of HA-STIM1ΔK R500A in SOCE, Ca2+ imaging experiments were 
performed. I found that the increase in cytosolic Ca2+ levels, upon 2-APB treatment, was weaker 
in cells co-expressing Orai1 and HA-STIM1∆K or HA-STIM1∆K R500A as compared to cells co-
expressing Orai1 and wild type HA-STIM1 (Figure 3.32A). Only half of the Tg-induced Ca2+-
influx was sensitive towards the SOCE inhibitor 2-APB, whereas in cells co-expressing wild type 
STIM1 and Orai1, Ca2+-influx was completely abolished by 2-APB (Figure 3.32A). These data 
suggest that surface-located HA-STIM1∆K and HA-STIM1∆K R500A function in an alternative 
Ca2+ influx process. Moreover, this SOCE-independent Ca2+ influx requires co-expression of 
Orai1. Co-expression of HA-STIM1∆K R500A with TRPC1 or TRPC4 Ca2+ channels did not 
generate Ca2+ influx (data not shown). Since Orai2 showed the same response to 2-APB, either 
with HA-STIM1∆K R500A or HA-STIM1 (data not shown) and Orai3 was activated by 2-APB 
(data not shown and (152)), it was not feasible to investigate whether surface STIM1∆K R500A 
controls Orai2 and Orai3 in a SOCE-independent manner. 
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Figure 3.31 HA-STIM1ΔK R500A localizes to reticular ER and to the cell surface. 
(A) RPE-1 cells were cotransfected with HA-STIM1ΔK R500A (red) and GFP-Orai1 (green). Upper panel 
shows the distribution of both proteins in permeabilized cells. Lower panel shows four times magnification 
of the indicated region. (B) Quantification of cell surface expression of HA-STIM1ΔK R500A on the surface 
after co-expression with GFP or Orai1. 
 
Based on the observed 2-APB-insensitive Ca2+ influx (Figure 3.32A), I hypothesized that 
surface located pools of HA-STIM1∆K and HA-STIM1∆K R500A recruit and open Orai1. A 
control experiment in RPE-1 cells showed that depletion of Ca2+ from the ER lumen by Tg 
resulted in accumulation of HA-STIM1∆K R500A and GFP-Orai1 in puncta, as seen in 
permeabilized cells (Figure 3.32B). However, the surface pool of HA-STIM1∆K R500A did not 
co-localize with GFP-Orai1 puncta (Figure 3.32B).  
 
This suggests the existence of two independent STIM1-Orai1 complexes: one between ER-
located STIM1 and Orai1 and the other one between cell surface-located STIM1 and Orai1.   
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Figure 3.32 The surface pool of STIM1 is not involved in SOCE and co-localizes with Orai1. 
(A) Ca2+ imaging of FURA2-AM loaded HEK293T cells expressing HA-STIM1, HA-STIM1ΔK or HA-
STIM1ΔK R500A together with Orai1. Cells were kept in NCF Ringer solution for 5 min before imaging. 
Cells were treated with 1 µM Tg in order to induce SOCE. 2 mM Ca2+ containing Ringer solution was 
applied to observe Ca2+ influx. The SOCE was inhibited by adding of 50 µM 2-APB. The HA-STIM1 and 
Orai1 curve was normalised to the curve of HA-STIM1ΔK and Orai1 for a better comparison. (B) 
Localization of HA-STIM1ΔK R500A (red) and GFP-Orai1 (green) in RPE-1 cells after treatment with 0.5 
µM Tg for 10 min. The upper panels show the co-localization at punctuate structures in a permeabilized 
cell, the middle panels show co-localization in a nonpermeabilized cell and the bottom panels show a four-
fold magnification of the indicated area.  
 
Focusing on the surface pool of HA-STIM1∆K R500A in nonpermeabilized cells revealed two 
phenotypes: even distribution of HA-STIM1∆K R500A and GFP-Orai1 over the entire PM or co-
localization of the two proteins in ill-defined domains of the PM (Figure 3.33). Co-localization of 
HA-STIM1K R500A and Orai1 under nonpermeabilized conditions suggests that surface located 
STIM1 and Orai1 can interact and mediate SOCE-independent Ca2+ influx. 
 
Figure 3.33  Different phenotypes of HA-STIM1ΔK R500A and GFP-Orai1 co-localizations. 
Localization of HA-STIM1ΔK R500A (red) and GFP-Orai1 (green) in nonpermeabilized RPE-1 cells. The 
lower panels and the magnified inserts show a cell where GFP-Orai1 and the HA-STIM1ΔK R500A co-
localize to yet unknown domains of PM. 
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4 Discussion 
 
In this study, I contributed to the understanding of the mechanistic features of the ER-PM 
contact site formation in mammalian cells and analyzed the ER retention mechanisms of STIM1 
in detail. First of all, I showed that the expression of transmembrane proteins with PM-lipid 
binding domains led to the formation of ER-PM contact sites. This principal is conserved in both 
yeast and mammalian cells. It was previously shown that Ist2 protein, which localizes to the 
cortical ER of yeast, makes contacts with the PM-lipids. The attachment of the lipid-binding 
domain of Ist2 (CSSIst2) to integral membrane proteins and their expression in mammalian cells 
resulted in the formation of ER-PM contact sites. The CSSIst2 can be replaced by phospholipase 
C-δ1 PH domain, which binds PI(4,5)P2 at the PM. Any ER membrane protein, used in this 
study, including CD4, MHC Class I heavy chain, Tap1 and Kir6.2, carrying a cytosolically 
exposed PM lipid-binding signal was capable of forming ER-PM contacts.  
 
The phenomenon of ER-PM contact site formation is observed in mammalian STIM proteins, 
which function in store-operated Ca2+ entry (SOCE). Mammalian cells express two STIM 
proteins, STIM1 and STIM2. These proteins are activated upon depletion of ER Ca2+ and form 
ER-PM contact sites, where they interact with and activate PM Ca2+ channels. In addition to 
their interaction with the channel protein, I demonstrated that both proteins are capable of 
binding PM lipids via their K-rich domains.  
 
Further analysis of the differences between STIM1 and STIM2 revealed that the localization of 
STIM2, which has the di-lysine ER retention signal, is restricted to the ER. On the other hand, 
STIM1 lacks this di-lysine signal and therefore can travel to the cell surface. However, in order 
to function in SOCE, STIM1 must be retained in the ER. To solve this puzzling phenomenon, I 
investigated STIM1 localization in detail and found two types of ER-retention mechanisms. In a 
search for additional ER-retention signals, I found multiple di-arginine signals that contribute to 
the retention of STIM1 in the ER. Moreover, I identified a role of the K-rich region in retention of 
STIM1. The K-rich region is capable of binding Ca2+/CaM and the levels of cytosolic Ca2+ 
regulated the ER-retention of STIM1. Trafficking of STIM1 to the cell surface required 
inactivation of the K-rich domain.  
 
4.1  Features required for ER-PM contact site formation 
 
In mammalian cells, the ER is capable of interacting with the PM. This interaction requires 
localization of an ER domain in close proximity to PM, which is around 6-25 nm (61, 62). These 
contact sites are dynamic and transient. They are formed and dissociated frequently. For 
instance in epithelial Vero cells, the rate of the ER movement towards or away from the PM is 
4.3–4.6 µm/second (155). By the help of artificial dimerizers, such as FKBP and FKBP-
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rapamycin binding (FRB) protein these contact zones can be stabilized (62). Besides formation 
of ER-PM contact sites by using these artificial dimerizers, the formation of ER-PM contact sites 
is observed under physiological conditions. During SOCE, STIM proteins, which reside in the 
ER membrane, associate with the PM-localized Orai1 Ca2+ channel, thereby forming ER-PM 
contact sites (61, 124). Interestingly, activated and/or overexpressed STIM1 is capable of 
forming ER-PM contact sites in the absence of Orai1 and this contact site formation is 
independent of its function in SOCE (62). This is consistent with the formation of ER-PM contact 
sites by overexpression of CSSIst2-tagged membrane proteins (94).  
 
The formation of ER-PM contact site in the absence of the PM localized Orai1, depends on the 
K-rich domain of STIMs (94). The formation of ER-PM contact sites was abolished in cells 
expressing YFP-STIM1EFΔK or YFP-STIM2EFΔK. Moreover, in this study, liposome-binding 
experiments clearly showed that C-terminal domains of STIM1 and STIM2 bind to PM-lipids. 
STIM2 C-terminus showed better binding to PM-lipids than STIM1 C-terminus. Moreover, the 
deletion of the K-rich domains demolished this interaction (94). These data suggest that the K-
rich domains of STIMs function as PM-lipid binding domains, as K-rich domain of CSSIst2 does 
(91, 94).  
 
The FRAP and FLIP experiments revealed that the ER-PM contact sites that are formed by 
expression of CSSIst2-tagged GFP-Kir6.2, are stable structures (94). This may be explained by 
the strong interaction of CSSIst2 with the PM-lipids.  
 
A PM-lipid binding signal should have two features, as it was previously demonstrated for the 
CSSIst2: a multimerization domain and a domain with multiple basic residues (K-rich) that 
interact with the PM-lipids. The multimerization domain of CSSIst2 is the N-terminal region of the 
signal and is composed of threonine, histidine and serine stretches (T/H/S-cluster). The function 
of this T/H/S-cluster can be replaced by another multimerization domain such as a leucine 
zipper (90). This suggests that multimerization and a certain distance between ER and PM are 
required for the function. The C-terminal part of the CSSIst2 consists of basic residues and an 
amphipathic α-helix. In a mutational analysis, it was shown that the basic residues upstream of 
the α-helix and the hydrophobic residues in the α-helix are crucial for the function of CSSIst2 
(85). Interestingly, in vitro liposome-binding experiments showed that STIM2 K-rich domain 
alone is capable of binding to PM-lipids, whereas STIM1 K-rich domain is not. STIM1 but not 
STIM2 needs its coiled-coil multimerization domain to interact with PM-lipids. With respect to 
the requirement of an extra multimerization domain, CSSIs2 and STIM1 are different than 
STIM2. The putative amphipathic α-helix of STIM2 may insert its hydrophobic patch to the lipid 
bilayer much more efficiently than the helices of CSSIst2 or STIM1. Moreover, the hydrophobic 
patch of STIM2 by itself may drive multimerization, which promotes the binding to lipids. On the 
other hand the reason of the inability of STIM1 K-rich domain to bind to PM-lipids may be due to 
the presence of proline residues. The very C-terminal proline residue may result in kinking or 
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breaking the α-helix and therefore abolish the formation of a functional α-helix (156). STIM1 
therefore might severely need its multimerization domain, which consists of two coiled-coil 
domains after the TMD (Figure 4.1), or other unknown factors in cells for interaction with PM-
lipids.  
 
Moreover, the concentration of a protein with the PM-lipid binding domain is of significant 
importance for the formation of ER-PM contact sites. The overexpressions of the STIM2C- or 
CSSIst2-tagged proteins led to the formation of ER-PM contact sites (94). This may be due to 
overexpression, which can promote the multimerization state of these proteins. The necessity of 
a multimerization domain for lipid binding might be explained by the avidity effect. The avidity of 
proteins can be described as the combined strength of multiple bond interactions. The affinity of 
a protein to another protein or to lipid is explained by the strength of a single bond, whereas in 
avidity, the combined synergistic bond strength is required (157). For instance, without 
multimerization and formation of multiple bonds, the protein with a PM-lipid binding signal can 
still interact with the PM-lipid but this interaction is not stable (158). Thus, via multimerization, 
many binding interactions are formed and thus transient unbinding of a single site does not 
allow the protein to diffuse away (157). At the same time, the phosphoinositides of the PM 
(PI(4,5)P2 and PI(3,4,5)P3) may be clustered by the interactions with these proteins, which in 
turn increases the strength of the binding as observed in other proteins carrying a membrane 
deforming BAR domain (159).  
 
The exact mechanism of the ER-PM contact site formation remains elusive. However, there are 
several plausible scenarios. One is based on the dynamic feature of the ER. As ER makes 
transient contacts with the PM, the proteins that localize at the contact sites may stabilize the 
ER-PM connection through their PM-lipid binding domains. Supporting this idea, it was shown 
that under resting conditions, STIM1 can appear in the ER-PM contact sites without being 
activated, and leading to the opening of the Orai1 channel (62). Moreover, according to the 
study of Wu et al., which was based on the TIRF and electron microscopy (EM) experiments in 
Jurkat T cells, two thirds of the ER-PM contact sites were shown to exist before store depletion, 
whereas only one third of the ER-PM contact sites were found to be newly formed upon store 
depletion (61). Furthermore, upon STIM1 overexpression both pre-existing and newly formed 
ER-PM contact sites are elongated in length, suggesting that STIM1 functions as a stabilizer of 
these specific domains (61, 62). Moreover, by EM, overexpressed STIM1 was shown to localize 
pre-cortical ER domains (160). These domains differ from the rest of the ER, since they are 
localized close to the PM but do not form contacts with the PM. Upon activation of STIM1, these 
ER domains make contacts with the PM, creating the cortical ER (160).  
 
STIM1 stabilizes the pre-existing ER-PM contact sites upon activation and multimerization. 
However, the mechanism of the formation of new ER-PM contact sites by recruitment of a 
deeper ER domain to the PM is still unclear. One possibility to create a newly formed ER-PM 
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contact site may occur by the contribution of COPI. COPI has been identified to function in 
retrograde transport from the Golgi to ER (57, 58). Besides its role in retrograde transport, COPI 
promotes vesicle budding from the ER membrane in vitro (161) and localizes to certain ER 
subdomains in mammalian cells (162). Consistently, Lavieu et al. showed that the di-lysine 
signal of Ist2 binds to COPI and knockdown of α or β-COP by siRNA destroys the formation of 
ER-PM contact sites (95). The interaction of Ist2 di-lysine signal with COPI may contribute to 
the localization of CSSIst2-tagged proteins to the specific domains of ER, which can be readily 
recruited to the PM.  
 
CSSIst2-tagged proteins and STIM1 are shown to localize to specific ER domains, but how are 
these domains recruited to the PM? A possible answer to this question may be the contribution 
of microtubules to peripheral transport of the ER. STIM1 was shown to interact with the 
microtubule (+)-end-binding protein, EB1. Through this interaction and growing of the 
microtubules, the STIM1 molecules, which are localized in the deeper ER, may reach to the PM. 
However, in the same study, it was shown that in Hela cells, microtubule growth-dependent 
localization of STIM1 is not necessary for activation of SOCE upon depletion of ER Ca2+ stores 
(25). On the other hand, silencing of EB1 by shRNA destroyed the CSSIst2-dependent formation 
of ER-PM contact sites, but a direct interaction of Ist2 with EB1 was not shown (95). 
Interestingly, β-COP, which is a component of COPI complex, was initially identified as a 
microtubule binding protein at the Golgi (163). Therefore, binding of microtubules to the COPI, 
which interacts with the CSSIst2, may promote the recruitment of specialized ER domains to the 
PM. Moreover, as di-lysine signals, the di-arginine signals were previously shown to bind β-
COP (164). A similar interaction may occur between STIM1 and β-COP. This may in turn result 
in binding to microtubules, which may drag the ER to the PM. This interaction between STIM1 
and β-COP, which may further the understanding of ER-PM contact site formation, remains to 
be elucidated.  
4.2  Regulation of ER-PM contact site formation 
 
In order to interact with Orai1 and the PM-lipids, STIMs initially has to undergo conformational 
changes, which start with the multimerization of the N-termini. This multimerization extends to 
the C-terminal coiled-coil domains and continues with possible exposure of the channel binding 
(CAD) and the lipid-binding (K-rich) domain (103, 114, 115, 120). Under resting conditions, 
although STIM1 appears in the ER-PM contact sites, it remains inactive (62). This suggests that 
without a conformational change upon ER Ca2+ store depletion, only the presence of STIM1 in 
close proximity to PM is not sufficient to induce Ca2+ influx. Consistent with an inactive STIM1 
molecule at resting state, it was shown that STIM1 exists as a dimer in vitro and the multimer 
formation is required for the activation of the Orai1 channel (115, 165).  The Ca2+ uptake into 
the cell is strictly regulated, since very high cytosolic Ca2+ levels can result in apoptosis (166). 
Therefore, the activation and inactivation of STIM1 should be under tight control. In this section, 
Discussion 
 90 
I discuss the regulation of STIM1 activation, which in turn regulates the formation of ER-PM 
contact site formation. 
 
It has been shown that a polybasic stretch in CAD, which interacts and activates the Orai1 at 
the ER-PM contact sites, interacts with a negatively charged amino acid stretch in the first 
coiled-coil domain of STIM1. This domain is named auto-inhibitory domain and the interaction of 
this domain with CAD, keeps STIM1 inactive, probably in a conformation where CAD is shielded 
(123, 132). I found that this polybasic stretch binds to Ca2+/CaM. This may suggest that 
Ca2+/CaM binding regulates the transition of STIM1 from inactive (bound to auto-inhibitory 
domain) to the active state (bound to Orai1). Moreover, in Ca2+/CaM binding experiments, I 
found that the deletion of both K-rich domain and the polybasic stretch in CAD did not abolish 
the binding of Ca2+/CaM. This may suggest existence of other CaM-binding domains, which 
could become accessible upon a conformational change. During initiation of the SOCE and 
multimerization of STIM1, the auto-inhibitory domain is released from the CAD and the C-
terminal domain goes into an extended conformation (132, 167). This conformational change 
might promote binding of Ca2+/CaM to CAD and to yet undefined sites in STIM1. Moreover, 
these interactions of STIM1 with Ca2+/CaM may in turn keep the protein in an extended 
conformation to allow binding of STIM1 K-rich domain to PM lipids and CAD to Orai1.  
 
Moreover, by using isotermal calorimetry and nuclear magnetic resonance approaches Bauer et 
al. showed that synthetic peptides of STIM1 and STIM2 K-rich domains bind Ca2+/CaM (127). In 
this study, I used purified GFP-tagged STIM1 C-terminal fragments and investigated their 
interactions with CaM-coated beads. This binding of STIM1 C-terminal fragments to CaM-beads 
required Ca2+. I observed that the binding of GFP-STIM1CΔK to CaM-beads is reduced, 
suggesting a role of K-rich domain in binding Ca2+/CaM. However, STIM1 K-rich domain alone 
(GFP-STIM1 K-rich) was not able to bind Ca2+/CaM, whereas STIM2 K-rich domain alone (GFP-
STIM2 K-rich) showed binding. Similar as for binding to PM-lipids, STIM1 may need its 
multimerization domain to bind Ca2+/CaM, whereas STIM2 does not. Thus, in physiological 
conditions, the oligomerization of STIM1 may control binding to Ca2+/CaM or to PM-lipids. There 
are two alternative explanations for the interplay between Ca2+/CaM and PM-lipids in binding to 
K-rich domains of STIMs. First, Ca2+/CaM may bind to the K-rich domain during activation of 
STIM1 in SOCE. This binding of Ca2+/CaM may promote formation of an amphipathic α-helix 
(130), which in turn promotes binding of STIM1 K-rich domain to PM-lipids. Second, contrarily, 
the binding of Ca2+/CaM may abolish the binding of STIM1 K-rich domain to PM-lipids. This may 
promote dissociation of ER-PM contact sites, thus termination of SOCE. In addition, Orai1 was 
shown to be inactivated by binding of Ca2+/CaM to its N-terminus (133). Interestingly, this 
Ca2+/CaM binding domain of Orai1 overlaps with a putative PI(4,5)P2 binding domain 
(unpublished data). This suggests that Ca2+/CaM and PM-lipids regulate the functions of both 
STIM1 and Orai1. This striking feature needs to be clarified by further experiments. Moreover, 
since the higher-order states of STIM1 either in resting state or in activated state during SOCE 
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is not fully described (108), it remains to be answered under which state of STIM1 the binding of 
Ca2+/CaM takes place.  
 
Based on these results I suggest the following model for the initiation of SOCE: the Ca2+/CaM 
molecules bind STIM1 to keep it in an extended conformation. The binding of Ca2+/CaM to CAD 
will abolish the inhibitory effect of the autoinhibitory domain and prepare the CAD for the 
interaction with the Orai1 C-terminus. On the other hand the binding of Ca2+/CaM to the K-rich 
domain may promote formation of an α-helix, thus binding to PM-lipids. Taken together, at the 
ER-PM contact sites, negatively charged phosphoinositides can replace Ca2+/CaM at the K-rich 
domain and the C-terminal acidic region in Orai1 substitutes Ca2+/CaM at the CAD (Figure 4.1). 
 
 
Figure 4.1 Proposed role of Ca2+/CaM during activation of STIM1 in SOCE. 
The Ca2+/CaM molecules may bind STIM1 in its resting state (dimeric STIM1 is depicted but the 
oligomerization state of STIM1 under resting condition is not yet defined). This binding keeps STIM1 in a 
conformation, where the di-arginine signal at position 500RQR is exposed and functional. By depletion of 
ER Ca2+, STIM1 forms higher-order oligomers. This conformational change promotes binding of additional 
Ca2+/CaM to CAD and yet undefined regions. STIM1 molecules then travel to the ER-PM contact sites and 
recruit Orai1. Orai1 forms tetrameric channel and this channel is activated by interaction of STIM1 CAD 
with C-terminal domain of Orai1. At ER-PM contact sites Ca2+/CaM is released from CAD and K-rich 
domain, enabling STIM1 interaction with Orai1 and PM-lipids (PI(4,5)P2). 
 
 
Furthermore, the mechanism of Orai1 recruitment to the ER-PM contact sites is also crucial for 
the activation of SOCE. It was shown that the channel is activated after the formation of ER-PM 
contact sites (62). This may suggest that STIM1 initially interacts with the PM-lipids and then 
with newly recruited Orai1. But how is Orai1 recruited to the ER-PM contact sites? One possible 
answer may be an association of Orai1 with lipid microdomains in the PM. Orai1 cytosolic N-
terminus has a putative overlapping PI(4,5)P2 and cholesterol binding domain (unpublished 
data). This feature of Orai1 might determine its specific lipid environment in the PM. It was also 
shown that Orai1 and STIM1 cluster in the detergent resistant domains of the PM, so called 
rafts (168, 169). Rafts contain cholesterol and sphingolipids and as well phospholipids such as 
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PI(4,5)P2 (170). A proposed scenario therefore may be that sequestration of PI(4,5)P2 by STIM1 
results in recruitment of surrounding PI(4,5)P2, which contain Orai1 via lateral diffusion (171).  
 
4.3  Importance of ER-retention signals in STIM proteins 
 
A prerequisite for the function of SOCE is that STIM proteins must be retained in the ER. In this 
study, I identified di-arginine (RXR) ER-retention signals in STIM1. The identity of the residue X 
modulates the efficiency of the signal, where negatively charged residues or small, non-polar 
side chains inactivates the signal (59). STIM1 has four arginine signals at positions 311RSR, 
424RER, 500RQR and 530RQR. In addition, STIM2 has three potential di-arginine signals at 
positions, 303RLR, 428RER and 514RSR. The RER signal has been previously shown not to 
function as ER-retention signal. Moreover the N- and C-terminal residues around the signal 
affect the strength of the retention (59). In addition to the di-arginine signals, STIM2 has a di-
lysine retention signal, whereas STIM1 lacks this di-lysine signal. Differences in the retention 
mechanisms of STIM1 and STIM2 may contribute to their physiological roles. A phylogenetic 
analysis showed that the STIM genes duplicated in fishes during chordate evolution (172). 
Further sequence alignment analysis suggested, that the di-lysine signal emerges in STIM2-like 
molecules after duplication, whereas all STIM1-like molecules lack this signal (R. Bhardwaj, 
unpublished data).  
 
I focused on the retention of STIM1, since it was previously shown that this protein travels to the 
cell surface (101, 102). This suggests that STIM1 can escape from the retention under certain 
circumstances. In surface expression studies, I found that the 500RQR functions as the most 
active di-arginine ER retention signal compared to the others. The other signals had minor 
effects on the retention and this may be a consequence of their positions within the STIM1 C-
terminal domain. The 311RSR resides in the coiled-coil domain and may be not accessible to 
the COPI machinery, which is responsible for retention. The 530RQR on the other hand is not in 
the coiled-coil domain but the surrounding amino acids are either acidic or non-polar in nature, 
which may affect the efficiency of the signal. I did not investigate the 424RER signal, which 
resides in CAD, as this kind of signal was previously shown to be inactive (59). The most active 
signal, 500RQR, is located downstream of the coiled-coil domains. Therefore, multimerization 
through the coiled-coil domains might not mask this signal. The existence of more than one di-
arginine signals may suggest an alternative function. One possible function may be the 
interaction with COPI. COPI may bind to 311RSR and 530RQR at the ER and promote the 
formation of STIM1 specific ER domains, which are readily recruited to the PM, as in the case of 
Ist2 (95, 162).  
 
The function of STIM2, which has a di-lysine signal and potential di-arginine signals, is 
restricted to the ER. Brandman et al., has shown that the STIM2 EF-hand domain is more 
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sensitive to drop of Ca2+ in the ER lumen than that of STIM1 (113). In addition to its more 
sensitive EF-hand domain, I showed that STIM2 has higher affinity to PM-lipids than STIM1 by 
in vitro liposome-binding experiments. Moreover, STIM2 can interact both with PI(4,5)P2 and 
PI(3,4,5)P3, whereas STIM1 only interacts with PI(4,5)P2 (94). Since STIM2 is activated faster 
than STIM1 upon Ca2+ decreases in the ER lumen and since it has higher affinity to PM-lipids 
than STIM1, the function of STIM2 has to be restricted to the ER. The activation of STIM2 but 
not STIM1 upon subtle decrease of ER Ca2+ levels suggests that STIM2 refills cytosolic and ER 
Ca2+ upon small changes rather than amplifying signals as STIM1 does (113).  
 
4.4  Regulated trafficking of STIM1 to the cell surface 
 
In addition to di-arginine signals, I found that the K-rich domain of STIM1 contributes to its 
retention in the ER. The deletion of the K-rich domain promotes the trafficking of STIM1 to the 
cell surface. How could the K-rich domain without a di-lysine signal contribute to the retention of 
STIM1? There are two likely answers to this question. First, the interaction with the lipids might 
favour the retention in the ER. However, the lipid binding would occur after depletion of ER-
stores and this can only explain why STIM1 does not travel to the cell surface upon depletion of 
the ER Ca2+ stores. Second, during resting conditions, a cytosolic trigger might affect the K-rich 
domain, which in turn keeps the protein in a conformation where the di-arginine signals are 
exposed and functional. The idea of having a cytosolic trigger arose from the finding that not all 
cells express STIM1 on their cell surface. Cell surface expression was not dependent on the 
concentration of the protein but indeed required a triggering factor. I observed differences in 
cytosolic Ca2+ levels between cells by using NFAT localization as reporter for cytosolic Ca2+ 
concentration. The observed cell-to-cell variation of NFAT localization suggested that the 
cytosolic Ca2+ levels regulate the distribution of STIM1. This was also supported by additional 
experiments where the depletion of cytosolic Ca2+ by addition of EGTA increased the number of 
cells expressing STIM1 on the surface. Consistently, localization of STIM1, which was lacking 
its K-rich domain, was not affected by the depletion of cytosolic Ca2+. This suggests that the K-
rich domain may function as a sensor for cytosolic Ca2+.  
 
The next question emerged was: how does the K-rich domain sense the cytosolic Ca2+? The K-
rich domain in addition to binding PM-lipids is capable of binding Ca2+/CaM (94, 127). This 
binding of Ca2+/CaM might enable STIM1 to sense the cytosolic Ca2+ indirectly. At low cytosolic 
Ca2+ levels, the Ca2+ unbound CaM might be released from STIM1 and this may result in a 
conformational change where the di-arginine ER-retention signal is masked. This in turn 
promotes the trafficking of STIM1 to the cell surface. Moreover, Brefeldin A treatment, a drug, 
which blocks trafficking through Golgi (66), revealed that the trafficking of HA-STIM1ΔK R500A 
to the cell surface occurs through Golgi. 
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However, this trafficking of STIM1 to the cell surface should take place during subtle changes of 
cytosolic Ca2+ levels so that the ER stores are not affected. In other words, STIM1 N-terminus 
should be bound to the Ca2+ in the ER and the protein should not multimerize through its N-
terminus. Since multimerization of the N-terminus promotes accumulation at the ER-PM contact 
sites. On the other hand, a multimerization that is restricted to the C-termini of STIM1 may mask 
the di-arginine signal and promote trafficking to the cell surface (Figure 4.2).  
 
4.5  Possible function of STIM1 at the cell surface 
 
In initial studies it was found that STIM1 localizes to the cell surface (101, 102). Latter studies 
however, focused on the function of STIM1 pool, which stays in the ER (61, 103, 104, 114, 115, 
120). In this study, I was interested in the function of STIM1 pool, which localizes to the cell 
surface.  
 
The Ca2+ imaging experiments with STIM1∆K and STIM1∆K R500A, which lacks all retention 
signals, showed that the expression of these mutants lead to 2-APB resistant Ca2+ influx. 2-APB 
is a drug, which blocks SOCE, by inactivating the IP3 receptors in the ER (152). Under the same 
conditions Orai1-dependent Ca2+ influx, which was triggered by single STIM1 R500A mutant or 
wild type STIM1, was 2-APB sensitive. This suggests that either the K-rich domain is required 
for 2-APB mediated termination of SOCE or that the surface pool of mutant STIM1 interacts with 
Orai1 and thereby forms a 2-APB resistant Ca2+ channel. The latter is supported by partial co-
localizations of surface STIM1 and Orai1 in structures that are different from the Tg-induced 
puncta, typically observed during SOCE. Since with biochemical methods, such as surface 
biotinylation, it is not possible to discriminate between surface- and ER-located STIM1 (61), it 
remains open whether surface-located STIM1∆K and STIM1∆K R500A can directly bind Orai1. 
 
A surface function of STIM1 has been suggested for the store-independent arachidonate-
controlled (ARC) heteromeric Orai1/Orai3 Ca2+ influx channel (139). This channel is activated by 
arachidonic acid, which is a polyunsaturated fatty acid derived from PI(4,5)P2, however 
physiological function of the channel is yet undefined (140, 173). Antibodies targeting the 
extracellular N-terminal domain of STIM1 or mutation of a N-linked glycosylation site, which 
abolished cell surface expression of STIM1, abrogated ARC channel activity (140).  
 
Until now, it was proposed that STIM2 functions in Ca2+ uptake both for refilling of the stores 
and for signal amplification, whereas STIM1 only functions in the latter mechanism. According 
to the results presented here, I suggest that STIM1 is also capable of functioning in stabilizing 
basal Ca2+ levels. This alternative function of STIM1 does not take place at the ER-PM contact 
sites as it does for STIM2 but rather occurs at the cell surface. If STIM2 is sufficient to fine-tune 
the basal Ca2+ levels, why STIM1 should have a similar function? Differential expression levels 
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of these proteins in different cell lines may provide an explanation. Although STIM1 and STIM2 
are ubiquitously expressed, there are variations in their expression levels (174). For example 
naive CD4+ T cells express much less STIM2 than STIM1 (110). Furthermore, the function of 
STIM1 in basal regulation of Ca2+ levels may be conserved during evolution. Ancestral STIM 
molecules, which exist before gene duplication and emerging of STIM2-like molecules, may use 
their surface function to uptake of Ca2+ into the cytosol. Moreover, this surface function in 
controlling Ca2+ homeostasis might be conserved until today as a redundant safety mechanism 
in cells where the function of STIM2 is reduced or lost.  
 
Taken together, STIM1 senses changes in Ca2+ levels in the ER and cytosol, allowing this 
sensor to respond over a wide range of Ca2+ signals. Besides activation during SOCE by a 
dramatic decrease in Ca2+ in the ER lumen, subtle changes in cytosolic Ca2+ levels promote 
surface localisation of STIM1, thereby allowing it to perform additional functions, such as 
refilling the Ca2+ stores and/or as initially suggested, interacting with ligands or receptors of 
lymphocytes (101).  
 
 
 
Figure 4.2 Proposed model for trafficking of STIM1 to the ER-PM contact sites or to the cell 
surface. 
During resting state, where the STIM1 N-terminus is bound to Ca2+, a decrease in cytosolic Ca2+ levels 
may release Ca2+ unbound CaM from the K-rich domain. This release of CaM, might promote a 
conformational change where the di-arginine signal at position 500RQR is shielded. STIM1 can then travel 
to the cell surface through Golgi and at the cell surface it may activate Ca2+ channels such as Orai1. The 
left part of the figure is described in Figure 4.1. 
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Although this study revealed many interesting findings, one limitation of the analysis of the 
localization of STIM1 and its mutants was the choice of cell type. In this study I used either 
HEK293T or RPE-1 cells due to the fact that they have good transfection efficiencies and are 
large enough to differentiate the intracellular structures by standard light microscopy. Additional 
functions of STIM1 in immune cells, in which STIM1 has a signal amplification function, remain 
to be identified. Moreover, in order to further analyze the function of STIM1 on the cell surface, 
and its interacting channels, electrophysiological approaches are required. 
 
In summary, my PhD thesis reveals the mechanistic features of the ER-PM contact site 
formation in mammalian cells and expands our understanding of the additional functions of 
STIM1. I demonstrate here that the expression of transmembrane proteins with PM-lipid binding 
domains lead to the formation of ER-PM contact sites. STIM1, one of the PM-lipid binding 
proteins, remains in the ER by two types of mechanisms. One is retention by di-arginine signals; 
the other is retention by high cytosolic Ca2+. STIM1 on the cell surface may interact with Orai1 
or other yet unidentified channels in order to uptake Ca2+ into the cytosol. In addition to its 
known function as Ca2+ sensor of the ER lumen, I propose that by binding to Ca2+/CaM, STIM1 
senses cytosolic Ca2+ levels as well. Thus, STIM1 functions for the integration of Ca2+ signals in 
the cytosol and the ER. 
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5 Appendix 
 
Standard Solutions and Buffers 
 
10X PBS 
For 1 l 
80 g NaCl 
2.0 g KCl 
14.4 g Na2HPO4 
2.4 g KH2PO4 
 
1X PBS-T 
For 1 l 
100 ml  10X PBS 
0.05%  Tween-20 
 
10X TAE 
 
For 1 l 
48.4 g  Tris base 
11.4 ml  glacial acetic acid 
3.7 g  EDTA, disodium salt 
 
2× SDS-Loading buffer 
100 mM Tris-HCl pH 6.8 
20 %  Glycerol (v/v) 
4 % SDS (w/v) 
100 mM  DTT 
0.08 % Bromphenolblue (w/v) 
 
SDS-Running buffer 
25 mM  Tris-HCl 
192 mM  Glycine 
0.1 %  SDS 
 
 
Coomassie stain  
0.2 %  Coomassie® Brilliant Blue 
R250  
7 % Acetic acid 
50 %  Ethanol 
 
Destain solution  
7 %  Acetic acid 
50 %  Methanol 
 
10x Blotting buffer 
For 1l 
30.3 g (= 0.25 M) Trizma base  
144 g (= 1.92 M) Glycine  
 
LB-medium:  
For 1l 
10 g  bacto-tryptone 
5 g  yeast extract 
5 g  NaCl 
pH 7.5 
 
Mowiol 
6 g   glycerol 
2.4 g   Mowiol 
6 ml  dH2O 
12 ml   0.2M Tris pH 8.5 
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